Vandetanib	MAP4K5	450.0
Lestaurtinib	SgK110	120.0
Tozasertib	SgK110	530.0
Tozasertib	AXL	210.0
Fedratinib	ABL1(Y253F)-phosphorylated	56.0
PKC412	SGK3	1400.0
Lestaurtinib	TEC	1200.0
PI103	PIK3CA(M1043I)	3.0
Bosutinib	EPHA8	9.0
Dasatinib	YSK1	3400.0
SB 203580	EGFR(L858R)	1900.0
Doramapimod	EPHB2	440.0
Fedratinib	CHEK1	3800.0
MLN8054	RSK1(Kin.Dom.1-N-terminal)	4800.0
Erlotinib	JNK3	4300.0
KW2449	CSF1R	120.0
Bosutinib	MP2K5	8.2
Masitinib	EGFR(L747-E749del,A750P)	800.0
GDC-0879	TGFBR1	4900.0
Nilotinib	RAF1	3900.0
Fedratinib	ERK8	510.0
Foretinib	MAP3K3	4800.0
PKC412	MARK4	370.0
RAF 265	FLT3(K663Q)	730.0
Alvocidib	EGFR(L747-S752del,P753S)	2200.0
Erlotinib	EPHA5	710.0
Barasertib	CSK	3800.0
R406	PRKR	180.0
Dasatinib	SRC	0.21
KW2449	MP2K5	120.0
Alvocidib	RSK2(Kin.Dom.1-N-terminal)	1000.0
PKC412	CAMK2G	140.0
Enzastaurin	MET(Y1235D)	8400.0
Canertinib	EPHA6	270.0
KW2449	CLK1	64.0
Barasertib	EGFR(G719C)	120.0
Neratinib	INSR	3000.0
Tozasertib	DAPK3	9900.0
Bosutinib	TYK2(JH1domain-catalytic)	6500.0
Dasatinib	EGFR(L861Q)	110.0
PHA-665752	NEK2	600.0
RAF 265	FLT3	1400.0
Doramapimod	MKNK1	6300.0
Gefitinib	ABL2	1600.0
GSK461364	RIOK1	3400.0
Brivanib	LOK	220.0
Neratinib	NEK3	2400.0
Pictilisib	ICK	9300.0
Dasatinib	DMPK	1300.0
Neratinib	EGFR(L858R,T790M)	27.0
Tozasertib	ROS1	610.0
Tozasertib	LKB1	1300.0
Foretinib	EGFR(S752-I759del)	1100.0
PKC412	BRSK1	1200.0
NVP-TAE684	ABL1(F317L)-phosphorylated	19.0
Ruxolitinib	MELK	2200.0
Ruxolitinib	ALK	1500.0
Dovitinib	KKCC1	3100.0
R406	MK12	390.0
SNS-032	MKNK1	3800.0
KW2449	RPS6KA4(Kin.Dom.1-N-terminal)	2200.0
Tozasertib	AURKB	7.4
R406	ABL1(Y253F)-phosphorylated	1800.0
Vandetanib	MERTK	1400.0
Nilotinib	CSK	2400.0
Ruxolitinib	SBK1	1300.0
Brivanib	MAP4K4	590.0
Dovitinib	GAK	490.0
Tozasertib	M3K12	190.0
Neratinib	FLT3(D835H)	4600.0
Erlotinib	FLT3(ITD)	820.0
Nintedanib	TNK2	1600.0
Dasatinib	KIT(L576P)	0.57
NVP-TAE684	GRK7	360.0
NVP-TAE684	FGFR4	110.0
Foretinib	LOK	0.5
KW2449	KPCD3	780.0
R406	TIE2	310.0
Sunitinib	IKKA	520.0
Motesanib	FLT3(D835H)	4500.0
NVP-TAE684	TAK1	160.0
Linifanib	DDR1	58.0
Fedratinib	NUAK1	34.0
Lestaurtinib	ICK	39.0
RAF 265	HCK	1200.0
Linifanib	MET(Y1235D)	2600.0
Fedratinib	FGFR4	2000.0
Tofacitinib	ABL1(H396P)-phosphorylated	6700.0
Foretinib	JNK3	3900.0
GSK1838705A	DCLK1	4100.0
Barasertib	CDK16	6300.0
Lestaurtinib	NUAK1	3.7
Foretinib	MUSK	13.0
Pazopanib	FLT3(D835Y)	810.0
GSK1838705A	ERBB4	2400.0
Doramapimod	FLT4	7100.0
PHA-665752	LCK	320.0
PI103	PIK3CA(H1047Y)	3.4
PKC412	RIOK3	420.0
Alvocidib	EPHA5	3500.0
PI103	FLT3(ITD)	7200.0
Gefitinib	EGFR(E746-A750del)	0.5
Afatinib	DYRK1B	2800.0
Lestaurtinib	PCTK2	720.0
PHA-665752	CSF1R	700.0
Vandetanib	PGFRA	230.0
Sunitinib	M3K13	95.0
Dasatinib	TAK1	3700.0
PHA-665752	YES	1400.0
PLX-4720	MLTK	41.0
VX-745	MK11	74.0
Nintedanib	CLK4	18.0
Barasertib	CIT	5700.0
KW2449	CLK3	6200.0
Tofacitinib	SNARK	240.0
Gefitinib	CHK2	800.0
Ki20227	FLT3(N841I)	4200.0
BI-2536	ABL1-phosphorylated	3500.0
Nilotinib	KIT(V559D)	46.0
SNS-032	CDKL2	41.0
R406	LOK	70.0
NVP-TAE684	PGFRB	150.0
Barasertib	ANKK1	1500.0
Foretinib	CDKL3	4400.0
Foretinib	DDR2	3.6
Dasatinib	FGFR3	3900.0
Nilotinib	TRKC	600.0
Lestaurtinib	MELK	26.0
GSK1838705A	TAOK1	3300.0
R406	KIT(A829P)	3.5
Erlotinib	ALK	1200.0
NVP-TAE684	ABL1(M351T)-phosphorylated	95.0
Dovitinib	KIT(V559D,V654A)	3.1
Vandetanib	ABL1-phosphorylated	16.0
Fedratinib	TIE1	700.0
Nintedanib	DDR1	12.0
MLN8054	EGFR(L858R)	3200.0
Nintedanib	PHKG2	260.0
Tozasertib	PGFRB	310.0
KW2449	FLT3(N841I)	13.0
PLX-4720	RIPK1	5100.0
Foretinib	STK33	98.0
Bosutinib	ABL1(Q252H)-nonphosphorylated	0.09
R406	TGFBR1	2600.0
NVP-TAE684	PI42C	2300.0
GSK461364	NEK9	1100.0
PLX-4720	KIT(V559D)	38.0
Lestaurtinib	DDR2	400.0
Barasertib	KIT(L576P)	34.0
Alvocidib	PIM2	770.0
Alvocidib	JNK3	5500.0
Alvocidib	RSK1(Kin.Dom.1-N-terminal)	2300.0
R406	STK36	230.0
Ruxolitinib	DYRK2	3700.0
BI-2536	SYK	4700.0
Linifanib	AURKC	71.0
NVP-TAE684	RET(M918T)	140.0
Sunitinib	RPS6KA5(Kin.Dom.2-C-terminal)	1700.0
Crizotinib	RET(V804L)	2100.0
Alvocidib	RPS6KA4(Kin.Dom.1-N-terminal)	1300.0
Vandetanib	SRMS	1900.0
Nilotinib	PGFRB	73.0
Ki20227	KIT	0.7
NVP-TAE684	CLK2	82.0
Lestaurtinib	KPCD	240.0
Doramapimod	MK12	2.9
Neratinib	SLK	66.0
Tozasertib	TAK1	2300.0
Alvocidib	MKNK2	3200.0
NVP-TAE684	PRP4	7600.0
Lestaurtinib	YANK3	8000.0
Linifanib	DMPK2	8300.0
Canertinib	FLT3(N841I)	2400.0
Fedratinib	RIOK3	91.0
Dasatinib	RAF1	570.0
Dovitinib	ABL1(Q252H)-nonphosphorylated	75.0
NVP-TAE684	ABL1(H396P)-nonphosphorylated	73.0
Neratinib	ABL1(Q252H)-phosphorylated	6000.0
PHA-665752	FLT3	250.0
Crizotinib	SIK2	200.0
Canertinib	MP2K7	110.0
Sunitinib	SIK1	3200.0
Lestaurtinib	MAP4K4	23.0
Ki20227	EGFR(G719C)	2600.0
Brivanib	FGFR3	160.0
Foretinib	KIT	2.5
RAF 265	RIPK2	950.0
Lestaurtinib	NDR1	220.0
AC220	VGFR2	87.0
KW2449	SRC	2800.0
NVP-TAE684	KCC2D	570.0
Imatinib	KIT(A829P)	15.0
Tozasertib	MAP4K5	83.0
GSK1838705A	AXL	300.0
AC220	FLT3	1.3
Sorafenib	KIT(D816V)	310.0
Pictilisib	HIPK3	600.0
RAF 265	RET(V804M)	89.0
Tozasertib	EPHA4	4300.0
PKC412	STK33	190.0
KW2449	SBK1	580.0
Erlotinib	ABL1(F317L)-phosphorylated	150.0
Lestaurtinib	BMPR1B	57.0
R406	ULK1	14.0
Crizotinib	SBK1	1300.0
BI-2536	CDK4-cyclinD3	1900.0
Canertinib	KIT(D816V)	3900.0
NVP-TAE684	RSK2(Kin.Dom.1-N-terminal)	17.0
R406	RET(V804M)	3.1
Sunitinib	AAK1	11.0
Sorafenib	HIPK2	1700.0
MLN8054	YES	260.0
Gefitinib	MKNK1	290.0
Doramapimod	KIT	170.0
Canertinib	MLTK	1200.0
GSK461364	KPCI	5800.0
Linifanib	LTK	550.0
KW2449	EGFR(T790M)	560.0
NVP-TAE684	CASK	920.0
Neratinib	CHK2	850.0
NVP-TAE684	CAMK1D	230.0
Foretinib	RIPK4	900.0
Foretinib	MAP4K5	4.0
Tozasertib	HCK	6200.0
Pictilisib	CAMK1	4700.0
MLN8054	TIE1	1600.0
R406	M4K3	2400.0
Lestaurtinib	MKNK2	1.4
RAF 265	YSK4	54.0
RAF 265	GCN2(Kin.Dom.2,S808G)	55.0
KW2449	EPHA2	1500.0
Nintedanib	JAK1(JH2domain-pseudokinase)	4.8
Neratinib	MAP3K4	39.0
Tozasertib	MLK1	390.0
NVP-TAE684	ANKK1	9400.0
NVP-TAE684	NDR2	580.0
R406	MARK1	270.0
Bosutinib	ERBB4	26.0
Sunitinib	JAK1(JH2domain-pseudokinase)	49.0
BI-2536	ALK	160.0
Bosutinib	PKNB(M.tuberculosis)	5500.0
Barasertib	FLT3(ITD)	140.0
Pazopanib	TAOK2	1800.0
Sunitinib	GRK1	290.0
Nintedanib	STK35	810.0
Canertinib	KIT(L576P)	5700.0
NVP-TAE684	MAP4K4	970.0
Foretinib	TAOK1	3700.0
Afatinib	SLK	3700.0
Barasertib	RIPK5	3000.0
Nintedanib	MAP4K5	390.0
Crizotinib	EGFR(G719C)	2700.0
PKC412	FLT3(D835H)	6.8
PLX-4720	KIT(L576P)	400.0
Pazopanib	KIT	2.8
Crizotinib	TIE2	270.0
R406	HIPK3	3200.0
GSK 690693	KPCD3	990.0
Fedratinib	FGFR3(G697C)	760.0
Foretinib	PI42C	28.0
PLX-4720	DCLK1	8100.0
NVP-TAE684	YANK1	13.0
R406	ULK3	7.1
Erlotinib	FLT3(K663Q)	1300.0
Tozasertib	BLK	2200.0
Bosutinib	LTK	3000.0
Alvocidib	CLK3	1600.0
Vandetanib	ALK	2100.0
Sorafenib	AURKB	440.0
Fedratinib	JNK3	200.0
Ki20227	YSK4	2400.0
Canertinib	AURKB	4200.0
Bosutinib	FES	330.0
PKC412	MET(M1250T)	2100.0
GSK461364	SNARK	23.0
KW2449	FGFR2	850.0
Tozasertib	BMPR2	7100.0
Dovitinib	KPCT	3200.0
R406	EGFR(T790M)	72.0
PHA-665752	ULK2	1500.0
Fedratinib	CAMK2B	6800.0
Alvocidib	DRAK2	1900.0
KW2449	FAK2	760.0
Canertinib	MKNK1	260.0
R406	TAK1	49.0
Pazopanib	YES	5000.0
Pictilisib	HIPK4	5000.0
Sorafenib	AXL	4500.0
Gefitinib	PIM3	5800.0
Crizotinib	EPHB6	6.0
Ki20227	FLT3(ITD)	2200.0
Erlotinib	FRK	2000.0
Doramapimod	ABL1(Y253F)-phosphorylated	8500.0
Nintedanib	RET(V804L)	9.8
Neratinib	FYN	6400.0
Sunitinib	DYRK1B	2300.0
Selumetinib	EGFR(T790M)	2200.0
KW2449	CAMKK2	470.0
Dovitinib	S6K1	570.0
Nintedanib	FES	1200.0
Sunitinib	GAK	20.0
NVP-TAE684	TNNI3K	2000.0
Ki20227	CSK	2500.0
Foretinib	HIPK4	0.5
Foretinib	MRCKA	660.0
Sunitinib	PAK6	2400.0
Lestaurtinib	IKKB	12.0
Alvocidib	KIT(D816V)	4600.0
R406	DYRK2	470.0
Doramapimod	ABL1(H396P)-nonphosphorylated	3300.0
Vandetanib	FLT3(N841I)	1200.0
Lestaurtinib	GRK7	7.2
Erlotinib	PRKR	1300.0
Dovitinib	AMPK-alpha2	820.0
Tozasertib	MARK1	4900.0
Motesanib	FYN	2800.0
BI-2536	CAMK2B	4200.0
Tozasertib	MLK3	680.0
PHA-665752	KIT(V559D)	2500.0
Crizotinib	VGFR1	2300.0
Tofacitinib	RSK1(Kin.Dom.2-C-terminal)	1400.0
Lestaurtinib	KIT(A829P)	35.0
Brivanib	TNIK	160.0
Bosutinib	ABL1-phosphorylated	0.06
Nintedanib	KPCT	5500.0
Dasatinib	M3K13	5300.0
Nintedanib	MINK	82.0
Dovitinib	CSNK2A1	2600.0
R406	FGFR4	350.0
PI103	PIK3CA(Q546K)	1.5
Neratinib	CSK	550.0
NVP-TAE684	ACVR2A	2200.0
Lestaurtinib	CSNK2A2	970.0
R406	MP2K3	100.0
Bosutinib	TYK2(JH2domain-pseudokinase)	4500.0
Gefitinib	DCAMKL3	2900.0
Sorafenib	LOK	150.0
Fedratinib	M3K2	580.0
Bosutinib	CDK14	1400.0
PHA-665752	MAP4K2	3600.0
Motesanib	KIT(V559D,V654A)	23.0
Sunitinib	EPHB4	3100.0
Sorafenib	TGFBR2	6900.0
Canertinib	EPHB2	2700.0
KW2449	VGFR2	120.0
Sorafenib	FLT3(R834Q)	17.0
NVP-TAE684	NEK2	1800.0
VX-745	CSF1R	2600.0
Lestaurtinib	MUSK	4100.0
Bosutinib	AAK1	2300.0
Vandetanib	MKNK2	1700.0
NVP-TAE684	KPCD1	80.0
GSK1838705A	RSK1(Kin.Dom.1-N-terminal)	410.0
Afatinib	EGFR(E746-A750del)	0.1
Dovitinib	FGFR3(G697C)	370.0
Alvocidib	DYRK1A	77.0
R406	RIOK1	340.0
Gefitinib	ERK3	1600.0
Fedratinib	M4K3	1800.0
Dovitinib	GSK3B	350.0
Foretinib	RAF1	4400.0
Lestaurtinib	CDKL5	10.0
R406	RIPK2	970.0
Sunitinib	MP2K3	1700.0
Linifanib	FLT3(K663Q)	1.3
Afatinib	MK14	1300.0
Pazopanib	MAP4K5	3000.0
Foretinib	MP2K5	2.5
Enzastaurin	AMPK-alpha2	5000.0
Erlotinib	FGR	1100.0
Tozasertib	WEE2	4200.0
Lestaurtinib	FLT3(K663Q)	5.4
PKC412	KIT(D816H)	16.0
Sunitinib	RSK1(Kin.Dom.1-N-terminal)	140.0
PKC412	CAMK1	2000.0
Doramapimod	MINK	310.0
PKC412	AURKB	62.0
Foretinib	CDC2L5	210.0
Sunitinib	MST1	19.0
NVP-TAE684	FGFR3	95.0
Sunitinib	PKNB(M.tuberculosis)	87.0
Lestaurtinib	MAP4K2	4.7
Sunitinib	FER	1100.0
PLX-4720	NEK2	5000.0
Sorafenib	EPHA3	1900.0
Fedratinib	CAMK2G	540.0
Bosutinib	CSNK1D	240.0
Vandetanib	RSK4(Kin.Dom.2-C-terminal)	240.0
SB 203580	CSNK1A1L	1700.0
NVP-TAE684	KPCD2	160.0
Sunitinib	KPCD1	310.0
PI103	MYLK	1500.0
Sunitinib	MAP3K15	1300.0
PHA-665752	M3K2	5200.0
Barasertib	ABL1(F317L)-nonphosphorylated	1400.0
Erlotinib	AURKC	600.0
NVP-TAE684	KIT(V559D,T670I)	130.0
R406	EGFR(E746-A750del)	1100.0
Crizotinib	EPHA2	100.0
SNS-032	ERK8	120.0
NVP-TAE684	PIP5K1A	9700.0
PLX-4720	FLT3(K663Q)	2300.0
PHA-665752	DDR2	7600.0
Barasertib	EGFR(L858R)	980.0
Bosutinib	CSNK1A1L	2600.0
Nintedanib	CAMK1	5900.0
Bosutinib	HUNK	5000.0
Canertinib	EGFR(L747-S752del,P753S)	0.26
Nintedanib	LATS2	380.0
Tozasertib	ABL1(M351T)-phosphorylated	5.3
PHA-665752	TIE1	1200.0
Crizotinib	RIPK4	2100.0
MLN8054	CLK2	3200.0
Sorafenib	CDK14	2900.0
Alvocidib	S6K1	3700.0
Doramapimod	CDK11	200.0
Neratinib	ERBB2	6.0
Nintedanib	MUSK	590.0
Doramapimod	KIT(A829P)	1400.0
Bosutinib	NUAK1	5900.0
NVP-TAE684	CDK2	5200.0
Neratinib	SYK	5100.0
SNS-032	MELK	5600.0
Neratinib	M4K1	93.0
RAF 265	EPHB6	43.0
Selumetinib	EGFR(L747-E749del,A750P)	3000.0
Pazopanib	PLK4	290.0
MLN8054	EPHA6	580.0
PHA-665752	CAMK1	2100.0
Barasertib	HIPK3	2500.0
Dovitinib	GCN2(Kin.Dom.2,S808G)	250.0
PHA-665752	MERTK	1300.0
Tozasertib	CDC2L2	260.0
Ruxolitinib	MP2K2	4000.0
PLX-4720	ABL1(H396P)-phosphorylated	5000.0
R406	INSR	1100.0
Crizotinib	ABL1(M351T)-phosphorylated	97.0
PKC412	MAP4K5	1100.0
Lestaurtinib	CDK4-cyclinD1	30.0
Nilotinib	JNK3	2000.0
NVP-TAE684	STK33	3.2
Tozasertib	DRAK1	9000.0
R406	NEK6	6.3
Lestaurtinib	NEK5	5600.0
Lestaurtinib	MK03	9800.0
R406	HIPK2	4800.0
PKC412	LRRK2	570.0
KW2449	MLTK	580.0
Fedratinib	EPHB2	3900.0
Nintedanib	M3K12	140.0
Crizotinib	ACVR1	440.0
Nintedanib	YSK4	5.2
Brivanib	ABL1(E255K)-phosphorylated	580.0
Erlotinib	EPHA6	440.0
R406	ABL1(T315I)-nonphosphorylated	670.0
R406	HIPK1	820.0
KW2449	MET	170.0
Lestaurtinib	EGFR(E746-A750del)	400.0
Canertinib	HCK	4200.0
Ruxolitinib	PLK1	130.0
Neratinib	FLT3	5400.0
PLX-4720	FLT3(D835H)	6100.0
Linifanib	KIT	2.0
Pazopanib	SLK	240.0
NVP-TAE684	MARK2	44.0
BMS345541	KPCD1	4600.0
NVP-TAE684	PLK1	20.0
Dasatinib	RET	730.0
Linifanib	PGFRA	4.2
Dovitinib	CSNK2A2	200.0
Lestaurtinib	CAMKK2	15.0
KW2449	ABL1(M351T)-phosphorylated	19.0
Sunitinib	MKNK1	3900.0
NVP-TAE684	OSR1	48.0
Pazopanib	JNK1	2000.0
R406	MLK1	4.3
Dovitinib	CDKL2	180.0
Lestaurtinib	CLK1	9.6
Sunitinib	STK33	17.0
RAF 265	FGFR1	4700.0
Pictilisib	TTK	4300.0
PLX-4720	BLK	1100.0
Vandetanib	KIT(D816H)	420.0
Neratinib	MST2	58.0
Bosutinib	PLK2	960.0
PHA-665752	NIM1	8700.0
Fedratinib	TAOK2	760.0
Erlotinib	ABL2	200.0
PHA-665752	CSNK1D	4200.0
Barasertib	DDR1	1800.0
SGX523	JNK3	1900.0
Nintedanib	MST3	110.0
Ruxolitinib	YSK4	270.0
Tozasertib	BMX	2600.0
RAF 265	YES	940.0
GDC-0879	CIT	3500.0
Tozasertib	FLT3	6.5
Fedratinib	CDK15	8600.0
Nintedanib	ULK1	340.0
NVP-TAE684	STK35	260.0
Lestaurtinib	MST1R	8200.0
Tofacitinib	ROCK2	420.0
PKC412	GAK	380.0
PI103	PIK3CA(H1047L)	3.2
PHA-665752	FLT3(ITD)	58.0
Gefitinib	RPS6KA4(Kin.Dom.2-C-terminal)	1200.0
KW2449	FER	1100.0
R406	PAK1	260.0
Dasatinib	FLT3(D835H)	8100.0
Linifanib	CDK16	2800.0
Lestaurtinib	TGFBR1	120.0
Bosutinib	ERBB2	2500.0
Fedratinib	ABL1(Q252H)-phosphorylated	54.0
NVP-TAE684	FGFR2	250.0
Dovitinib	CIT	8200.0
Foretinib	DYRK2	2000.0
Canertinib	CSNK1D	4600.0
NVP-TAE684	FGR	120.0
Linifanib	SLK	450.0
PKC412	MP2K3	5300.0
PKC412	RPS6KA5(Kin.Dom.1-N-terminal)	240.0
Bosutinib	TAK1	100.0
Lestaurtinib	EPHA6	1200.0
R406	BMX	180.0
Fedratinib	PLK2	2400.0
Lestaurtinib	MST4	230.0
Pazopanib	ABL1(Q252H)-nonphosphorylated	530.0
Lestaurtinib	ITK	290.0
PKC412	JNK1	4400.0
PKC412	DMPK	3800.0
Sunitinib	RSK3(Kin.Dom.1-N-terminal)	17.0
Neratinib	YSK4	16.0
PKC412	GRK1	85.0
Pazopanib	PIK4CB	960.0
KW2449	FGR	440.0
Imatinib	PI42C	380.0
Nintedanib	DRAK2	670.0
Tozasertib	MKNK2	5200.0
Barasertib	IRAK3	7900.0
NVP-TAE684	MAP4K2	190.0
Sorafenib	ABL1(F317I)-phosphorylated	4900.0
Barasertib	EPHB6	50.0
Masitinib	ABL1(Q252H)-nonphosphorylated	6.0
Vandetanib	CIT	1800.0
GSK 690693	PAK2	270.0
Linifanib	CLK1	8900.0
R406	CAMK1D	200.0
Sunitinib	RET(M918T)	19.0
Brivanib	FLT4	56.0
SB 203580	MRCKB	2700.0
SNS-032	CDC2L1	98.0
Pictilisib	DYRK1B	3800.0
Bosutinib	MINK	3.2
Dovitinib	HIPK1	4200.0
Tozasertib	TAOK2	430.0
NVP-TAE684	FLT4	170.0
Bosutinib	EGFR(L858R)	23.0
Nintedanib	PAK7	1300.0
Canertinib	LOK	1900.0
Tozasertib	BMPR1B	1100.0
Selumetinib	EGFR(L858R)	8000.0
Dovitinib	MARK1	2300.0
Vandetanib	ERK3	1500.0
BMS345541	PKNB(M.tuberculosis)	2400.0
Foretinib	INSR	210.0
R406	NDR1	9400.0
Foretinib	TNK2	200.0
Lestaurtinib	CDK9	530.0
Bosutinib	ULK2	450.0
PKC412	HIPK4	950.0
Sorafenib	EPHA7	5300.0
Fedratinib	EPHA4	4000.0
Nintedanib	IGF1R	62.0
KW2449	MP2K6	820.0
Sunitinib	RET	13.0
Pazopanib	FES	1400.0
Tofacitinib	CAMK1D	1600.0
Lestaurtinib	FGFR1	310.0
GSK1838705A	TAK1	4700.0
Tozasertib	ALK	3100.0
R406	KIT(V559D,T670I)	11.0
Lestaurtinib	STK33	26.0
Crizotinib	FRK	2900.0
BI-2536	PLK1	0.2
Fedratinib	EPHA2	4400.0
Linifanib	RIPK1	2800.0
GSK1838705A	MYLK	11.0
Erlotinib	LOK	19.0
Lestaurtinib	PLK4	1.5
Lestaurtinib	MYLK2	56.0
MLN8054	TEC	730.0
Lestaurtinib	SIK3	120.0
Imatinib	ABL1(Q252H)-nonphosphorylated	1.8
Tozasertib	FER	4200.0
RAF 265	MLTK	63.0
Enzastaurin	AKT3	1000.0
Vandetanib	EPHB6	76.0
PHA-665752	ABL1-nonphosphorylated	2600.0
NVP-TAE684	YSK1	7700.0
NVP-TAE684	MP2K2	630.0
NVP-TAE684	ACVR1B	97.0
Barasertib	FLT3(D835Y)	670.0
Selumetinib	EGFR(L747-S752del,P753S)	5300.0
Canertinib	FRK	3400.0
Dasatinib	KIT(D816V)	2.6
Fedratinib	CLK4	2000.0
Barasertib	RET(M918T)	120.0
Lestaurtinib	LIMK1	1600.0
Erlotinib	EGFR(L861Q)	1.2
Crizotinib	RIPK1	1600.0
Foretinib	TIE1	0.8
Vandetanib	ABL2	69.0
Erlotinib	YSK4	25.0
Lestaurtinib	RIPK4	13.0
BMS345541	IKKA	1700.0
Crizotinib	SRPK1	1800.0
Lestaurtinib	CLK4	3.0
Linifanib	AURKB	390.0
Pazopanib	LIMK1	720.0
Sunitinib	MST2	56.0
Dasatinib	HCK	0.35
KW2449	CSNK2A1	1200.0
Masitinib	ABL1(F317I)-phosphorylated	78.0
Foretinib	ROCK2	1800.0
Bosutinib	TLK1	570.0
Fedratinib	KIT(V559D,T670I)	1500.0
R406	RSK1(Kin.Dom.1-N-terminal)	490.0
PHA-665752	TIE2	6700.0
Masitinib	DDR1	8.7
Tozasertib	MERTK	1700.0
Nintedanib	ACVRL1	4200.0
Ruxolitinib	ABL1(Q252H)-phosphorylated	3500.0
RAF 265	EPHA4	8900.0
Pazopanib	IRAK1	5900.0
Nintedanib	IRAK3	5300.0
Tozasertib	LIMK1	2600.0
Gefitinib	EGFR(T790M)	40.0
Bosutinib	JAK2(JH1domain-catalytic)	1100.0
PKC412	MP2K6	6500.0
SB 203580	SIK3	3900.0
Lapatinib	ERBB3	5500.0
NVP-TAE684	ERK5	48.0
MLN8054	ABL1(H396P)-phosphorylated	940.0
Dovitinib	RIPK1	320.0
MLN8054	TIE2	300.0
Ruxolitinib	BRAF	2200.0
R406	RSK2(Kin.Dom.1-N-terminal)	8000.0
Bosutinib	ABL1(F317L)-phosphorylated	0.03
Fedratinib	MLK2	6900.0
PKC412	PKAC-beta	240.0
Ruxolitinib	ABL1(F317L)-nonphosphorylated	9500.0
GSK461364	CAMK2G	1300.0
Canertinib	TESK1	3200.0
Nintedanib	M4K1	35.0
Sunitinib	CAMK1D	510.0
Dasatinib	JAK3(JH1domain-catalytic)	640.0
BI-2536	ABL1(F317L)-phosphorylated	2400.0
NVP-TAE684	ERK8	210.0
Dovitinib	MP2K1	520.0
Tozasertib	KIT(V559D,V654A)	2300.0
Erlotinib	MET(M1250T)	2800.0
Ki20227	ABL1(F317I)-phosphorylated	1300.0
Dasatinib	EPHA3	0.09
Tozasertib	JNK3	2800.0
Nintedanib	TTK	22.0
R406	EGFR(L858R,T790M)	61.0
NVP-TAE684	SRC	280.0
Alvocidib	ERK8	330.0
NVP-TAE684	NIM1	2600.0
Imatinib	KIT(D816H)	560.0
Linifanib	MYLK2	2800.0
SB 203580	MK09	130.0
BI-2536	HUNK	9700.0
BI-2536	SLK	4100.0
NVP-TAE684	MLK2	1100.0
PKC412	M4K3	120.0
Crizotinib	ABL1(Y253F)-phosphorylated	74.0
Pazopanib	JAK2(JH1domain-catalytic)	1700.0
Ruxolitinib	KIT(A829P)	6300.0
NVP-TAE684	CHEK1	44.0
Alvocidib	JAK3(JH1domain-catalytic)	1600.0
VX-745	DDR1	1100.0
Bosutinib	EGFR(L747-E749del,A750P)	29.0
Bosutinib	CTK	5800.0
PHA-665752	TRKB	800.0
Bosutinib	MST2	370.0
R406	JAK3(JH1domain-catalytic)	36.0
NVP-TAE684	EPHA2	890.0
PLX-4720	ABL1(E255K)-phosphorylated	4500.0
Crizotinib	RIPK2	900.0
Nintedanib	SRC	580.0
Dovitinib	IKKA	1800.0
Canertinib	MAP3K3	2300.0
Ruxolitinib	PAK7	1300.0
Sunitinib	HUNK	500.0
Nintedanib	TYRO3	4900.0
Dovitinib	SBK1	1500.0
Sunitinib	CHK2	10.0
Bosutinib	ALK	690.0
Ruxolitinib	DAPK1	72.0
Canertinib	EGFR(G719C)	0.13
Erlotinib	DDR1	790.0
Tozasertib	TGFBR1	8400.0
Crizotinib	CSF1R	210.0
Barasertib	FLT3(K663Q)	3.9
Doramapimod	LOK	12.0
Canertinib	SIK2	4900.0
Canertinib	EGFR(E746-A750del)	0.26
KW2449	DMPK	3800.0
Fedratinib	ULK1	270.0
Crizotinib	EPHB4	570.0
Pazopanib	MARK3	4000.0
Neratinib	MAP4K4	330.0
PHA-665752	RET(V804L)	460.0
NVP-TAE684	RET(V804M)	140.0
Lestaurtinib	M4K1	38.0
GSK 690693	HIPK1	510.0
NVP-TAE684	TAOK1	25.0
Sorafenib	LIMK1	1600.0
GDC-0879	ABL1(H396P)-nonphosphorylated	3200.0
Nintedanib	M4K3	290.0
Vandetanib	EGFR(S752-I759del)	12.0
Crizotinib	GRK4	4200.0
PHA-665752	JAK3(JH1domain-catalytic)	470.0
Dovitinib	BIKE	54.0
GSK1838705A	CSNK2A1	2800.0
Lestaurtinib	MARK1	83.0
PKC412	PHKG1	900.0
Dovitinib	MYLK2	92.0
R406	FAK1	250.0
PLX-4720	FGFR2	3100.0
R406	TAOK1	490.0
Lestaurtinib	NLK	770.0
Bosutinib	RET(M918T)	3800.0
NVP-TAE684	TAOK2	740.0
R406	DRAK1	32.0
Fedratinib	KIT	130.0
GSK1838705A	CLK4	60.0
SGX523	DYRK1B	1800.0
Tozasertib	PAK4	4300.0
SB 203580	YANK2	2100.0
R406	FLT3(N841I)	1.5
Nintedanib	OSR1	1300.0
PLX-4720	NEK11	190.0
Pictilisib	PIK3CD	5.0
Sunitinib	TLK2	330.0
Motesanib	FGFR4	6800.0
Gefitinib	ERBB3	790.0
Linifanib	MST1	1400.0
Alvocidib	ERBB4	5000.0
Bosutinib	YES	4.0
NVP-TAE684	LIMK1	1100.0
RAF 265	TAOK2	140.0
Nilotinib	EPHB1	1300.0
Imatinib	JNK1	5000.0
RAF 265	TIE2	1300.0
KW2449	ACVR1	140.0
NVP-TAE684	CSNK2A2	9600.0
Fedratinib	ROCK1	2100.0
Linifanib	MKNK2	270.0
Doramapimod	VGFR1	410.0
RAF 265	ABL1-phosphorylated	3600.0
Dovitinib	MAP4K4	160.0
Sunitinib	ERN1	600.0
NVP-TAE684	FYN	1400.0
Masitinib	FYN	140.0
Dovitinib	DCAMKL3	1300.0
Lestaurtinib	JAK2(JH1domain-catalytic)	3.7
RAF 265	HIPK4	560.0
NVP-TAE684	ERBB2	540.0
Barasertib	EGFR(L747-E749del,A750P)	2900.0
KW2449	LCK	1200.0
Ki20227	TNIK	2300.0
Lestaurtinib	PIK3CA(E545A)	5600.0
Dasatinib	ULK3	4600.0
PLX-4720	ABL1(F317I)-nonphosphorylated	1300.0
RAF 265	DDR1	13.0
Neratinib	RIPK5	6400.0
GSK 690693	NUAK1	420.0
Neratinib	MST1	270.0
Pictilisib	PIK3CA(E545A)	0.9
Tozasertib	ABL1(E255K)-phosphorylated	3.0
Erlotinib	BLK	190.0
Lestaurtinib	MK13	3500.0
PHA-665752	ABL1(T315I)-phosphorylated	3900.0
GSK 690693	ROCK2	200.0
Enzastaurin	PIP5K1C	6600.0
Dasatinib	TNIK	2000.0
NVP-TAE684	FRK	27.0
Lestaurtinib	AMPK-alpha1	25.0
PKC412	PGFRA	380.0
Bosutinib	TAOK3	340.0
BI-2536	KKCC1	22.0
Linifanib	PGFRB	1.9
Motesanib	EPHA6	490.0
R406	IKKB	71.0
Vandetanib	ADCK4	1700.0
Ki20227	FYN	7100.0
Vandetanib	EPHA5	240.0
Erlotinib	TBK1	3100.0
PLX-4720	DYRK2	2700.0
Gefitinib	FLT3(D835Y)	1000.0
RAF 265	CIT	87.0
Enzastaurin	PIM1	200.0
Brivanib	ABL1(Q252H)-phosphorylated	1200.0
Fedratinib	ABL1(T315I)-nonphosphorylated	240.0
Lestaurtinib	AURKA	16.0
Vandetanib	AMPK-alpha1	3000.0
PHA-665752	CAMK2A	3400.0
PHA-665752	CAMKK2	73.0
PLX-4720	KIT(D816V)	3100.0
Vandetanib	AURKC	1500.0
Crizotinib	ULK1	1000.0
Enzastaurin	CDK16	5300.0
Sorafenib	CDK11	250.0
Ki20227	PFCDPK1(P.falciparum)	1800.0
NVP-TAE684	NUAK1	13.0
Pazopanib	MET(M1250T)	3400.0
Alvocidib	ROCK1	1200.0
Dovitinib	ABL1(F317L)-phosphorylated	1100.0
GSK461364	KCC2D	620.0
Masitinib	FRK	87.0
SB 203580	STK36	1300.0
Nintedanib	RIPK4	440.0
Fedratinib	MARK2	3100.0
Nintedanib	MST4	49.0
Alvocidib	FLT3(D835Y)	3200.0
Dasatinib	ABL1(T315I)-phosphorylated	120.0
Dovitinib	GRK1	2200.0
KW2449	JAK2(JH1domain-catalytic)	76.0
AC220	PGFRB	7.7
KW2449	CTK	3000.0
R406	ABL1(T315I)-phosphorylated	190.0
Gefitinib	ABL1(F317L)-nonphosphorylated	2700.0
R406	LRRK2	36.0
R406	MYLK4	810.0
Doramapimod	FAK1	7100.0
GSK1838705A	DAPK2	1100.0
Foretinib	FAK1	180.0
PLX-4720	ABL1(Q252H)-phosphorylated	4000.0
Tozasertib	NUAK1	200.0
Vandetanib	SIK2	430.0
KW2449	MYO3B	6000.0
Sorafenib	FGFR3(G697C)	5900.0
Barasertib	CDKL2	1200.0
Enzastaurin	FLT3(R834Q)	1800.0
PI103	MRCKA	1800.0
RAF 265	KIT(A829P)	990.0
Bosutinib	CAMK1D	550.0
Dovitinib	STK39	530.0
R406	CDKL1	2100.0
NVP-TAE684	SRMS	160.0
KW2449	PAK1	2100.0
SB 203580	DDR1	1000.0
Dasatinib	TAOK2	5400.0
Nintedanib	TNK1	210.0
Erlotinib	ABL1(T315I)-nonphosphorylated	620.0
Lestaurtinib	PIP5K1A	36.0
NVP-TAE684	M3K6	1800.0
Doramapimod	NLK	1000.0
Dasatinib	FLT3	4800.0
Dovitinib	M3K12	2100.0
Nintedanib	MARK4	2000.0
Canertinib	ABL1(E255K)-phosphorylated	30.0
Afatinib	ABL1(F317I)-phosphorylated	750.0
PLX-4720	DDR1	2400.0
Lestaurtinib	ABL1(H396P)-phosphorylated	870.0
Canertinib	EPHB6	640.0
Sunitinib	JNK3	4300.0
Tozasertib	FRK	3800.0
Alvocidib	ABL1-nonphosphorylated	3400.0
Sunitinib	MYLK	280.0
Neratinib	SNARK	140.0
Nintedanib	STK39	520.0
SNS-032	TAK1	1400.0
Tozasertib	CAMK1	7000.0
Enzastaurin	PIM2	870.0
Sunitinib	LYN	270.0
Ruxolitinib	CLK2	460.0
Crizotinib	DCAMKL2	370.0
Alvocidib	TGFBR2	5600.0
Sunitinib	CDK14	270.0
Erlotinib	LRRK2(G2019S)	4800.0
Pazopanib	FYN	2700.0
Enzastaurin	PKAC-alpha	330.0
Lestaurtinib	TSSK1	98.0
PLX-4720	SIK1	520.0
KW2449	DCAMKL3	86.0
KW2449	EGFR(E746-A750del)	7100.0
Dasatinib	EPHB6	0.04
Barasertib	AURKC	4.4
Sorafenib	TAOK3	2700.0
Neratinib	GCN2(Kin.Dom.2,S808G)	96.0
Sorafenib	MK14	370.0
Tozasertib	RIOK1	360.0
Sorafenib	PCTK2	1600.0
MLN8054	LCK	590.0
Sunitinib	SRPK1	250.0
Vandetanib	EGFR(G719C)	9.6
Canertinib	EPHA1	2500.0
Lestaurtinib	FLT3(N841I)	1.4
Foretinib	TRKA	4.8
Linifanib	EPHB1	880.0
GSK 690693	CHK2	5300.0
GSK1838705A	EGFR	4100.0
Gefitinib	FGR	2600.0
Sorafenib	CSF1R	28.0
Brivanib	RET	390.0
PLX-4720	MP2K4	190.0
Alvocidib	PCTK3	1100.0
Nintedanib	SgK110	2000.0
Canertinib	RET	4200.0
Pazopanib	FGFR3(G697C)	620.0
Tozasertib	FAK2	2600.0
Motesanib	ABL1(F317L)-nonphosphorylated	910.0
Dovitinib	KIT(D816V)	1400.0
Sunitinib	CDK16	150.0
Doramapimod	FGFR1	4300.0
KW2449	DYRK1B	940.0
BMS345541	CDK9	1900.0
R406	VGFR1	16.0
Lapatinib	PIK4CB	940.0
Vandetanib	MRCKB	2500.0
Nintedanib	LATS1	420.0
NVP-TAE684	CDK15	2100.0
R406	CIT	440.0
Crizotinib	ABL1(H396P)-nonphosphorylated	33.0
NVP-TAE684	DDR1	140.0
GSK461364	FLT3	620.0
Fedratinib	MARK3	300.0
Lestaurtinib	CLK2	44.0
Tozasertib	TYK2(JH2domain-pseudokinase)	6600.0
Tozasertib	RET	28.0
AC220	EPHA6	9100.0
Nintedanib	HIPK3	850.0
Neratinib	CSF1R	670.0
SNS-032	PHKG1	3800.0
Pazopanib	ABL1(M351T)-phosphorylated	560.0
KW2449	RSK2(Kin.Dom.1-N-terminal)	280.0
Nilotinib	EPHB2	640.0
BI-2536	LOK	4900.0
PHA-665752	TYK2(JH2domain-pseudokinase)	6600.0
Masitinib	RIOK2	1700.0
Foretinib	NLK	170.0
Ruxolitinib	RPS6KA5(Kin.Dom.2-C-terminal)	140.0
NVP-TAE684	VGFR2	940.0
PKC412	AURKA	120.0
PKC412	CDK11	7200.0
Nilotinib	ABL1(M351T)-phosphorylated	15.0
GSK 690693	PKN2	3100.0
PKC412	DYRK1B	330.0
Fedratinib	IKKE	360.0
Tozasertib	GRK4	400.0
Doramapimod	MKNK2	1600.0
Enzastaurin	PAK3	4300.0
PKC412	IKKA	3800.0
Nintedanib	KPCD2	720.0
Bosutinib	EGFR(G719S)	26.0
Erlotinib	ERBB3	1100.0
Ruxolitinib	NEK3	1100.0
Barasertib	EGFR(G719S)	170.0
Lestaurtinib	KIT(D816H)	11.0
Fedratinib	EPHA1	730.0
PI103	PIK3CA(I800L)	2.9
Tozasertib	M4K3	290.0
Canertinib	LCK	320.0
Nintedanib	FER	73.0
Doramapimod	YES	4900.0
Lestaurtinib	CDKL3	430.0
Dasatinib	M4K3	640.0
Canertinib	KIT(V559D,V654A)	7900.0
R406	EPHA2	140.0
Dasatinib	TNK2	5.6
Ki20227	ABL1(Y253F)-phosphorylated	430.0
Enzastaurin	CDK9	1300.0
Motesanib	STK35	5400.0
GSK 690693	TAOK3	9300.0
Lestaurtinib	RSK4(Kin.Dom.2-C-terminal)	9100.0
Nilotinib	ABL1(F317I)-phosphorylated	56.0
Foretinib	MYO3A	2800.0
NVP-TAE684	BRSK2	190.0
Afatinib	DYRK2	1800.0
Bosutinib	GAK	1.3
Tozasertib	CSK	4800.0
Sunitinib	GRK4	140.0
Crizotinib	MAP3K3	110.0
Fedratinib	CDK14	2600.0
Erlotinib	M3K2	2500.0
Crizotinib	AXL	7.8
Bosutinib	ITK	1700.0
Ruxolitinib	ABL1(Q252H)-nonphosphorylated	2000.0
Tofacitinib	LRRK2	1300.0
Canertinib	ACVR1	1700.0
NVP-TAE684	MLK1	410.0
Foretinib	ABL1(Q252H)-phosphorylated	120.0
Lestaurtinib	CSNK1A1L	7100.0
Lestaurtinib	FGFR4	1800.0
Nintedanib	KIT(V559D,T670I)	2.9
RAF 265	ABL1(Q252H)-phosphorylated	7400.0
GSK461364	KIT(D816V)	1600.0
Nintedanib	MLCK	110.0
Pictilisib	AAK1	9100.0
Motesanib	RAF1	880.0
SB 203580	CIT	420.0
Foretinib	RIPK2	21.0
Lestaurtinib	GRK1	24.0
Barasertib	MUSK	1500.0
R406	ACVR1	4800.0
Nintedanib	PIP5K1A	49.0
Sunitinib	NEK2	1400.0
BI-2536	NEK7	6100.0
Lestaurtinib	MP2K5	7.0
Ruxolitinib	EPHB6	3100.0
KW2449	ERN1	3500.0
GSK461364	CAMK2A	1000.0
Pazopanib	RET(V804L)	5900.0
Barasertib	CDC2L1	1200.0
PLX-4720	FLT3	1300.0
Fedratinib	JAK2(JH1domain-catalytic)	1.1
Lestaurtinib	MERTK	32.0
Tozasertib	PAK3	3300.0
Sunitinib	PLK2	4700.0
Fedratinib	FLT3(D835Y)	6.4
R406	TNIK	1300.0
Dasatinib	MRCKB	2100.0
NVP-TAE684	WEE1	3000.0
GSK 690693	MELK	890.0
MLN8054	TYRO3	3100.0
Imatinib	TYK2(JH2domain-pseudokinase)	8700.0
NVP-TAE684	FLT3(ITD)	8.6
Crizotinib	EPHA3	700.0
Foretinib	CDK15	32.0
SNS-032	IRAK3	2900.0
GSK 690693	KIT(A829P)	1800.0
Fedratinib	PIK3CG	7500.0
NVP-TAE684	SIK2	17.0
Ruxolitinib	CAMK2A	46.0
Crizotinib	FLT3	850.0
Pazopanib	ABL1(T315I)-nonphosphorylated	3800.0
Linifanib	YANK2	270.0
R406	ADCK4	64.0
Lestaurtinib	M3K5	70.0
SB 203580	TNIK	820.0
Tozasertib	KIT	240.0
R406	LCK	30.0
Lapatinib	EGFR(S752-I759del)	4.2
Vandetanib	TIE1	1500.0
Nintedanib	MAP4K4	150.0
Foretinib	MLCK	3000.0
Sunitinib	AMPK-alpha1	19.0
Crizotinib	FLT3(N841I)	860.0
SNS-032	AURKA	7400.0
R406	CSF1R	31.0
Bosutinib	NEK2	1600.0
Sorafenib	EPHA5	3500.0
Enzastaurin	BIKE	2900.0
Fedratinib	EGFR(E746-A750del)	6200.0
R406	CAMK2G	920.0
R406	AURKB	110.0
Lestaurtinib	RPS6KA4(Kin.Dom.1-N-terminal)	62.0
Tozasertib	VGFR1	100.0
KW2449	IKKB	430.0
Alvocidib	MRCKA	9500.0
Linifanib	TIE2	450.0
Linifanib	CDK9	3000.0
R406	MET	280.0
Foretinib	KIT(L576P)	2.7
Imatinib	DDR2	15.0
Sorafenib	RAF1	230.0
PKC412	WEE1	4600.0
Vandetanib	FLT3(K663Q)	190.0
R406	MP2K4	200.0
Masitinib	HCK	690.0
KW2449	MARK2	440.0
R406	CSK	160.0
Ki20227	RIPK2	290.0
PHA-665752	DCAMKL3	4500.0
BI-2536	CLK2	460.0
PHA-665752	CLK3	3600.0
Lestaurtinib	ABL1(Q252H)-nonphosphorylated	2500.0
PKC412	GSK3A	2500.0
Nintedanib	FAK1	210.0
Foretinib	TYK2(JH1domain-catalytic)	5000.0
Sunitinib	RET(V804L)	8.7
BI-2536	EGFR(L858R,T790M)	240.0
MLN8054	IRAK3	1400.0
Fedratinib	ABL2	570.0
Ruxolitinib	OSR1	2700.0
NVP-TAE684	MET(M1250T)	64.0
MLN8054	FLT3(K663Q)	9500.0
Foretinib	BTK	76.0
PKC412	CAMK2A	20.0
Dasatinib	EGFR(L858R)	120.0
Sorafenib	FLT3	13.0
PLX-4720	AURKC	2500.0
GSK461364	GRK4	2800.0
Tofacitinib	KPCD	2000.0
Lapatinib	EGFR(L747-E749del,A750P)	2.2
Crizotinib	NEK9	790.0
Bosutinib	PIP5K1A	3300.0
Nintedanib	TXK	860.0
NVP-TAE684	ERBB4	280.0
PHA-665752	MAP3K3	5900.0
Fedratinib	TRKA	840.0
Nintedanib	TSSK1	6100.0
KW2449	MAP3K4	1600.0
Bosutinib	MAP4K5	0.5
Crizotinib	ABL1-nonphosphorylated	78.0
Crizotinib	EPHA7	470.0
GSK461364	NEK5	1100.0
Pazopanib	LTK	6800.0
R406	WEE2	9400.0
PHA-665752	PGFRB	1900.0
Enzastaurin	AAK1	2700.0
Doramapimod	FLT3(K663Q)	890.0
R406	TNNI3K	310.0
Lestaurtinib	YSK1	97.0
Ruxolitinib	GRK7	540.0
Fedratinib	ABL1-phosphorylated	44.0
Fedratinib	KIT(V559D)	58.0
Motesanib	LOK	1100.0
Foretinib	MST1	1100.0
Lestaurtinib	SIK1	82.0
Canertinib	TEC	1500.0
NVP-TAE684	KGP1	430.0
Dovitinib	DYRK2	6000.0
Neratinib	EGFR(L747-T751del,Sins)	1.0
Crizotinib	EPHA1	140.0
GSK 690693	GSK3B	100.0
Linifanib	GAK	2300.0
SGX523	MET(Y1235D)	3.9
Linifanib	AXL	340.0
NVP-TAE684	PIK4CB	780.0
Dasatinib	MINK	430.0
Lestaurtinib	MLK3	18.0
Foretinib	ABL1(E255K)-phosphorylated	150.0
Canertinib	STK35	2900.0
Dasatinib	EPHA2	0.85
PLX-4720	GCN2(Kin.Dom.2,S808G)	1300.0
Foretinib	PGFRA	4.5
Foretinib	ABL1(F317I)-nonphosphorylated	40.0
Bosutinib	DCAMKL3	5400.0
NVP-TAE684	CDK5	1600.0
Motesanib	FLT3(K663Q)	54.0
Lestaurtinib	PIK3CG	350.0
NVP-TAE684	MST1R	610.0
R406	SRPK3	400.0
Sorafenib	MK13	6600.0
Ruxolitinib	BIKE	210.0
Neratinib	LCK	120.0
Dovitinib	MLCK	2.0
Sunitinib	PAK3	16.0
Lestaurtinib	ERK5	1100.0
Lestaurtinib	EGFR(G719C)	1200.0
Crizotinib	FLT3(K663Q)	900.0
PLX-4720	RIPK2	430.0
Pictilisib	PCTK3	4600.0
Afatinib	MP2K5	1300.0
Vandetanib	ABL1(H396P)-nonphosphorylated	9.8
Gefitinib	ABL1(F317I)-phosphorylated	4700.0
Vandetanib	ABL1(M351T)-phosphorylated	15.0
Enzastaurin	FGFR1	4000.0
PLX-4720	FES	3600.0
Foretinib	ERBB4	610.0
Brivanib	KIT	36.0
Dovitinib	PCTK3	8400.0
KW2449	MYLK4	170.0
SB 203580	CSNK1E	100.0
Sunitinib	JAK3(JH1domain-catalytic)	1200.0
NVP-TAE684	MK12	9400.0
Nintedanib	SBK1	110.0
Bosutinib	EPHA2	18.0
Sunitinib	STK35	1300.0
Lestaurtinib	ABL1(E255K)-phosphorylated	840.0
Dasatinib	FYN	0.79
Crizotinib	MST4	2800.0
Vandetanib	DDR1	11.0
GDC-0879	LOK	1300.0
MLN8054	EPHB1	330.0
SNS-032	CIT	3900.0
GSK1838705A	STK33	70.0
Lestaurtinib	M3K2	4.8
Pazopanib	STK16	360.0
SB 203580	EGFR(G719S)	1300.0
Alvocidib	KPCL	350.0
GSK 690693	SNARK	86.0
Foretinib	TBK1	800.0
Nintedanib	PFCDPK1(P.falciparum)	1200.0
Fedratinib	NEK6	120.0
AC220	KIT(V559D,T670I)	6.0
Sunitinib	RPS6KA5(Kin.Dom.1-N-terminal)	28.0
PHA-665752	ALK	2700.0
Tozasertib	TNIK	1800.0
Pazopanib	FGFR2	210.0
Sunitinib	KIT(V559D,T670I)	0.3
Tozasertib	ABL1-phosphorylated	7.5
PKC412	DAPK1	4700.0
Lestaurtinib	DYRK1B	29.0
Selumetinib	MP2K1	99.0
Vandetanib	STK33	1400.0
Dovitinib	MAP3K4	5500.0
SNS-032	CDK3	56.0
Lestaurtinib	BMPR1A	950.0
Fedratinib	SNARK	49.0
Fedratinib	SIK1	39.0
PKC412	STK16	280.0
Pazopanib	VGFR1	14.0
Fedratinib	FLT3(ITD)	16.0
Lestaurtinib	KIT(V559D)	76.0
Barasertib	MP2K1	1900.0
Nilotinib	KIT(A829P)	46.0
NVP-TAE684	TIE2	46.0
GSK461364	RSK3(Kin.Dom.1-N-terminal)	1200.0
Ki20227	KIT(A829P)	38.0
Pictilisib	MK09	1800.0
Nintedanib	CDK14	470.0
R406	JAK2(JH1domain-catalytic)	3.5
Enzastaurin	MYLK4	230.0
Sunitinib	MARK4	3600.0
R406	HIPK4	2800.0
Vandetanib	ABL1(T315I)-nonphosphorylated	150.0
Pazopanib	MP2K6	4100.0
Crizotinib	ABL2	460.0
Vandetanib	FLT3	850.0
Lestaurtinib	KIT	150.0
PI103	RIOK2	770.0
Ruxolitinib	CASK	1500.0
Motesanib	EGFR(G719S)	1000.0
Lestaurtinib	BIKE	16.0
BI-2536	CSNK1D	1500.0
Gefitinib	ABL1-nonphosphorylated	2200.0
Nintedanib	STK16	18.0
Crizotinib	ULK2	1600.0
Bosutinib	GCN2(Kin.Dom.2,S808G)	270.0
NVP-TAE684	PRKX	5800.0
PHA-665752	MAP4K4	280.0
Ruxolitinib	PKNB(M.tuberculosis)	4200.0
Erlotinib	FLT3(D835H)	350.0
AC220	RET(V804L)	13.0
MLN8054	FYN	1300.0
Sorafenib	TRKA	6300.0
Afatinib	CIT	2900.0
Pazopanib	ABL1(F317L)-phosphorylated	2700.0
Canertinib	ERBB4	6.5
NVP-TAE684	FAK2	1.1
NVP-TAE684	LCK	49.0
MLN8054	FGFR3	1200.0
Nintedanib	SNARK	21.0
PHA-665752	FLT4	1400.0
Bosutinib	MAP4K4	8.2
Dasatinib	EPHB1	0.45
Vandetanib	MAP4K4	1400.0
Foretinib	MRCKB	330.0
KW2449	PRKX	1200.0
Foretinib	TTK	430.0
Bosutinib	BLK	3.3
Ki20227	TNK2	250.0
Imatinib	CDK11	5500.0
Sunitinib	KPCT	4300.0
Pazopanib	MLK2	2100.0
NVP-TAE684	MP2K1	550.0
NVP-TAE684	ABL1(Q252H)-nonphosphorylated	39.0
Foretinib	BRAF(V600E)	2300.0
PKC412	ULK3	1300.0
Bosutinib	LRRK2	500.0
KW2449	CAMK1	1400.0
NVP-TAE684	EGFR(E746-A750del)	81.0
Neratinib	SIK2	3300.0
Nintedanib	CHEK1	290.0
Linifanib	M4K1	830.0
KW2449	BMPR2	370.0
KW2449	LATS2	1500.0
GSK1838705A	DAPK1	620.0
Pazopanib	FLT3	1100.0
VX-745	PGFRA	8800.0
Canertinib	VGFR1	7500.0
Foretinib	EGFR(E746-A750del)	310.0
GSK1838705A	TTK	76.0
PKC412	MLK2	790.0
R406	DRAK2	9.2
Sunitinib	FGFR1	520.0
R406	PGFRA	60.0
Nintedanib	CDKL2	1300.0
Tozasertib	PKNB(M.tuberculosis)	2200.0
KW2449	BIKE	9.6
Lestaurtinib	EGFR(T790M)	16.0
GSK461364	PKN2	620.0
Foretinib	MLK3	340.0
NVP-TAE684	NEK9	800.0
Canertinib	ABL1(Q252H)-nonphosphorylated	91.0
Canertinib	ULK3	4700.0
PHA-665752	SRPK2	500.0
SNS-032	AMPK-alpha1	8200.0
SNS-032	AURKC	5000.0
Foretinib	ABL1-phosphorylated	56.0
Nintedanib	KIT	5.7
AC220	RET(M918T)	3.0
Foretinib	CDK8	130.0
GSK461364	DAPK2	2900.0
Crizotinib	EGFR(L861Q)	2700.0
Vandetanib	MINK	3400.0
Sorafenib	CLK1	7500.0
Motesanib	RET(M918T)	20.0
Nintedanib	PGFRB	15.0
NVP-TAE684	BMPR1A	170.0
Motesanib	CIT	300.0
Tozasertib	JAK2(JH1domain-catalytic)	190.0
Pazopanib	RET(V804M)	2300.0
PKC412	TRKA	380.0
Nilotinib	ABL1(F317L)-phosphorylated	14.0
Ruxolitinib	DAPK3	89.0
Lestaurtinib	PFPK5(P.falciparum)	5600.0
Brivanib	PGFRA	11.0
Doramapimod	EPHA1	9800.0
Bosutinib	FLT3(ITD)	2900.0
Crizotinib	MP2K3	3300.0
Sunitinib	CSNK1D	15.0
PKC412	RIPK5	4700.0
Linifanib	FLT3	0.6
NVP-TAE684	EPHB1	340.0
Canertinib	EGFR(L858R,T790M)	0.28
R406	DAPK3	13.0
Pazopanib	ABL1(Q252H)-phosphorylated	530.0
Dasatinib	EPHA5	0.24
Pazopanib	ABL1(T315I)-phosphorylated	2100.0
BI-2536	RSK1(Kin.Dom.1-N-terminal)	5400.0
Fedratinib	IKKA	830.0
Dovitinib	SGK3	960.0
RAF 265	ABL1(F317I)-nonphosphorylated	7800.0
Lestaurtinib	TRKA	8.3
NVP-TAE684	TRKA	460.0
Alvocidib	YANK1	5500.0
Sunitinib	RIPK1	370.0
PHA-665752	RET(M918T)	580.0
PI103	PIK3CB	1.7
Erlotinib	LCK	250.0
PKC412	KIT(V559D,T670I)	150.0
Fedratinib	MP2K4	9900.0
R406	ULK2	19.0
Alvocidib	EGFR(L858R)	1700.0
NVP-TAE684	HIPK3	6900.0
Bosutinib	SIK2	29.0
Tozasertib	ERN1	5600.0
Doramapimod	EGFR(G719S)	9100.0
KW2449	MP2K4	250.0
SNS-032	PCTK3	44.0
Pazopanib	JNK3	1900.0
Bosutinib	RIPK5	380.0
Alvocidib	MP2K3	1200.0
R406	LATS2	4000.0
KW2449	JNK3	51.0
Vandetanib	M4K3	1500.0
Foretinib	MET(M1250T)	1.0
Doramapimod	RET(M918T)	240.0
Linifanib	PLK4	2300.0
Lestaurtinib	MLK2	15.0
Canertinib	TNIK	8200.0
R406	MYLK	6500.0
Foretinib	TIE2	3.1
Nintedanib	ERN1	2000.0
Nintedanib	WEE1	2900.0
Tozasertib	NEK5	4200.0
Fedratinib	ADCK4	300.0
Barasertib	FLT3(N841I)	43.0
Sunitinib	AXL	9.0
NVP-TAE684	TNIK	1200.0
Lestaurtinib	JNK3	12.0
Dovitinib	EGFR(T790M)	1400.0
Canertinib	AXL	5700.0
Dovitinib	PIP5K1A	1900.0
Pictilisib	PIK3CA(H1047Y)	4.1
Doramapimod	FLT3	2300.0
R406	ROS1	29.0
Nintedanib	RSK4(Kin.Dom.1-N-terminal)	230.0
Nintedanib	TBK1	150.0
Afatinib	MET	2200.0
Nilotinib	PI42C	8800.0
Lestaurtinib	CASK	330.0
Ruxolitinib	RIPK4	2100.0
R406	TNK1	25.0
Neratinib	KC1G2	6600.0
KW2449	JAK3(JH1domain-catalytic)	39.0
BMS345541	CDC2L5	800.0
KW2449	TIE1	300.0
Motesanib	KIT	3.7
PLX-4720	ABL1(F317I)-phosphorylated	5000.0
Nintedanib	ABL1(Y253F)-phosphorylated	37.0
GSK461364	CSNK2A1	7300.0
KW2449	JNK1	580.0
GSK461364	PLK2	500.0
KW2449	WEE1	2800.0
PHA-665752	KIT(V559D,V654A)	7200.0
Dasatinib	PGFRA	0.47
Foretinib	M4K1	44.0
Bosutinib	EPHB4	9.2
PKC412	LYN	4200.0
Crizotinib	MUSK	230.0
GSK1838705A	HIPK2	1200.0
Alvocidib	CSNK1A1L	2400.0
Bosutinib	MERTK	110.0
AC220	TRKC	550.0
Vandetanib	PTK6	160.0
BI-2536	LTK	1200.0
Vandetanib	VGFR2	820.0
Dovitinib	DDR1	2500.0
PHA-665752	PIP5K1A	280.0
Alvocidib	KPCT	350.0
Tozasertib	LATS1	5500.0
Fedratinib	RET(M918T)	150.0
Sorafenib	FYN	8400.0
KW2449	IKKA	180.0
Ruxolitinib	CDK7	3300.0
Canertinib	EPHA5	1200.0
Tozasertib	NDR2	6900.0
Crizotinib	S6K1	640.0
Alvocidib	CDK14	110.0
Sorafenib	MYO3B	7100.0
PHA-665752	S6K1	4100.0
Barasertib	ABL1(T315I)-nonphosphorylated	1100.0
KW2449	FLT3(ITD)	20.0
Masitinib	KIT(V559D)	5.8
R406	NEK5	13.0
Alvocidib	PKN1	3500.0
Alvocidib	PCTK2	480.0
Nilotinib	EPHB3	1000.0
Vandetanib	ABL1(F317L)-phosphorylated	33.0
Tozasertib	ABL1-nonphosphorylated	13.0
PKC412	GCN2(Kin.Dom.2,S808G)	39.0
PKC412	KPCL	290.0
Canertinib	EGFR(S752-I759del)	0.19
R406	M3K2	94.0
PKC412	KIT(L576P)	41.0
R406	SYK	19.0
Alvocidib	KIT(A829P)	8800.0
Nintedanib	TRKA	4.5
Enzastaurin	JAK3(JH1domain-catalytic)	1700.0
Alvocidib	SNARK	1400.0
Tozasertib	RIPK1	20.0
Alvocidib	CDK3	410.0
NVP-TAE684	M4K1	140.0
Barasertib	ABL1(Y253F)-phosphorylated	3800.0
SB 203580	EGFR(L747-T751del,Sins)	1500.0
Pazopanib	M4K3	1600.0
Brivanib	TIE2	440.0
PKC412	ERBB4	3100.0
Vandetanib	ULK3	6400.0
Fedratinib	PCTK2	350.0
R406	ABL1(M351T)-phosphorylated	390.0
Fedratinib	ULK3	290.0
Bosutinib	MLK1	2700.0
Bosutinib	YSK1	900.0
AC220	MAP4K5	440.0
PHA-665752	ABL1(H396P)-phosphorylated	9000.0
MLN8054	BLK	68.0
Neratinib	FES	590.0
Erlotinib	MP2K5	96.0
PD184352	MP2K1	120.0
SB 203580	GAK	19.0
Nintedanib	MYLK	290.0
Foretinib	YSK1	5700.0
Dasatinib	ACVR1B	330.0
NVP-TAE684	HIPK4	350.0
KW2449	PRP4	270.0
BMS345541	CDC2L1	420.0
Alvocidib	KC1G1	1200.0
Alvocidib	BMPR1B	450.0
Fedratinib	TAK1	3100.0
Afatinib	EGFR(L858R)	0.2
Nintedanib	ABL1-phosphorylated	64.0
BI-2536	EGFR(S752-I759del)	5300.0
Imatinib	PLK4	7800.0
Enzastaurin	FLT3(ITD)	72.0
PKC412	EGFR(T790M)	9.8
Lestaurtinib	PRKR	120.0
Bosutinib	TAOK1	1300.0
R406	MP2K5	41.0
NVP-TAE684	MK03	430.0
Imatinib	CLK4	2100.0
Lestaurtinib	MLTK	6700.0
PHA-665752	MET(Y1235D)	0.8
KW2449	DAPK3	310.0
Sunitinib	KIT(D816V)	380.0
Ruxolitinib	ANKK1	390.0
Foretinib	TRKC	3.4
Lestaurtinib	TAK1	2.9
NVP-TAE684	DCAMKL3	14.0
Lestaurtinib	EGFR(L858R,T790M)	7.8
Neratinib	FLT3(N841I)	6400.0
Alvocidib	ERBB3	9200.0
R406	MAP4K2	670.0
Dovitinib	AMPK-alpha1	520.0
Sorafenib	FLT4	95.0
NVP-TAE684	MUSK	260.0
KW2449	YSK4	5.2
PKC412	PIK3CA(H1047L)	1100.0
Dasatinib	RIPK2	31.0
Alvocidib	CDK8	120.0
Foretinib	EPHA2	3.6
Tozasertib	MP2K6	2600.0
Ruxolitinib	CAMK1G	2200.0
Sorafenib	TAOK1	3100.0
PKC412	MAP4K2	2500.0
Nintedanib	TIE1	2200.0
Imatinib	JNK3	3100.0
Doramapimod	EGFR	7000.0
Fedratinib	INSRR	1600.0
Lestaurtinib	ABL1(F317L)-nonphosphorylated	7600.0
KW2449	MET(M1250T)	210.0
SB 203580	TXK	4500.0
Foretinib	BRAF	3500.0
Gefitinib	DRAK1	2000.0
Dasatinib	ABL1(Q252H)-phosphorylated	0.06
Afatinib	SRC	2800.0
Sorafenib	HIPK3	440.0
R406	TGFBR2	330.0
KW2449	DRAK2	4.8
Tozasertib	ABL1(Y253F)-phosphorylated	7.8
SB 203580	MP2K5	1400.0
PKC412	CAMK1D	670.0
GSK1838705A	PHKG2	2100.0
KW2449	EGFR(G719S)	4600.0
GSK 690693	KPCD1	3500.0
Nintedanib	MET	200.0
Pazopanib	MERTK	3300.0
Fedratinib	DDR1	1900.0
Sunitinib	MAP3K4	4800.0
Pazopanib	FLT3(K663Q)	740.0
Alvocidib	AXL	3500.0
Erlotinib	AXL	4000.0
Lestaurtinib	ACVR1	75.0
SB 203580	EGFR(L861Q)	3200.0
Sunitinib	FGFR4	2100.0
KW2449	YANK1	4400.0
Foretinib	FLT3(D835Y)	2.0
Foretinib	KIT(V559D,V654A)	7.6
Tozasertib	CSF1R	1800.0
PHA-665752	PCTK3	1500.0
Brivanib	TIE1	1100.0
Fedratinib	MAP3K4	4100.0
Canertinib	DYRK2	6700.0
NVP-TAE684	KCC4	30.0
GSK1838705A	KPCD3	410.0
Vandetanib	ERBB3	160.0
GDC-0879	BRAF(V600E)	0.2
NVP-TAE684	RSK3(Kin.Dom.2-C-terminal)	160.0
Dasatinib	EPHA1	4.1
RAF 265	MLK3	9500.0
Neratinib	EGFR(G719C)	0.4
Alvocidib	CLK2	2200.0
PHA-665752	MST1R	2000.0
Pazopanib	NEK2	980.0
AC220	TAK1	8500.0
Doramapimod	EPHA5	1400.0
Crizotinib	AURKA	260.0
BMS345541	RSK4(Kin.Dom.2-C-terminal)	6700.0
Dasatinib	KIT(V559D)	0.68
SB 203580	EGFR(S752-I759del)	2000.0
PHA-665752	PHKG1	1900.0
Doramapimod	LTK	1400.0
KW2449	PAK2	2700.0
Crizotinib	TRKB	37.0
Vandetanib	DMPK2	2200.0
KW2449	CSK	4400.0
Afatinib	EPHB6	3100.0
NVP-TAE684	CAMK2A	980.0
Fedratinib	MUSK	800.0
R406	BRAF(V600E)	380.0
NVP-TAE684	M3K13	57.0
GSK 690693	AKT1	2.2
R406	PAK3	690.0
Gefitinib	MP2K5	600.0
Dovitinib	TAK1	630.0
PKC412	HCK	720.0
Bosutinib	MAP3K3	54.0
Nintedanib	IKKE	170.0
Nintedanib	TYK2(JH1domain-catalytic)	37.0
Erlotinib	ABL1(F317I)-phosphorylated	1100.0
NVP-TAE684	DCLK1	4.9
Foretinib	EPHB4	12.0
Fedratinib	ITK	490.0
SNS-032	DYRK2	1700.0
R406	ACVR1B	1100.0
PKC412	SLK	220.0
Fedratinib	ABL1(F317L)-phosphorylated	180.0
Vandetanib	YSK4	980.0
NVP-TAE684	MK01	300.0
Tozasertib	CDKL2	49.0
Alvocidib	ABL1-phosphorylated	1500.0
Nintedanib	KIT(A829P)	87.0
Ki20227	DDR1	12.0
BI-2536	AAK1	2800.0
BI-2536	CAMKK2	23.0
Bosutinib	STK39	3700.0
Tozasertib	MST2	510.0
Tozasertib	MUSK	300.0
Dovitinib	MAP4K5	620.0
BI-2536	HIPK1	4100.0
Dasatinib	ABL1-nonphosphorylated	0.03
PI103	CLK3	5900.0
R406	EGFR(L747-T751del,Sins)	340.0
Fedratinib	PRKR	1100.0
Tozasertib	LTK	7500.0
Alvocidib	STK35	450.0
GSK1838705A	INSR	1.7
VX-745	LYN	1700.0
R406	CLK1	1200.0
NVP-TAE684	TIE1	15.0
Fedratinib	KPCD3	9600.0
Vandetanib	TNNI3K	2800.0
R406	BLK	25.0
PKC412	YES	950.0
Bosutinib	TRKA	3100.0
PHA-665752	YSK4	78.0
VX-745	EPHB1	6200.0
PKC412	DYRK1A	100.0
GSK 690693	M3K2	340.0
PLX-4720	FLT3(D835Y)	6500.0
BI-2536	EGFR(G719C)	630.0
Ruxolitinib	MYLK	360.0
KW2449	YES	18.0
AC220	HIPK4	320.0
KW2449	FLT3(D835H)	13.0
RAF 265	NEK5	3200.0
Sorafenib	HIPK1	3300.0
PHA-665752	FLT3(D835H)	140.0
Doramapimod	ERK8	3000.0
Doramapimod	TTK	3300.0
Tozasertib	KKCC1	4600.0
Lestaurtinib	PLK3	2300.0
SB 203580	SRC	5300.0
Bosutinib	LCK	0.59
KW2449	INSR	400.0
VX-745	FYN	2100.0
KW2449	NEK5	2300.0
Canertinib	BTK	1600.0
Lestaurtinib	RET	20.0
NVP-TAE684	RSK1(Kin.Dom.2-C-terminal)	650.0
PKC412	TBK1	9.3
R406	KIT	6.8
Canertinib	ABL1(H396P)-nonphosphorylated	46.0
Lestaurtinib	HIPK2	370.0
Nilotinib	BRAF	1700.0
Foretinib	CDK7	3.7
Dovitinib	IRAK4	130.0
GSK461364	CDK7	7700.0
Fedratinib	PCTK3	2700.0
R406	PDPK1	120.0
Brivanib	FGFR3(G697C)	150.0
Crizotinib	DYRK2	4000.0
Sorafenib	EPHB2	1900.0
Selumetinib	EGFR(G719S)	5200.0
NVP-TAE684	MST2	310.0
Dovitinib	TNIK	24.0
PHA-665752	TBK1	970.0
AC220	TRKA	2300.0
Sunitinib	INSRR	430.0
Fedratinib	CDK7	120.0
MLN8054	ABL1(T315I)-nonphosphorylated	1600.0
Sunitinib	LTK	1800.0
NVP-TAE684	KPCD	3500.0
Alvocidib	ACVR2B	2400.0
RAF 265	RAF1	390.0
Neratinib	M3K2	450.0
RAF 265	VGFR2	1300.0
KW2449	RET	150.0
KW2449	AURKB	88.0
Erlotinib	ABL1(T315I)-phosphorylated	59.0
Dovitinib	LCK	250.0
Pictilisib	PIK3C2B	130.0
Dasatinib	TGFBR2	2900.0
GSK1838705A	FAK2	76.0
Brivanib	YANK2	3900.0
Sunitinib	TYRO3	49.0
Enzastaurin	MST4	6900.0
KW2449	ABL1(F317L)-phosphorylated	94.0
Nintedanib	KIT(D816H)	310.0
Alvocidib	MERTK	6800.0
Lestaurtinib	PKN1	5.3
R406	PCTK2	330.0
Dovitinib	VGFR1	69.0
Erlotinib	AURKB	1400.0
Doramapimod	FAK2	990.0
GDC-0879	ERBB3	2300.0
Sunitinib	JAK2(JH1domain-catalytic)	410.0
Tozasertib	MST3	3600.0
BI-2536	KPCD2	510.0
Gefitinib	DRAK2	3800.0
Nintedanib	CAMK1G	260.0
Fedratinib	RSK4(Kin.Dom.2-C-terminal)	360.0
Crizotinib	IKKB	5500.0
Foretinib	ABL1(T315I)-phosphorylated	310.0
PKC412	MAP3K3	210.0
Neratinib	EGFR(L858R)	0.7
Sorafenib	TRKC	600.0
NVP-TAE684	TYRO3	7200.0
SNS-032	GSK3A	28.0
Pazopanib	BMPR1B	1000.0
R406	LIMK1	620.0
Sunitinib	HIPK1	55.0
PHA-665752	GRK1	1100.0
Canertinib	MK09	1100.0
Linifanib	MK11	370.0
Fedratinib	EPHB6	300.0
Dasatinib	BRAF(V600E)	570.0
RAF 265	RET	150.0
Sunitinib	DRAK2	110.0
Vandetanib	ABL1(T315I)-phosphorylated	20.0
PKC412	KKCC1	130.0
KW2449	MYO3A	740.0
MLN8054	FER	4400.0
KW2449	TAK1	36.0
Dovitinib	FLT4	580.0
SNS-032	TAOK1	1300.0
NVP-TAE684	MET	170.0
Crizotinib	LYN	940.0
SNS-032	DCAMKL2	1000.0
SB 203580	MK14	12.0
Foretinib	FLT3(K663Q)	0.8
Erlotinib	ABL1-nonphosphorylated	330.0
Motesanib	PTK6	1000.0
NVP-TAE684	TGFBR2	250.0
Motesanib	EGFR(E746-A750del)	3800.0
Bosutinib	EGFR(E746-A750del)	18.0
R406	KIT(V559D)	5.7
Fedratinib	RSK3(Kin.Dom.2-C-terminal)	2300.0
Crizotinib	RIPK5	450.0
SNS-032	DCLK1	1600.0
Crizotinib	FAK1	310.0
Tozasertib	AURKA	3.9
Crizotinib	ABL1(T315I)-phosphorylated	10.0
Bosutinib	STK36	570.0
Pazopanib	KIT(D816H)	1000.0
KW2449	PAK4	1500.0
PKC412	PKAC-alpha	720.0
Ruxolitinib	JAK1(JH1domain-catalytic)	3.4
Fedratinib	KIT(L576P)	120.0
Pazopanib	MP2K4	590.0
Foretinib	MK13	54.0
Dovitinib	RSK2(Kin.Dom.1-N-terminal)	5600.0
Ruxolitinib	TAOK3	590.0
Canertinib	PGFRB	7500.0
Fedratinib	RPS6KA5(Kin.Dom.1-N-terminal)	4400.0
Sunitinib	SNRK	640.0
Tozasertib	ERK5	6800.0
GSK 690693	PRKX	7.2
GSK 690693	GSK3A	5200.0
Foretinib	EPHA5	6.6
NVP-TAE684	MAST1	3300.0
Gefitinib	NLK	4200.0
Bosutinib	HIPK2	1900.0
GSK461364	KPCD3	1900.0
R406	BMPR1B	720.0
PHA-665752	RIOK3	390.0
Foretinib	MINK	2600.0
Erlotinib	PGFRA	1800.0
Foretinib	RSK3(Kin.Dom.1-N-terminal)	5100.0
Foretinib	CAMK1D	5300.0
Sunitinib	SRPK3	59.0
Sorafenib	STK33	2400.0
Vandetanib	FLT3(ITD)	1800.0
Gefitinib	HIPK4	310.0
Pazopanib	LCK	1200.0
NVP-TAE684	BLK	130.0
NVP-TAE684	ABL1-nonphosphorylated	200.0
Lestaurtinib	BMX	200.0
Tofacitinib	MKNK2	1600.0
Sorafenib	KIT(V559D)	16.0
Vandetanib	AXL	250.0
Barasertib	TAK1	650.0
MLN8054	ABL1(Q252H)-nonphosphorylated	630.0
Fedratinib	PI42C	4100.0
Vandetanib	BTK	1700.0
R406	TTK	1100.0
Fedratinib	NEK5	570.0
Neratinib	MLK3	5800.0
Pictilisib	FLT3(K663Q)	2600.0
Erlotinib	EGFR(L747-E749del,A750P)	0.5
PHA-665752	FLT3(K663Q)	270.0
Crizotinib	TRKC	82.0
Ruxolitinib	ROCK2	52.0
Sorafenib	TIE1	68.0
GSK 690693	KIT(V559D,V654A)	3500.0
Enzastaurin	CDK15	4900.0
Bosutinib	ABL1(H396P)-nonphosphorylated	0.06
Imatinib	CSF1R	11.0
Bosutinib	IRAK1	600.0
Tozasertib	CDKL5	2800.0
Neratinib	EGFR(S752-I759del)	0.6
PHA-665752	PLK4	410.0
Nintedanib	MAST1	4600.0
R406	PKNB(M.tuberculosis)	34.0
Bosutinib	LYN	4.2
Gefitinib	EGFR(L747-T751del,Sins)	0.5
Alvocidib	CSNK1A1	3100.0
Fedratinib	ABL1(M351T)-phosphorylated	50.0
Lestaurtinib	DCAMKL2	4500.0
Fedratinib	SIK2	98.0
Gefitinib	FLT3(D835H)	1100.0
PLX-4720	FLT3(ITD)	6100.0
Barasertib	RET	80.0
PLX-4720	PAK1	1400.0
Vandetanib	CDK7	4100.0
KW2449	RIPK1	64.0
Vandetanib	MLTK	5100.0
PKC412	KGP2	74.0
Fedratinib	AURKA	4400.0
Tozasertib	KIT(V559D)	240.0
Neratinib	TIE2	3000.0
MLN8054	EPHA4	420.0
Tozasertib	PKN1	1500.0
Fedratinib	CIT	140.0
GSK1838705A	HIPK1	1300.0
Nintedanib	S6K1	190.0
Foretinib	MET	1.4
Motesanib	RIPK2	9300.0
Lapatinib	EGFR(L747-S752del,P753S)	3.9
Dovitinib	MYLK	3500.0
GSK1838705A	HIPK4	1200.0
Crizotinib	DDR1	510.0
Ki20227	CSNK1E	520.0
Bosutinib	CDK16	2400.0
R406	RIPK4	220.0
Alvocidib	EGFR(S752-I759del)	1400.0
Sunitinib	LKB1	38.0
Bosutinib	FLT3(D835H)	1000.0
Sunitinib	INSR	500.0
Tofacitinib	PKN2	1200.0
Sunitinib	MP2K6	5200.0
BI-2536	STK16	1100.0
Barasertib	KIT(A829P)	600.0
Lestaurtinib	EGFR(L747-E749del,A750P)	320.0
Ruxolitinib	MP2K1	1900.0
Erlotinib	PGFRB	1400.0
Sorafenib	AURKC	210.0
PKC412	M3K2	140.0
Nintedanib	PCTK2	93.0
Ki20227	GAK	1500.0
PHA-665752	HUNK	1400.0
Dovitinib	RET(M918T)	47.0
Tozasertib	FLT3(R834Q)	130.0
Afatinib	ABL1(E255K)-phosphorylated	420.0
Ki20227	FLT3	240.0
Linifanib	EPHA5	1500.0
R406	MST2	3000.0
Lestaurtinib	TESK1	290.0
PKC412	PAK2	3300.0
Sunitinib	CIT	3900.0
Dasatinib	FLT3(ITD)	9900.0
Nintedanib	MYLK4	440.0
Dasatinib	LCK	0.2
PKC412	LKB1	350.0
Enzastaurin	CDK14	1500.0
GDC-0879	CSNK1E	130.0
Crizotinib	FGFR3(G697C)	3500.0
Barasertib	EGFR(L861Q)	510.0
SB 203580	EGFR(L858R,T790M)	1300.0
Sunitinib	CLK4	29.0
Barasertib	ABL1(H396P)-nonphosphorylated	1200.0
Vandetanib	CSF1R	1200.0
Sunitinib	CLK2	20.0
NVP-TAE684	ULK3	11.0
Bosutinib	GRK7	1700.0
Dasatinib	BMPR1B	53.0
Sorafenib	MERTK	3600.0
R406	CDK7	7700.0
NVP-TAE684	YSK4	2800.0
Nintedanib	ABL1(T315I)-nonphosphorylated	66.0
NVP-TAE684	EGFR(L747-T751del,Sins)	79.0
Lestaurtinib	PDPK1	3.4
Pazopanib	GAK	200.0
KW2449	RIOK1	47.0
PKC412	AXL	620.0
R406	ITK	400.0
GSK 690693	RET(M918T)	1300.0
Sunitinib	RIOK2	49.0
Bosutinib	KIT(D816V)	73.0
Lestaurtinib	STK16	19.0
Canertinib	MET(M1250T)	1700.0
Alvocidib	ABL1(H396P)-phosphorylated	1700.0
NVP-TAE684	PLK2	1200.0
Nintedanib	SGK3	1000.0
NVP-TAE684	EPHB4	750.0
Barasertib	RIPK2	1800.0
NVP-TAE684	ACVRL1	57.0
Alvocidib	CDK16	440.0
Lestaurtinib	AMPK-alpha2	56.0
KW2449	SGK3	96.0
SNS-032	SNARK	1700.0
Fedratinib	TTK	450.0
PKC412	ABL1(H396P)-phosphorylated	5600.0
Dasatinib	FLT3(N841I)	7000.0
PHA-665752	MARK2	3600.0
Tozasertib	RSK1(Kin.Dom.1-N-terminal)	7900.0
Lestaurtinib	HCK	270.0
Nintedanib	JNK1	630.0
SNS-032	MLCK	1700.0
BI-2536	KPCD1	320.0
Fedratinib	AXL	160.0
Fedratinib	EPHB1	1700.0
SGX523	PI42C	3300.0
Imatinib	ABL1(F317L)-phosphorylated	110.0
BMS345541	IKKB	130.0
Sunitinib	CAMK2G	690.0
Ki20227	AXL	140.0
Sunitinib	LRRK2(G2019S)	76.0
Nintedanib	TRKB	19.0
Dasatinib	PKMYT1	130.0
NVP-TAE684	MST3	2900.0
Dovitinib	LOK	550.0
Pazopanib	RIOK2	610.0
Sunitinib	RET(V804M)	5.8
Erlotinib	SBK1	1200.0
NVP-TAE684	TEC	180.0
Imatinib	ABL1(H396P)-phosphorylated	65.0
NVP-TAE684	FER	1.4
Nilotinib	ABL2	26.0
KW2449	KPCD2	1500.0
KW2449	TRKB	140.0
KW2449	AXL	180.0
KW2449	ERK5	2700.0
PKC412	ROCK2	2300.0
Sunitinib	TAOK3	210.0
Lestaurtinib	PLK2	330.0
Crizotinib	TYK2(JH2domain-pseudokinase)	2000.0
Dasatinib	ERBB2	1400.0
R406	FLT3(R834Q)	4.4
KW2449	MP2K1	530.0
Alvocidib	ABL1(Q252H)-nonphosphorylated	3100.0
Alvocidib	CLK1	1700.0
Sunitinib	KKCC1	420.0
Canertinib	BMX	2600.0
Sunitinib	EPHA7	2400.0
Sorafenib	CDK5	8300.0
Dovitinib	LRRK2	1500.0
Dovitinib	ABL1-phosphorylated	54.0
Sunitinib	KCC2D	420.0
Enzastaurin	GRK1	1700.0
NVP-TAE684	BMX	1100.0
Sunitinib	SNARK	150.0
PI103	CSNK2A1	5400.0
R406	NEK2	260.0
Lestaurtinib	ULK2	60.0
KW2449	NDR2	1100.0
Afatinib	AXL	5300.0
Sunitinib	FES	960.0
Tozasertib	FLT3(D835Y)	55.0
Canertinib	IRAK1	450.0
Masitinib	EGFR(L747-T751del,Sins)	1300.0
R406	ALK	240.0
Doramapimod	DDR2	33.0
Ruxolitinib	MST4	3100.0
Pazopanib	ABL1(E255K)-phosphorylated	800.0
Tozasertib	CDC2L1	290.0
Motesanib	FLT3(N841I)	1100.0
SNS-032	BRAF(V600E)	1600.0
RAF 265	RET(V804L)	320.0
Lestaurtinib	PKAC-beta	160.0
Doramapimod	PGFRB	1100.0
Lestaurtinib	TGFBR2	540.0
Fedratinib	ACVRL1	2400.0
Tozasertib	M4K1	72.0
Foretinib	EGFR(G719S)	370.0
KW2449	KGP2	800.0
PHA-665752	ABL1-phosphorylated	8200.0
PHA-665752	GRK7	61.0
PKC412	TYK2(JH1domain-catalytic)	250.0
Lestaurtinib	RET(M918T)	14.0
Tozasertib	MET(M1250T)	480.0
Ruxolitinib	KIT(D816V)	7100.0
Bosutinib	ABL1(T315I)-nonphosphorylated	21.0
Nintedanib	JAK3(JH1domain-catalytic)	8.2
Bosutinib	CHEK1	3000.0
Fedratinib	RIPK5	1700.0
Lestaurtinib	RSK3(Kin.Dom.2-C-terminal)	1200.0
Foretinib	STK35	230.0
Nintedanib	LYN	940.0
Crizotinib	MAP3K15	2800.0
Enzastaurin	MINK	3500.0
PHA-665752	TAOK3	43.0
Motesanib	ABL1(H396P)-nonphosphorylated	1400.0
Canertinib	ABL1(F317L)-phosphorylated	91.0
PKC412	MP2K4	4800.0
Fedratinib	DAPK3	1.2
Alvocidib	CDK7	23.0
GSK 690693	PKAC-alpha	19.0
AC220	KIT(V559D,V654A)	36.0
Foretinib	TESK1	260.0
Nintedanib	AAK1	63.0
Nintedanib	SLK	51.0
Sunitinib	PCTK3	1700.0
Foretinib	AMPK-alpha2	1200.0
Crizotinib	ALK	3.3
Ruxolitinib	SRPK3	3300.0
Alvocidib	MST2	9400.0
NVP-TAE684	PCTK2	810.0
Sunitinib	FLT3(R834Q)	11.0
KW2449	ABL1(H396P)-phosphorylated	24.0
Nintedanib	PHKG1	140.0
Fedratinib	SRC	75.0
Canertinib	ADCK3	1500.0
NVP-TAE684	PAK6	3500.0
Erlotinib	SRPK3	8300.0
KW2449	KPCD1	1200.0
GDC-0879	MAP4K4	2300.0
Bosutinib	NEK11	650.0
KW2449	EPHA1	150.0
PKC412	RSK3(Kin.Dom.1-N-terminal)	730.0
Nilotinib	EPHA5	1900.0
PKC412	KPCT	920.0
Crizotinib	SLK	18.0
Sunitinib	MLCK	23.0
NVP-TAE684	CAMK1	1100.0
Alvocidib	TNNI3K	55.0
Bosutinib	VRK2	710.0
Fedratinib	ANKK1	4300.0
Bosutinib	FAK1	570.0
KW2449	ULK1	53.0
Alvocidib	DMPK	650.0
RAF 265	TAOK3	720.0
Sunitinib	DRAK1	1.0
BI-2536	EGFR(E746-A750del)	1900.0
Enzastaurin	PKAC-beta	590.0
Ruxolitinib	STK39	1900.0
Vandetanib	BMPR1B	240.0
Fedratinib	PKN1	1100.0
KW2449	LATS1	5000.0
Sunitinib	BTK	2100.0
Sorafenib	KIT	28.0
Foretinib	TAK1	540.0
Nintedanib	M3K2	9.4
GSK1838705A	IGF1R	7.0
Crizotinib	ROCK2	3300.0
Tozasertib	MST1R	1300.0
Gefitinib	EGFR(L858R,T790M)	140.0
Foretinib	ABL1(T315I)-nonphosphorylated	18.0
Sunitinib	CAMKK2	1500.0
Alvocidib	TAOK2	250.0
BI-2536	HIPK4	2000.0
Erlotinib	HCK	1800.0
GSK461364	SLK	1100.0
Dovitinib	PKN1	180.0
Foretinib	KIT(D816H)	36.0
Nilotinib	PGFRA	180.0
Lestaurtinib	PIK3CA	4900.0
SB 203580	MK12	1500.0
Barasertib	ABL1(F317L)-phosphorylated	2300.0
Vandetanib	VGFR1	260.0
Tozasertib	ABL2	4.0
Crizotinib	TESK1	380.0
Canertinib	CIT	1300.0
RAF 265	TNNI3K	5900.0
SB 203580	EPHB6	3100.0
Canertinib	PTK6	3800.0
Neratinib	SIK1	220.0
Sunitinib	ULK1	23.0
Sunitinib	KPCD3	280.0
Alvocidib	EGFR(T790M)	1600.0
Fedratinib	ROCK2	2200.0
Canertinib	FGR	2800.0
PKC412	MYLK4	640.0
Lestaurtinib	ABL1(H396P)-nonphosphorylated	1000.0
Nintedanib	MP2K2	42.0
Vandetanib	EGFR(L858R,T790M)	230.0
Nintedanib	VGFR2	2.9
Crizotinib	FLT3(R834Q)	3000.0
NVP-TAE684	MST4	510.0
NVP-TAE684	AURKB	150.0
AC220	ABL1(T315I)-nonphosphorylated	2600.0
Gefitinib	FLT3(ITD)	2900.0
PHA-665752	FGFR2	5200.0
Canertinib	MINK	2100.0
Imatinib	GAK	1000.0
Afatinib	TXK	3100.0
Imatinib	BRAF(V600E)	3300.0
SB 203580	ABL1(H396P)-nonphosphorylated	2600.0
Lestaurtinib	SRPK2	51.0
NVP-TAE684	STK16	800.0
Canertinib	LRRK2	500.0
PKC412	ROS1	430.0
Vandetanib	MP2K1	1800.0
PLX-4720	ABL1(M351T)-phosphorylated	2600.0
Ki20227	KIT(V559D)	0.5
Lestaurtinib	BMPR2	1500.0
PHA-665752	M3K12	670.0
Ruxolitinib	SIK3	1300.0
Tozasertib	TLK1	4000.0
Sorafenib	MKNK1	230.0
Bosutinib	KIT(V559D,V654A)	130.0
Lestaurtinib	BRSK2	16.0
KW2449	RPS6KA5(Kin.Dom.2-C-terminal)	1900.0
SNS-032	CDK9	76.0
Tozasertib	MARK2	1400.0
Foretinib	CDKL5	2700.0
Bosutinib	CAMKK2	780.0
Barasertib	BLK	1500.0
Crizotinib	TNNI3K	110.0
KW2449	TYK2(JH2domain-pseudokinase)	520.0
GSK461364	BRSK2	8300.0
NVP-TAE684	DDR2	4100.0
Nilotinib	YES	1100.0
PKC412	M3K13	2800.0
NVP-TAE684	DRAK1	2900.0
MLN8054	BTK	4200.0
Fedratinib	CSF1R	620.0
Neratinib	MP2K5	63.0
Doramapimod	ABL1(T315I)-nonphosphorylated	59.0
Doramapimod	MLTK	860.0
Alvocidib	ABL1(H396P)-nonphosphorylated	1200.0
Selumetinib	EGFR(G719C)	4200.0
Dasatinib	LOK	1200.0
Imatinib	DDR1	0.7
NVP-TAE684	MARK1	31.0
Bosutinib	ABL1(Q252H)-phosphorylated	0.04
Lestaurtinib	ACVR1B	86.0
Fedratinib	FYN	38.0
Imatinib	ABL1(F317L)-nonphosphorylated	2.5
Afatinib	ABL1(F317L)-nonphosphorylated	580.0
Linifanib	TRKA	3100.0
Lestaurtinib	AAK1	3.1
Erlotinib	GAK	3.1
Dasatinib	ABL1(H396P)-nonphosphorylated	0.03
KW2449	CHK2	95.0
GSK1838705A	PLK1	47.0
NVP-TAE684	AURKC	33.0
R406	RET(V804L)	2.2
Fedratinib	BTK	850.0
PHA-665752	PCTK2	880.0
PKC412	EGFR(E746-A750del)	7000.0
Erlotinib	CIT	680.0
Fedratinib	NEK7	160.0
R406	SRC	8.4
Ki20227	EPHB6	5.0
BMS345541	ERN1	1000.0
Ruxolitinib	TRKC	330.0
Nilotinib	TNNI3K	360.0
Ruxolitinib	DCAMKL2	760.0
R406	HCK	150.0
KW2449	M3K13	500.0
PKC412	HIPK2	3100.0
Erlotinib	EGFR(G719S)	0.5
Nintedanib	PRP4	8.4
KW2449	RET(V804L)	35.0
Sunitinib	PLK4	190.0
Neratinib	EGFR	1.1
Erlotinib	FLT3(N841I)	500.0
AC220	TIE1	3200.0
Dovitinib	HIPK2	500.0
Lestaurtinib	STK39	1100.0
Lestaurtinib	PIM3	18.0
Linifanib	RET	100.0
Sunitinib	ABL1(Y253F)-phosphorylated	140.0
KW2449	LTK	920.0
NVP-TAE684	AURKA	44.0
SNS-032	JNK3	5900.0
RAF 265	DDR2	960.0
Ruxolitinib	RSK1(Kin.Dom.2-C-terminal)	120.0
Sunitinib	PIP5K2B	39.0
Fedratinib	TIE2	1900.0
PLX-4720	KIT(A829P)	5800.0
Ki20227	MST1R	3200.0
PHA-665752	STK16	4800.0
Dovitinib	GRK4	97.0
NVP-TAE684	YANK2	24.0
Dasatinib	KIT(D816H)	1.6
Barasertib	CDK7	6200.0
Fedratinib	CDKL5	7300.0
Doramapimod	CSF1R	8100.0
R406	EPHB6	310.0
Neratinib	M3K13	740.0
Nilotinib	ABL1(T315I)-nonphosphorylated	660.0
Imatinib	ABL1(F317I)-phosphorylated	580.0
RAF 265	ABL1(F317L)-nonphosphorylated	2400.0
Erlotinib	EPHB6	1700.0
MLN8054	SIK1	1700.0
Dasatinib	VGFR1	5000.0
R406	RPS6KA5(Kin.Dom.2-C-terminal)	150.0
SNS-032	CDKL3	1400.0
Ki20227	AURKC	150.0
Dovitinib	RET(V804L)	27.0
Canertinib	EGFR(L858R)	0.24
PKC412	PAK1	2100.0
R406	PIK3CD	4200.0
Alvocidib	CDC2L5	430.0
Lapatinib	EGFR(L861Q)	1.2
Foretinib	VGFR2	12.0
Dovitinib	ALK	3500.0
Lestaurtinib	CAMK1G	470.0
NVP-TAE684	M3K12	42.0
Tozasertib	SNARK	530.0
KW2449	ABL1(E255K)-phosphorylated	36.0
Erlotinib	MYLK2	970.0
Brivanib	STK33	3200.0
Vandetanib	ABL1(F317L)-nonphosphorylated	75.0
AC220	FRK	1800.0
PHA-665752	PLK2	8300.0
Masitinib	BLK	150.0
Canertinib	TGFBR2	800.0
Nintedanib	AMPK-alpha1	87.0
Nintedanib	KIT(V559D,V654A)	29.0
Motesanib	FGFR1	6200.0
GSK461364	KPCD	3000.0
Gefitinib	EGFR(G719C)	2.0
Sorafenib	EPHB6	240.0
Vandetanib	LYN	110.0
Pictilisib	PIK3CA(H1047L)	3.7
Erlotinib	MET	3800.0
KW2449	TTK	110.0
Sunitinib	IRAK1	14.0
Sunitinib	ABL1-phosphorylated	150.0
GSK 690693	KPCD	54.0
Canertinib	FYN	5300.0
Sunitinib	MERTK	26.0
Nintedanib	KIT(D816V)	47.0
Sunitinib	RSK3(Kin.Dom.2-C-terminal)	8400.0
Crizotinib	LIMK2	690.0
KW2449	NEK1	3100.0
MLN8054	LOK	3700.0
Nintedanib	CSNK1E	230.0
Lestaurtinib	BTK	66.0
Bosutinib	MAST1	350.0
PKC412	DAPK3	1800.0
Fedratinib	PAK6	6900.0
Tozasertib	EPHB4	1700.0
Sunitinib	ANKK1	310.0
NVP-TAE684	KIT(V559D,V654A)	1200.0
PKC412	RPS6KA4(Kin.Dom.1-N-terminal)	260.0
Fedratinib	FLT3(N841I)	20.0
Brivanib	FGFR4	600.0
NVP-TAE684	LTK	1.0
Brivanib	PGFRB	50.0
NVP-TAE684	TTK	50.0
Foretinib	CDC2L2	480.0
Erlotinib	GRK4	7300.0
Dovitinib	KIT(V559D)	7.2
Dovitinib	ABL1(E255K)-phosphorylated	75.0
Lestaurtinib	TNIK	5.4
Erlotinib	KIT(V559D,T670I)	1300.0
Afatinib	EGFR(L861Q)	0.2
Pictilisib	STK16	1100.0
NVP-TAE684	PKN2	680.0
Sorafenib	TRKB	2100.0
Vandetanib	TNIK	2300.0
Lestaurtinib	HIPK1	590.0
Barasertib	EGFR(L747-T751del,Sins)	3500.0
Fedratinib	MLK1	3200.0
Alvocidib	PHKG1	2200.0
NVP-TAE684	ROCK1	37.0
Brivanib	EGFR(G719C)	3000.0
PKC412	TRKB	310.0
Lestaurtinib	TIE2	630.0
Erlotinib	AAK1	1200.0
Nintedanib	FLT4	95.0
NVP-TAE684	ABL1-phosphorylated	170.0
KW2449	FRK	2100.0
SNS-032	RIOK2	1500.0
Fedratinib	DAPK1	16.0
Lestaurtinib	RIPK5	5.3
Vandetanib	MET	5700.0
Afatinib	ABL1-phosphorylated	570.0
KW2449	TNK1	580.0
Canertinib	JAK3(JH1domain-catalytic)	630.0
NVP-TAE684	PKNB(M.tuberculosis)	1200.0
Gefitinib	EGFR(G719S)	1.1
Linifanib	HIPK3	2300.0
Dasatinib	TNNI3K	11.0
Lestaurtinib	LRRK2	3.6
Dasatinib	ACVR2A	210.0
Nintedanib	ULK2	380.0
Lestaurtinib	AKT3	6200.0
Tozasertib	GCN2(Kin.Dom.2,S808G)	1900.0
Crizotinib	EPHA6	65.0
Sunitinib	CSNK1A1	99.0
Crizotinib	HIPK4	3600.0
R406	RET	4.1
Vandetanib	YES	120.0
NVP-TAE684	EGFR(L747-S752del,P753S)	110.0
Fedratinib	RSK2(Kin.Dom.1-N-terminal)	8100.0
Erlotinib	EPHA7	1400.0
Fedratinib	EGFR(L747-S752del,P753S)	5600.0
Lestaurtinib	MP2K6	44.0
Masitinib	SRC	900.0
Doramapimod	DMPK2	1200.0
SNS-032	CLK4	800.0
Erlotinib	VGFR2	5700.0
MLN8054	AXL	440.0
Sunitinib	CDKL2	1100.0
Dovitinib	TIE1	4000.0
Foretinib	SRC	20.0
R406	CAMK1	230.0
Gefitinib	EGFR(S752-I759del)	1.0
AC220	EPHB6	1200.0
SNS-032	DCAMKL3	1600.0
NVP-TAE684	ABL1(F317L)-nonphosphorylated	54.0
RAF 265	FYN	2100.0
Fedratinib	DRAK1	610.0
Afatinib	PHKG2	470.0
NVP-TAE684	ICK	4000.0
Foretinib	RIPK1	850.0
PKC412	CSF1R	330.0
Dasatinib	JAK2(JH1domain-catalytic)	1000.0
Pictilisib	GAK	2700.0
MLN8054	SRC	800.0
Linifanib	KIT(D816H)	1100.0
Bosutinib	MET(M1250T)	6800.0
Sunitinib	MINK	29.0
Foretinib	CDKL2	240.0
Ruxolitinib	MAP3K15	1100.0
Sunitinib	BRSK2	1100.0
Motesanib	HCK	8600.0
Sunitinib	AURKC	220.0
Fedratinib	IRAK1	220.0
Lestaurtinib	HUNK	570.0
Motesanib	GCN2(Kin.Dom.2,S808G)	4400.0
Sunitinib	CHEK1	300.0
Afatinib	IRAK1	240.0
Neratinib	MP2K2	26.0
Barasertib	FLT4	2900.0
Bosutinib	ABL1(F317L)-nonphosphorylated	0.11
KW2449	FLT3(K663Q)	6.6
Dovitinib	PIP5K1C	4300.0
Bosutinib	PKN2	3200.0
NVP-TAE684	DYRK1B	4500.0
KW2449	KIT(A829P)	860.0
Foretinib	FES	110.0
GSK461364	FLT3(R834Q)	4800.0
Alvocidib	TAOK1	140.0
PKC412	ROCK1	7800.0
SB 203580	PFCDPK1(P.falciparum)	850.0
PHA-665752	HIPK3	63.0
GSK461364	NEK2	260.0
PKC412	PFCDPK1(P.falciparum)	950.0
Lestaurtinib	CSF1R	110.0
Crizotinib	ROCK1	3700.0
Pazopanib	FLT3(R834Q)	9600.0
Afatinib	RIPK2	2700.0
Ki20227	BMPR1B	2200.0
Lestaurtinib	DAPK2	63.0
Canertinib	ABL1-phosphorylated	30.0
Dasatinib	MK11	410.0
NVP-TAE684	S6K1	2700.0
Tozasertib	RSK3(Kin.Dom.1-N-terminal)	2000.0
Linifanib	CDC2L5	38.0
Sorafenib	ABL1(E255K)-phosphorylated	3400.0
NVP-TAE684	ERN1	180.0
Lestaurtinib	EPHB1	5200.0
Brivanib	EPHA7	1700.0
KW2449	DMPK2	2100.0
Bosutinib	MP2K7	5300.0
R406	TEC	1600.0
KW2449	BMPR1B	120.0
Canertinib	MAP4K2	330.0
Dovitinib	YES	580.0
Pazopanib	FLT3(ITD)	2500.0
Tozasertib	PCTK2	5600.0
R406	GAK	250.0
Erlotinib	LYN	530.0
Alvocidib	KKCC1	79.0
Alvocidib	M3K2	6100.0
PI103	HIPK1	3300.0
Vandetanib	SRC	70.0
Gefitinib	LCK	630.0
Fedratinib	MLCK	9700.0
Alvocidib	CDK15	330.0
R406	PKAC-alpha	600.0
Foretinib	FLT3(ITD)	2.6
R406	STK33	970.0
Foretinib	AXL	0.1
KW2449	MINK	25.0
R406	RSK1(Kin.Dom.2-C-terminal)	3800.0
PKC412	KCC2D	36.0
Fedratinib	STK36	870.0
Fedratinib	PAK1	3100.0
Neratinib	MELK	1600.0
Crizotinib	MERTK	3.6
Bosutinib	FRK	1.4
Gefitinib	ERK4	3100.0
PKC412	ALK	270.0
Dovitinib	ULK1	55.0
KW2449	GRK4	71.0
Sunitinib	MYLK2	49.0
Masitinib	FGR	640.0
Alvocidib	JAK2(JH1domain-catalytic)	5500.0
Neratinib	TXK	4800.0
Barasertib	MLTK	1700.0
Sunitinib	DCLK1	370.0
Ruxolitinib	EPHA3	6100.0
BI-2536	RSK3(Kin.Dom.2-C-terminal)	700.0
Sunitinib	YSK4	17.0
Crizotinib	MET	2.1
SNS-032	TGFBR2	2400.0
Lestaurtinib	KPCT	100.0
KW2449	EPHB4	2900.0
Alvocidib	ACVR1	1900.0
Gefitinib	MKNK2	1200.0
Imatinib	HIPK4	960.0
GSK1838705A	MP2K4	910.0
Nintedanib	ULK3	60.0
R406	BTK	190.0
Alvocidib	DCLK1	2100.0
Vandetanib	RSK1(Kin.Dom.2-C-terminal)	400.0
Canertinib	ABL1-nonphosphorylated	210.0
Nintedanib	MST2	38.0
KW2449	TAOK3	1000.0
Nilotinib	TAOK1	4700.0
Motesanib	KIT(A829P)	15.0
Alvocidib	DCAMKL3	1100.0
Nilotinib	CLK1	2100.0
KW2449	PRKR	3600.0
Tozasertib	SRPK3	240.0
Barasertib	ABL1-phosphorylated	5500.0
Neratinib	TNK2	680.0
PI103	MTOR	12.0
Foretinib	AURKC	12.0
Ruxolitinib	TYK2(JH1domain-catalytic)	0.9
Foretinib	EPHA3	1.0
Motesanib	EGFR(L858R)	7100.0
Nintedanib	PKNB(M.tuberculosis)	3.6
Lestaurtinib	EPHA4	1700.0
Afatinib	FLT3(N841I)	6200.0
Neratinib	SRC	4100.0
Ki20227	NEK11	1100.0
Doramapimod	MK13	78.0
Lestaurtinib	PLK1	220.0
Bosutinib	NIM1	1500.0
Foretinib	M3K12	22.0
PHA-665752	CSNK2A2	5600.0
Dasatinib	ABL1(M351T)-phosphorylated	0.02
RAF 265	MET	6200.0
Vandetanib	EPHA8	91.0
Tozasertib	CHEK1	8700.0
Erlotinib	ABL1-phosphorylated	76.0
Motesanib	FLT3	71.0
MLN8054	EPHB4	560.0
Pictilisib	DAPK3	1800.0
Ki20227	ABL1(Q252H)-phosphorylated	1400.0
Nilotinib	LYN	100.0
Bosutinib	MAP3K1	4400.0
NVP-TAE684	MAP3K3	320.0
Pazopanib	YSK4	940.0
Tozasertib	RIPK4	300.0
PKC412	GSK3B	1800.0
PHA-665752	IRAK4	2500.0
Lestaurtinib	KIT(V559D,T670I)	45.0
Sorafenib	LCK	2700.0
Lestaurtinib	ULK3	4.9
Gefitinib	MINK	1800.0
Lapatinib	LOK	4400.0
KW2449	MUSK	200.0
MLN8054	FAK2	2000.0
KW2449	MAP4K5	260.0
AC220	RET	8.0
Dovitinib	AAK1	170.0
NVP-TAE684	RIPK4	3200.0
Lestaurtinib	KKCC1	23.0
Afatinib	ABL1(F317I)-nonphosphorylated	2900.0
Dovitinib	TYK2(JH2domain-pseudokinase)	2200.0
Neratinib	WEE2	1300.0
Foretinib	JAK2(JH1domain-catalytic)	1500.0
Lestaurtinib	SBK1	200.0
NVP-TAE684	MET(Y1235D)	180.0
Bosutinib	CSF1R	380.0
GSK1838705A	EGFR(T790M)	74.0
Foretinib	HUNK	5400.0
NVP-TAE684	ABL1(T315I)-phosphorylated	5.4
R406	FLT4	9.1
Foretinib	FLT3	0.9
PHA-665752	CAMK2G	2000.0
PHA-665752	CDK16	1100.0
Foretinib	KIT(A829P)	3.2
Sunitinib	PGFRB	0.1
Dovitinib	TYK2(JH1domain-catalytic)	150.0
NVP-TAE684	LIMK2	1100.0
Barasertib	TIE1	350.0
KW2449	TBK1	130.0
R406	ABL1(E255K)-phosphorylated	220.0
VX-745	LCK	4600.0
Doramapimod	EGFR(G719C)	6000.0
Bosutinib	EPHB6	3000.0
Linifanib	FLT3(D835H)	2.7
Gefitinib	EPHA1	4000.0
Dovitinib	ITK	530.0
GSK461364	PIM1	250.0
Foretinib	DDR1	0.2
SB 203580	MAP4K4	3700.0
Tozasertib	CDKL3	350.0
Foretinib	ALK	69.0
Ruxolitinib	PAK6	2900.0
Alvocidib	HIPK1	6800.0
Fedratinib	SRPK3	170.0
AC220	DDR1	81.0
Lestaurtinib	GSK3A	2300.0
Brivanib	ABL1(Q252H)-nonphosphorylated	1500.0
Pazopanib	FER	2700.0
Fedratinib	PLK1	280.0
Fedratinib	FLT3(R834Q)	29.0
Vandetanib	ABL1(F317I)-nonphosphorylated	770.0
Erlotinib	LRRK2	2900.0
Bosutinib	FGR	6.3
Nintedanib	ABL1-nonphosphorylated	230.0
Ruxolitinib	MAST1	520.0
Lestaurtinib	ERBB4	1400.0
Fedratinib	DAPK2	29.0
Tozasertib	INSR	630.0
Dovitinib	PRKR	2800.0
Foretinib	MST1R	3.0
Lestaurtinib	NDR2	370.0
MLN8054	DRAK2	8.1
PKC412	FLT3(N841I)	6.0
Pazopanib	IRAK3	800.0
Nintedanib	MARK3	770.0
Linifanib	CLK4	1600.0
Dovitinib	NIM1	850.0
Dasatinib	ABL1(Y253F)-phosphorylated	0.06
BI-2536	RPS6KA5(Kin.Dom.2-C-terminal)	270.0
GSK1838705A	CHK2	280.0
Neratinib	MST1R	8400.0
NVP-TAE684	EGFR(G719C)	2000.0
Imatinib	EGFR(L747-E749del,A750P)	7600.0
Fedratinib	RET(V804L)	71.0
Nilotinib	TRKB	490.0
Gefitinib	MAP3K3	2100.0
Lestaurtinib	KGP1	370.0
Imatinib	KIT	13.0
Masitinib	ABL1(F317L)-nonphosphorylated	10.0
Vandetanib	KIT(V559D)	180.0
Nilotinib	ABL1(F317I)-nonphosphorylated	18.0
Barasertib	LCK	380.0
Crizotinib	KIT(V559D,T670I)	800.0
Sorafenib	TNIK	7900.0
Dasatinib	LIMK2	86.0
Nilotinib	RET	870.0
Erlotinib	EGFR(E746-A750del)	0.5
Vandetanib	PHKG1	1100.0
GSK1838705A	YSK4	190.0
Erlotinib	MERTK	980.0
KW2449	JAK1(JH1domain-catalytic)	1200.0
PHA-665752	GRK4	420.0
Canertinib	EPHA3	2100.0
PKC412	JNK3	3600.0
Tozasertib	FLT3(K663Q)	4.8
NVP-TAE684	MLK3	420.0
Lestaurtinib	MP2K4	3.8
Crizotinib	IGF1R	780.0
RAF 265	EPHA6	1500.0
Nintedanib	EPHA3	8600.0
Bosutinib	EGFR(T790M)	340.0
Fedratinib	MKNK2	380.0
MLN8054	ABL1-phosphorylated	890.0
Pictilisib	IRAK3	1700.0
Alvocidib	MLK1	5700.0
Tozasertib	NEK7	8700.0
Dovitinib	RSK3(Kin.Dom.1-N-terminal)	310.0
Foretinib	FGFR3	910.0
Bosutinib	FLT3(D835Y)	1100.0
Neratinib	WEE1	4100.0
Foretinib	PTK6	4.3
Tozasertib	WEE1	3200.0
KW2449	MARK1	310.0
KW2449	PHKG1	210.0
SNS-032	CDK4-cyclinD3	66.0
NVP-TAE684	ABL1(F317I)-nonphosphorylated	93.0
Masitinib	KIT(D816V)	1300.0
R406	AURKC	41.0
Alvocidib	PFPK5(P.falciparum)	3300.0
Fedratinib	MAP3K3	1300.0
Fedratinib	PGFRB	45.0
PLX-4720	CDK11	700.0
Ki20227	DDR2	88.0
Foretinib	MAP3K4	1900.0
Fedratinib	EPHA7	6500.0
Sunitinib	MKNK2	5700.0
GDC-0879	RIOK2	1200.0
Foretinib	M4K3	110.0
Brivanib	ABL1(H396P)-nonphosphorylated	390.0
KW2449	RET(V804M)	35.0
Fedratinib	MELK	2600.0
Imatinib	FGR	2400.0
PKC412	EGFR(L747-S752del,P753S)	1700.0
Lestaurtinib	KPCD3	8.9
GSK1838705A	DYRK1B	970.0
Barasertib	ABL1(Q252H)-phosphorylated	6800.0
Doramapimod	EGFR(S752-I759del)	7600.0
R406	JNK3	37.0
Bosutinib	WEE2	94.0
Ki20227	YES	3100.0
Vandetanib	MP2K2	1100.0
Doramapimod	ABL1-nonphosphorylated	800.0
Afatinib	FLT3(D835Y)	1400.0
Lestaurtinib	MAP3K1	4400.0
Dasatinib	GAK	2.6
Pazopanib	MAP3K1	2900.0
GSK461364	TIE1	1400.0
Fedratinib	GAK	1.1
NVP-TAE684	INSRR	6.2
KW2449	HIPK2	300.0
PKC412	PLK4	66.0
Lestaurtinib	CDK7	87.0
Tozasertib	TESK1	5600.0
Erlotinib	JAK3(JH1domain-catalytic)	700.0
Bosutinib	CAMK2G	3600.0
Linifanib	EPHA3	3500.0
Lestaurtinib	TIE1	680.0
Dovitinib	TYRO3	9300.0
Bosutinib	CAMK2A	4500.0
Alvocidib	TAOK3	99.0
Sunitinib	LCK	230.0
Afatinib	ERBB3	4500.0
Sunitinib	TNK2	8900.0
Gefitinib	KPCD1	3500.0
Bosutinib	RSK2(Kin.Dom.1-N-terminal)	1200.0
KW2449	PAK6	1300.0
NVP-TAE684	EPHA6	120.0
Gefitinib	DMPK	6900.0
KW2449	NEK7	210.0
Erlotinib	ADCK3	1900.0
Vandetanib	ACVRL1	470.0
SNS-032	CDK7	31.0
PKC412	FGR	730.0
Neratinib	RSK3(Kin.Dom.1-N-terminal)	4100.0
Dovitinib	GRK7	1300.0
PLX-4720	DDR2	4100.0
Dovitinib	NEK6	1500.0
R406	TLK1	490.0
Sorafenib	PGFRA	62.0
Sunitinib	IRAK3	940.0
Sorafenib	RSK4(Kin.Dom.2-C-terminal)	7500.0
R406	INSRR	4600.0
Alvocidib	KPCD2	1100.0
Vandetanib	KIT	260.0
Tozasertib	INSRR	290.0
GSK1838705A	EGFR(L747-T751del,Sins)	2900.0
Lestaurtinib	CDK4-cyclinD3	35.0
SNS-032	GAK	1800.0
Crizotinib	JAK3(JH1domain-catalytic)	200.0
Nintedanib	CLK2	760.0
Erlotinib	DMPK	2900.0
Vandetanib	KIT(D816V)	290.0
Fedratinib	M3K13	590.0
Lestaurtinib	KPCE	160.0
Sunitinib	CDK4-cyclinD3	2000.0
PHA-665752	RET	690.0
GSK1838705A	HIPK3	3400.0
Masitinib	ABL1-nonphosphorylated	2.1
NVP-TAE684	KIT(D816H)	140.0
Vandetanib	EPHA1	230.0
Enzastaurin	PIM3	1100.0
Canertinib	FLT3(ITD)	3000.0
Afatinib	ERBB4	6.3
Neratinib	KPCD1	820.0
Dovitinib	RSK1(Kin.Dom.1-N-terminal)	450.0
Bosutinib	EIF2AK1	630.0
Lestaurtinib	TBK1	18.0
Lestaurtinib	ABL1-phosphorylated	1000.0
Motesanib	EGFR	1300.0
NVP-TAE684	JNK3	67.0
Afatinib	RSK4(Kin.Dom.2-C-terminal)	3100.0
Alvocidib	CDK5	110.0
MLN8054	ABL1(M351T)-phosphorylated	750.0
Crizotinib	YES	770.0
Vandetanib	MRCKA	2600.0
Dasatinib	SRMS	13.0
Lestaurtinib	MP2K1	3.5
Imatinib	ABL1(Q252H)-phosphorylated	92.0
Tozasertib	RIOK2	250.0
NVP-TAE684	ITK	34.0
KW2449	MYLK2	52.0
Enzastaurin	PKN1	5100.0
Nilotinib	EPHA8	37.0
Ruxolitinib	PIK4CB	3400.0
Lestaurtinib	EGFR(L858R)	860.0
Tozasertib	EPHB6	28.0
R406	KGP2	3600.0
Fedratinib	ABL1(F317I)-phosphorylated	560.0
Neratinib	DRAK2	1100.0
Lestaurtinib	SRPK3	13.0
PLX-4720	CLK1	6600.0
KW2449	MK09	230.0
PLX-4720	TNK2	1100.0
PKC412	MLCK	2300.0
Tozasertib	FLT3(ITD)	45.0
Lestaurtinib	PIK3CD	4000.0
Tozasertib	SRPK2	680.0
Brivanib	SRC	1600.0
Bosutinib	TIE2	3900.0
PKC412	S6K1	1300.0
Dovitinib	RET(V804M)	26.0
Sunitinib	BIKE	5.5
R406	NEK4	1800.0
Fedratinib	AURKC	350.0
Lestaurtinib	ABL1(T315I)-phosphorylated	160.0
Foretinib	VGFR1	3.8
SB 203580	EGFR(L747-S752del,P753S)	1600.0
Alvocidib	GAK	370.0
Tozasertib	ABL1(F317L)-phosphorylated	400.0
Gefitinib	AXL	1800.0
Vandetanib	DDR2	320.0
Vandetanib	FGFR1	560.0
PKC412	RET(V804L)	27.0
PLX-4720	OSR1	3900.0
PHA-665752	DRAK2	3500.0
Dovitinib	LATS1	1700.0
Nintedanib	ACVR1B	4900.0
Sunitinib	M4K3	180.0
Crizotinib	PRKR	1100.0
Nintedanib	BLK	380.0
BI-2536	ABL1(H396P)-nonphosphorylated	2000.0
Dovitinib	CDK4-cyclinD3	2900.0
MLN8054	FGFR1	2400.0
PHA-665752	CDK7	130.0
Foretinib	CDC2L1	640.0
Canertinib	ABL2	870.0
Crizotinib	MAP4K2	80.0
Barasertib	ERBB4	470.0
KW2449	ABL1(T315I)-nonphosphorylated	12.0
Pazopanib	RAF1	900.0
Bosutinib	EPHB1	33.0
Dovitinib	ABL1(T315I)-nonphosphorylated	110.0
Nintedanib	EPHB1	550.0
PKC412	EGFR(L858R,T790M)	8.8
Sunitinib	FGFR3	290.0
Pictilisib	JNK3	560.0
Pazopanib	TGFBR2	3000.0
Masitinib	PIM3	720.0
Canertinib	LYN	810.0
Sunitinib	IRAK4	66.0
PLX-4720	SRMS	21.0
Sunitinib	ICK	470.0
PHA-665752	AMPK-alpha1	310.0
Fedratinib	MYLK2	3000.0
Fedratinib	LRRK2(G2019S)	1000.0
Bosutinib	MYO3B	2300.0
Bosutinib	BMX	200.0
Doramapimod	CDK7	3100.0
SB 203580	CSNK1D	37.0
Ruxolitinib	ABL1(E255K)-phosphorylated	2200.0
PHA-665752	FGFR3	5200.0
SB 203580	DDR2	5000.0
R406	EPHA7	39.0
Lestaurtinib	TYK2(JH2domain-pseudokinase)	910.0
NVP-TAE684	MAP3K15	800.0
Sorafenib	KIT(V559D,V654A)	240.0
NVP-TAE684	JAK1(JH1domain-catalytic)	410.0
PKC412	SRPK1	42.0
Fedratinib	RSK1(Kin.Dom.2-C-terminal)	420.0
Alvocidib	JNK1	1600.0
Gefitinib	ABL1(M351T)-phosphorylated	520.0
Linifanib	MUSK	10.0
MLN8054	ABL1(H396P)-nonphosphorylated	510.0
BMS345541	YSK4	260.0
Ki20227	MAP4K5	3000.0
PHA-665752	KIT(L576P)	1300.0
Lestaurtinib	KPCL	140.0
Fedratinib	CSNK2A1	920.0
Alvocidib	STK33	1700.0
KW2449	SIK3	2300.0
Neratinib	EGFR(T790M)	1.5
Linifanib	RET(V804L)	970.0
KW2449	RPS6KA4(Kin.Dom.2-C-terminal)	1100.0
Tofacitinib	RET(M918T)	3300.0
KW2449	MAP4K2	11.0
Barasertib	VGFR2	500.0
Lestaurtinib	VGFR2	220.0
Bosutinib	WEE1	510.0
Alvocidib	PRKR	5200.0
Linifanib	CDC2L2	1200.0
Sorafenib	CDK8	310.0
Sunitinib	MP2K5	46.0
Lestaurtinib	TLK2	64.0
Vandetanib	FLT3(D835Y)	830.0
SNS-032	GSK3B	37.0
NVP-TAE684	PFCDPK1(P.falciparum)	710.0
Sorafenib	TAK1	690.0
Selumetinib	EGFR(L747-T751del,Sins)	5500.0
Linifanib	KIT(V559D,V654A)	21.0
Vandetanib	TIE2	1000.0
Lestaurtinib	FGFR3	580.0
Sunitinib	CSNK1G3	240.0
Nintedanib	MET(Y1235D)	460.0
Masitinib	KIT(A829P)	12.0
R406	ABL2	720.0
R406	TIE1	76.0
SNS-032	CDC2L5	23.0
KW2449	IKKE	340.0
PHA-665752	GCN2(Kin.Dom.2,S808G)	3400.0
Sunitinib	PIM3	2400.0
Sunitinib	YSK1	290.0
Tozasertib	MET(Y1235D)	360.0
Vandetanib	MAP4K2	1600.0
Fedratinib	TRKC	8600.0
Barasertib	TTK	8500.0
Linifanib	KIT(D816V)	81.0
PKC412	PRKR	6900.0
Crizotinib	FGR	670.0
Sunitinib	ABL1(F317L)-phosphorylated	370.0
Tozasertib	SIK1	2500.0
Gefitinib	ABL1(H396P)-nonphosphorylated	680.0
Ki20227	MP2K2	2800.0
Motesanib	LCK	360.0
Alvocidib	LRRK2	1000.0
Foretinib	MKNK1	72.0
PHA-665752	AURKB	2000.0
Pazopanib	SIK1	2200.0
PKC412	MARK1	170.0
Tozasertib	KIT(L576P)	230.0
R406	AXL	82.0
R406	CAMK2A	1100.0
GSK461364	GCN2(Kin.Dom.2,S808G)	4100.0
Lestaurtinib	MET(Y1235D)	41.0
KW2449	CDK16	830.0
Enzastaurin	DRAK1	760.0
Crizotinib	MET(Y1235D)	1.5
PKC412	MST2	220.0
R406	MK09	47.0
Foretinib	DAPK3	3100.0
Vandetanib	ROCK2	3600.0
Lestaurtinib	YES	160.0
Sorafenib	ABL1(F317I)-nonphosphorylated	1700.0
Linifanib	MERTK	870.0
SNS-032	CASK	400.0
Selumetinib	EGFR(S752-I759del)	5000.0
Tozasertib	FLT3(D835H)	14.0
Sunitinib	CTK	7700.0
Vandetanib	HCK	360.0
Nintedanib	CAMK1D	2200.0
Sunitinib	MELK	350.0
GSK1838705A	OSR1	4200.0
Tofacitinib	CAMK1	1200.0
Ruxolitinib	CLK4	1700.0
Fedratinib	AURKB	490.0
Pazopanib	KIT(V559D)	2.3
R406	ANKK1	330.0
Alvocidib	CAMK2B	4700.0
Fedratinib	FGFR2	470.0
Vandetanib	MET(Y1235D)	4100.0
R406	CDKL2	5900.0
SNS-032	CLK2	1100.0
Pazopanib	FLT3(N841I)	1600.0
NVP-TAE684	GRK1	410.0
PHA-665752	CDK9	1800.0
Linifanib	KIT(V559D)	1.7
Vandetanib	EPHB4	520.0
Neratinib	MLK1	5400.0
Alvocidib	IRAK1	540.0
Dovitinib	HCK	3300.0
Doramapimod	TNIK	140.0
Foretinib	TRKB	4.1
Sunitinib	FLT3(D835Y)	2.3
Motesanib	RET	14.0
Pazopanib	TYK2(JH1domain-catalytic)	3400.0
NVP-TAE684	STK39	150.0
Alvocidib	HIPK2	4200.0
Fedratinib	PIK3CA(H1047L)	3900.0
Nintedanib	LRRK2	46.0
GSK1838705A	EGFR(L858R,T790M)	150.0
GSK1838705A	JAK2(JH1domain-catalytic)	5300.0
NVP-TAE684	HUNK	350.0
Dasatinib	STK36	210.0
Erlotinib	HIPK4	960.0
Fedratinib	FAK1	42.0
Bosutinib	MLTK	80.0
Alvocidib	MLK2	5200.0
Bosutinib	IRAK4	360.0
Foretinib	ABL1(Y253F)-phosphorylated	37.0
Gefitinib	FLT3(R834Q)	3500.0
NVP-TAE684	IRAK3	160.0
Alvocidib	EGFR(L861Q)	1200.0
Foretinib	ABL2	27.0
Pictilisib	FLT3(D835H)	1700.0
SNS-032	CSNK1E	950.0
Canertinib	JNK3	5500.0
Dasatinib	EGFR(L747-E749del,A750P)	110.0
R406	IRAK1	9.7
Fedratinib	INSR	850.0
R406	VGFR2	40.0
Vandetanib	EPHA6	50.0
Linifanib	DDR2	3800.0
Lestaurtinib	M4K3	110.0
Barasertib	CDC2L2	1000.0
Fedratinib	SGK3	2500.0
Sunitinib	MAP4K5	41.0
AC220	LCK	2500.0
VX-745	BLK	3100.0
Motesanib	ABL1(Q252H)-nonphosphorylated	670.0
R406	GRK4	450.0
Vandetanib	EPHA7	2400.0
MLN8054	AURKA	6.5
Dovitinib	JAK1(JH2domain-pseudokinase)	380.0
GSK1838705A	FLT3(D835H)	2400.0
R406	TRKC	570.0
Dovitinib	NEK5	2300.0
Motesanib	MAP4K4	5800.0
Lestaurtinib	MARK3	49.0
PKC412	MERTK	2900.0
PKC412	CLK4	410.0
Brivanib	ABL1(H396P)-phosphorylated	640.0
Crizotinib	M4K3	75.0
NVP-TAE684	MRCKB	4800.0
R406	SRMS	610.0
Sorafenib	LIMK2	9600.0
Canertinib	IRAK3	3000.0
Pazopanib	FGR	1600.0
Bosutinib	MST4	37.0
Alvocidib	CDK4-cyclinD3	3.3
Ruxolitinib	STK16	490.0
Motesanib	EGFR(L747-S752del,P753S)	4500.0
NVP-TAE684	MARK3	12.0
Pictilisib	PIK3C2G	300.0
PHA-665752	PAK1	2900.0
Sunitinib	VGFR1	1.8
Canertinib	RET(M918T)	840.0
Fedratinib	FLT3	13.0
Canertinib	AURKC	2800.0
PI103	TYK2(JH2domain-pseudokinase)	5900.0
GSK461364	FLT3(D835Y)	430.0
Brivanib	ABL1(M351T)-phosphorylated	450.0
Foretinib	CDK14	31.0
Lestaurtinib	FGR	52.0
Gefitinib	EPHA8	1800.0
Dasatinib	EPHB2	0.39
Sunitinib	EPHA5	1200.0
RAF 265	MAP4K4	1300.0
PKC412	VGFR2	3200.0
Lestaurtinib	KPCI	1800.0
Sunitinib	M4K1	16.0
Crizotinib	CDC2L2	420.0
PLX-4720	CLK2	2600.0
Vandetanib	FGFR4	2300.0
Tozasertib	ACVRL1	9500.0
GSK461364	PIK3CG	1900.0
KW2449	ABL1(Y253F)-phosphorylated	36.0
Dovitinib	MST2	480.0
Dovitinib	KIT	7.5
Foretinib	HCK	15.0
KW2449	CDK15	2600.0
Tozasertib	ABL1(F317L)-nonphosphorylated	480.0
GSK1838705A	CLK2	16.0
Erlotinib	EPHA3	2400.0
Canertinib	TIE1	2200.0
Tozasertib	TRKA	38.0
SB 203580	YANK1	1300.0
PLX-4720	VGFR1	1900.0
Lestaurtinib	CTK	970.0
Tozasertib	IRAK4	3700.0
Neratinib	FLT3(D835Y)	3100.0
Dovitinib	TBK1	130.0
PKC412	PIM3	560.0
PI103	DAPK2	2700.0
NVP-TAE684	BRSK1	310.0
Tozasertib	EPHA2	840.0
Dasatinib	ERBB4	55.0
Foretinib	ABL1(Q252H)-nonphosphorylated	4.0
BI-2536	IRAK1	1900.0
Lestaurtinib	ACVR2B	3800.0
Nintedanib	MLK3	700.0
R406	EGFR(S752-I759del)	450.0
Sunitinib	KIT(A829P)	43.0
Crizotinib	KPCD3	510.0
KW2449	DDR2	2100.0
PKC412	SIK2	560.0
Pictilisib	EPHB6	1600.0
BI-2536	DMPK	2900.0
Crizotinib	ULK3	6700.0
NVP-TAE684	DAPK1	1800.0
Alvocidib	CIT	110.0
PKC412	AURKC	170.0
KW2449	SLK	13.0
Ruxolitinib	ROCK1	60.0
Crizotinib	ABL1(Q252H)-phosphorylated	100.0
Nintedanib	ABL1(H396P)-phosphorylated	49.0
Erlotinib	AURKA	2200.0
Pazopanib	M3K2	290.0
Linifanib	KIT(V559D,T670I)	3.8
Foretinib	AURKA	440.0
Fedratinib	LKB1	310.0
PHA-665752	IRAK3	610.0
PKC412	EGFR(L747-T751del,Sins)	1900.0
Foretinib	ANKK1	1500.0
PKC412	FLT3(R834Q)	12.0
Brivanib	MAP4K5	1400.0
Nintedanib	DAPK2	3200.0
SB 203580	DMPK2	400.0
Dovitinib	ROCK2	3100.0
NVP-TAE684	EGFR(L861Q)	98.0
SNS-032	CDK15	740.0
GSK1838705A	MK09	520.0
Alvocidib	TYK2(JH1domain-catalytic)	180.0
Fedratinib	ABL1(E255K)-phosphorylated	40.0
Crizotinib	LTK	12.0
Tozasertib	TRKC	200.0
NVP-TAE684	M3K2	110.0
R406	MK13	690.0
Linifanib	YANK1	640.0
Lestaurtinib	MK12	370.0
Canertinib	ITK	5600.0
PKC412	MELK	280.0
Neratinib	EGFR(L747-S752del,P753S)	0.9
Lestaurtinib	YANK1	2100.0
GSK1838705A	JNK3	130.0
PKC412	PRP4	55.0
Bosutinib	EPHA5	27.0
Fedratinib	CASK	2800.0
Lestaurtinib	FAK1	1100.0
Bosutinib	YSK4	16.0
Nintedanib	EPHA6	940.0
Nilotinib	JNK1	450.0
AC220	RET(V804M)	9.1
GSK 690693	PKNB(M.tuberculosis)	3.2
Vandetanib	RIPK4	620.0
Sunitinib	EGFR(T790M)	2400.0
Enzastaurin	RPS6KA5(Kin.Dom.1-N-terminal)	370.0
Ruxolitinib	PLK2	1500.0
Bosutinib	FER	360.0
Gefitinib	EPHB1	1300.0
Ki20227	FLT3(K663Q)	200.0
NVP-TAE684	PLK4	0.9
Canertinib	FLT3(D835H)	1200.0
Fedratinib	PIP5K1A	66.0
Linifanib	MAP4K5	910.0
PHA-665752	CDK4-cyclinD3	380.0
SNS-032	FLT3(D835Y)	3000.0
Foretinib	EGFR(L747-E749del,A750P)	160.0
Foretinib	IGF1R	430.0
KW2449	LKB1	240.0
R406	ABL1(H396P)-nonphosphorylated	170.0
AC220	CSF1R	10.0
BI-2536	TTK	2500.0
Alvocidib	RSK1(Kin.Dom.2-C-terminal)	720.0
KW2449	PAK3	460.0
Masitinib	ERBB2	1200.0
Imatinib	MLTK	2600.0
Nintedanib	ROS1	3700.0
Pictilisib	TYK2(JH2domain-pseudokinase)	1800.0
Alvocidib	PHKG2	2900.0
Enzastaurin	MELK	5600.0
Pazopanib	SYK	4700.0
Fedratinib	RET(V804M)	81.0
Sunitinib	ABL1(F317I)-phosphorylated	890.0
Neratinib	JAK3(JH1domain-catalytic)	2000.0
PHA-665752	RPS6KA5(Kin.Dom.2-C-terminal)	1100.0
Bosutinib	TYRO3	61.0
Sunitinib	RPS6KA4(Kin.Dom.2-C-terminal)	2000.0
KW2449	BRSK1	1900.0
Fedratinib	EPHA6	3900.0
Ki20227	AURKA	2300.0
NVP-TAE684	PAK4	2000.0
Sunitinib	CSNK1E	13.0
Dovitinib	DRAK2	1800.0
AC220	FLT3(K663Q)	2.2
Sunitinib	ABL1(E255K)-phosphorylated	180.0
PI103	BRAF	2900.0
KW2449	ERK3	5500.0
Crizotinib	TAOK1	1200.0
RAF 265	PGFRB	240.0
Fedratinib	GRK7	2600.0
PKC412	SRPK3	80.0
Tozasertib	TIE2	450.0
KW2449	MP2K2	850.0
R406	MAP3K3	150.0
NVP-TAE684	FLT3(R834Q)	34.0
Barasertib	KIT(V559D)	15.0
KW2449	ZAP70	940.0
Sunitinib	KIT	0.4
Ki20227	ABL1(H396P)-phosphorylated	620.0
R406	RET(M918T)	4.1
Fedratinib	NEK9	150.0
Bosutinib	ABL1-nonphosphorylated	0.12
Fedratinib	ERK3	1200.0
Erlotinib	DMPK2	3400.0
PLX-4720	FLT3(N841I)	3900.0
Lestaurtinib	IKKE	11.0
Sunitinib	FYN	520.0
Nintedanib	MELK	4.9
Bosutinib	M4K1	15.0
Alvocidib	EGFR(L747-T751del,Sins)	3000.0
Vandetanib	MKNK1	360.0
Erlotinib	KIT(V559D)	3100.0
Neratinib	JNK3	2500.0
PHA-665752	ABL2	6900.0
Sunitinib	TYK2(JH2domain-pseudokinase)	360.0
Nintedanib	MLK2	2300.0
Vandetanib	PGFRB	88.0
Motesanib	KIT(V559D)	3.2
R406	EPHB1	390.0
PKC412	VGFR1	450.0
Ki20227	NLK	3000.0
Dasatinib	EGFR(L747-S752del,P753S)	320.0
R406	YSK4	67.0
PKC412	DRAK1	1900.0
Crizotinib	ABL1(T315I)-nonphosphorylated	12.0
NVP-TAE684	ROCK2	130.0
Sorafenib	CDKL2	130.0
Fedratinib	DMPK	1000.0
Lestaurtinib	PIP5K2B	18.0
Barasertib	FLT3(D835H)	210.0
PKC412	TNK2	120.0
Vandetanib	RET(M918T)	14.0
NVP-TAE684	SRPK1	4800.0
RAF 265	LCK	640.0
Canertinib	EPHB1	1500.0
Alvocidib	MP2K5	180.0
Sunitinib	FRK	530.0
Crizotinib	ABL1(F317I)-phosphorylated	3200.0
GSK 690693	GRK1	610.0
Masitinib	EPHA8	1800.0
Brivanib	MP2K5	3100.0
GSK 690693	PIP5K1C	1500.0
KW2449	STK33	140.0
Dasatinib	DDR1	0.69
GDC-0879	SLK	1300.0
Nintedanib	JAK1(JH1domain-catalytic)	2500.0
Lestaurtinib	JNK1	11.0
Lestaurtinib	CAMK2A	10.0
GSK 690693	KPCI	250.0
Sunitinib	NEK7	4100.0
Fedratinib	TAOK3	1900.0
Sorafenib	SLK	1000.0
NVP-TAE684	MYO3B	81.0
Lestaurtinib	PHKG2	1.7
Tozasertib	FGR	790.0
Tofacitinib	JAK3(JH1domain-catalytic)	0.2
Brivanib	FGFR2	110.0
Bosutinib	IKKE	53.0
Lestaurtinib	VGFR1	120.0
PKC412	MST1	40.0
R406	CLK3	1900.0
Bosutinib	HIPK3	3200.0
Linifanib	BMPR2	7800.0
Barasertib	EGFR(T790M)	1500.0
Bosutinib	YANK1	1800.0
Bosutinib	MST1	190.0
Crizotinib	LIMK1	830.0
Dovitinib	M4K3	560.0
Vandetanib	ABL1(H396P)-phosphorylated	14.0
PKC412	TAK1	130.0
Barasertib	ABL1(Q252H)-nonphosphorylated	860.0
Imatinib	KIT(V559D)	15.0
Erlotinib	DRAK2	9400.0
KW2449	M4K3	150.0
Fedratinib	LTK	6300.0
Lestaurtinib	CSNK2A1	2600.0
Sunitinib	TYK2(JH1domain-catalytic)	1600.0
Gefitinib	MK09	1700.0
Linifanib	MK09	240.0
NVP-TAE684	RSK4(Kin.Dom.2-C-terminal)	160.0
Dovitinib	MUSK	830.0
Alvocidib	CDK4-cyclinD1	9.0
Nintedanib	FLT3(ITD)	0.7
Crizotinib	EPHA5	1000.0
Foretinib	CDK16	890.0
Sorafenib	FRK	510.0
PKC412	PKN2	15.0
Doramapimod	ABL2	1300.0
Tozasertib	DDR2	230.0
Enzastaurin	MET	2800.0
GSK 690693	PKAC-beta	13.0
Nintedanib	PAK4	3000.0
Nintedanib	MARK1	1400.0
SNS-032	CDK5	740.0
Linifanib	YSK4	250.0
Fedratinib	RIPK4	9800.0
Barasertib	KIT(D816H)	2900.0
AC220	FLT4	41.0
Foretinib	EPHA8	1.8
Neratinib	TIE1	390.0
Nintedanib	GSK3B	83.0
Canertinib	KIT(A829P)	700.0
Neratinib	MAP4K2	220.0
KW2449	CLK2	93.0
PLX-4720	PGFRB	200.0
KW2449	DDR1	3200.0
PHA-665752	BLK	1900.0
Dasatinib	NEK11	470.0
R406	TAOK3	4600.0
Bosutinib	BTK	4.8
GSK461364	PIP5K1A	770.0
Tozasertib	TYK2(JH1domain-catalytic)	510.0
Sorafenib	FLT3(K663Q)	4.5
Foretinib	RET(M918T)	0.7
Fedratinib	FGR	82.0
Enzastaurin	FLT3(K663Q)	420.0
Afatinib	ABL1-nonphosphorylated	1300.0
Foretinib	EPHA1	6.2
Ruxolitinib	BMPR2	930.0
Lestaurtinib	RPS6KA5(Kin.Dom.2-C-terminal)	960.0
BI-2536	FAK1	150.0
Imatinib	FYN	3100.0
Lestaurtinib	KPCD1	14.0
Nintedanib	GCN2(Kin.Dom.2,S808G)	2000.0
Vandetanib	EGFR(T790M)	100.0
PHA-665752	FGR	1900.0
PI103	YSK4	930.0
Tozasertib	GAK	3200.0
Pictilisib	CSNK1E	1200.0
KW2449	MARK4	210.0
Foretinib	LIMK1	680.0
Lestaurtinib	MYLK4	29.0
Doramapimod	CDK8	220.0
Tozasertib	MAP4K4	2400.0
Tozasertib	FLT4	1900.0
Foretinib	RET(V804L)	1.6
Vandetanib	SIK1	1900.0
Barasertib	ABL1(F317I)-phosphorylated	4600.0
PKC412	CAMK2B	210.0
Masitinib	ABL2	110.0
GSK1838705A	MERTK	2700.0
PHA-665752	KIT(D816V)	590.0
R406	FES	200.0
AC220	FLT3(D835Y)	7.1
PHA-665752	CLK1	730.0
NVP-TAE684	FLT3	15.0
KW2449	FGFR3(G697C)	280.0
Nintedanib	SIK2	280.0
Lestaurtinib	RIOK3	7.7
Nintedanib	MP2K1	10.0
KW2449	KGP1	2500.0
KW2449	RSK3(Kin.Dom.2-C-terminal)	7500.0
Dasatinib	ABL1(T315I)-nonphosphorylated	890.0
Barasertib	YSK4	2400.0
Dovitinib	PGFRB	3.8
Dovitinib	M3K2	71.0
Ruxolitinib	DMPK	3500.0
Sunitinib	MP2K1	130.0
MLN8054	AURKB	43.0
Dovitinib	DDR2	8600.0
R406	IRAK3	11.0
Tozasertib	LATS2	6500.0
MLN8054	LYN	1400.0
Imatinib	BLK	520.0
GSK461364	PIP5K2B	4500.0
Lestaurtinib	ABL1(M351T)-phosphorylated	780.0
Dasatinib	EPHA6	2100.0
Dasatinib	EGFR(E746-A750del)	130.0
Ruxolitinib	DRAK2	3500.0
Linifanib	LATS2	1700.0
Sunitinib	MP2K2	110.0
GSK1838705A	EGFR(L747-E749del,A750P)	1800.0
Lapatinib	RIPK2	3600.0
PHA-665752	BIKE	47.0
PLX-4720	MAP4K5	3200.0
Masitinib	ABL1(F317L)-phosphorylated	110.0
Ruxolitinib	BMPR1B	1800.0
PKC412	KPCE	540.0
Lestaurtinib	RSK1(Kin.Dom.2-C-terminal)	2400.0
Dovitinib	TRKC	190.0
Foretinib	RET	0.7
Nintedanib	AMPK-alpha2	84.0
KW2449	KIT(V559D,T670I)	12.0
SGX523	DYRK1A	780.0
Fedratinib	TBK1	92.0
Lestaurtinib	PAK7	24.0
Canertinib	EGFR(L747-E749del,A750P)	0.17
R406	PIP5K1A	1900.0
Sunitinib	TNK1	680.0
Neratinib	FAK2	8000.0
PLX-4720	HIPK1	5500.0
Sunitinib	RIOK3	3800.0
Sunitinib	MARK3	410.0
Crizotinib	CASK	140.0
KW2449	RIOK3	61.0
PKC412	PIP5K1A	310.0
Ruxolitinib	TTK	480.0
PKC412	RSK4(Kin.Dom.1-N-terminal)	1500.0
Gefitinib	ABL1(Q252H)-phosphorylated	230.0
NVP-TAE684	DMPK2	9500.0
Crizotinib	SRC	560.0
Fedratinib	NIM1	4400.0
Lapatinib	EGFR(L747-T751del,Sins)	3.5
KW2449	LRRK2	350.0
Imatinib	ABL1-nonphosphorylated	1.1
Dovitinib	FLT3(ITD)	3.6
PKC412	YANK1	2400.0
RAF 265	KIT	200.0
Dasatinib	BTK	1.4
Pazopanib	ABL1(H396P)-nonphosphorylated	380.0
Foretinib	ABL1(F317L)-phosphorylated	170.0
PHA-665752	CLK2	410.0
Sunitinib	TAOK1	890.0
Lestaurtinib	FYN	84.0
Lestaurtinib	INSR	1100.0
Foretinib	YES	48.0
Afatinib	EGFR(G719C)	0.1
Bosutinib	ULK3	460.0
PHA-665752	FLT3(R834Q)	4600.0
Alvocidib	EPHA1	2300.0
Nintedanib	KCC4	3700.0
RAF 265	FLT4	2000.0
Dovitinib	NEK4	2700.0
Dovitinib	MARK4	1700.0
Foretinib	TAOK2	6900.0
Lestaurtinib	SGK3	5.8
Dovitinib	CLK2	1700.0
Gefitinib	EPHB4	2500.0
PHA-665752	MET(M1250T)	0.6
Dasatinib	AURKA	9300.0
Sunitinib	AURKA	1700.0
Fedratinib	IKKB	360.0
Doramapimod	CIT	2100.0
Motesanib	DDR1	260.0
Doramapimod	CDK5	2000.0
Pazopanib	FGFR4	2800.0
Lestaurtinib	MST1	3.0
NVP-TAE684	ROS1	0.5
NVP-TAE684	RPS6KA4(Kin.Dom.1-N-terminal)	2500.0
Vandetanib	ABL1(Q252H)-nonphosphorylated	18.0
NVP-TAE684	CHK2	72.0
Brivanib	KIT(D816V)	4000.0
Gefitinib	FRK	2000.0
Bosutinib	CASK	830.0
Fedratinib	CDKL2	1300.0
Fedratinib	ULK2	79.0
Pazopanib	LOK	84.0
PI103	PIK3CA	1.5
PKC412	FLT4	670.0
PKC412	FGFR3	1700.0
Crizotinib	JAK1(JH1domain-catalytic)	330.0
Doramapimod	MK11	7.2
Bosutinib	EGFR	35.0
Masitinib	YES	570.0
BI-2536	GAK	180.0
R406	ABL1-nonphosphorylated	530.0
Crizotinib	MST1	580.0
Ruxolitinib	TRKB	360.0
Erlotinib	KIT	1700.0
Tozasertib	AMPK-alpha1	1100.0
Erlotinib	DYRK2	1300.0
Pazopanib	AAK1	2900.0
GSK 690693	KIT(D816V)	130.0
Fedratinib	M3K12	6300.0
Enzastaurin	RSK4(Kin.Dom.1-N-terminal)	25.0
Nintedanib	AURKB	420.0
Bosutinib	PAK2	1900.0
Brivanib	SLK	170.0
R406	FLT3	0.7
GSK 690693	KCC4	370.0
Alvocidib	SRMS	1400.0
Doramapimod	LYN	2700.0
SNS-032	MAK	2300.0
Erlotinib	MET(Y1235D)	1100.0
NVP-TAE684	FLT3(K663Q)	8.2
PLX-4720	CAMK1	1900.0
Masitinib	ABL1(F317I)-nonphosphorylated	8.0
Sunitinib	BLK	65.0
R406	GCN2(Kin.Dom.2,S808G)	3.3
Lestaurtinib	ABL2	6500.0
Nintedanib	CSNK2A2	890.0
KW2449	FLT3(D835Y)	13.0
PI103	PI42C	620.0
Bosutinib	RSK4(Kin.Dom.1-N-terminal)	2700.0
Sunitinib	MAP4K4	140.0
Sunitinib	PHKG2	5.9
Nintedanib	ABL1(F317L)-phosphorylated	640.0
R406	MLK2	3.8
PHA-665752	TNIK	310.0
Canertinib	ABL1(F317I)-nonphosphorylated	3200.0
BI-2536	JNK3	1100.0
Bosutinib	PGFRA	5100.0
Lestaurtinib	HIPK4	150.0
KW2449	WEE2	4700.0
Masitinib	MLTK	770.0
Crizotinib	M3K12	170.0
Gefitinib	KIT(D816V)	4300.0
Bosutinib	EPHA3	5.8
Neratinib	MET	4000.0
Ruxolitinib	LRRK2	290.0
Bosutinib	MP2K4	2600.0
Gefitinib	ABL1(F317L)-phosphorylated	780.0
Lestaurtinib	PIK3CA(E542K)	5900.0
Vandetanib	ADCK3	4500.0
Foretinib	EPHB6	1.3
Doramapimod	TIE1	8.3
Crizotinib	TAK1	1800.0
R406	KIT(L576P)	5.6
R406	ABL1(Q252H)-phosphorylated	430.0
Lestaurtinib	MRCKB	1000.0
PI103	CDK7	7200.0
NVP-TAE684	JNK1	160.0
KW2449	NEK4	1100.0
KW2449	TSSK1	2300.0
Fedratinib	PHKG1	330.0
Canertinib	EPHA8	2000.0
PHA-665752	CDK14	1300.0
Fedratinib	FES	530.0
Nintedanib	BMPR2	56.0
SNS-032	KPCD2	3900.0
KW2449	GRK7	5000.0
GDC-0879	RAF1	6.6
Alvocidib	ALK	670.0
Fedratinib	YSK1	7200.0
Lestaurtinib	PAK3	35.0
Vandetanib	HUNK	4100.0
Nintedanib	TRKC	32.0
SNS-032	MAST1	6200.0
KW2449	FAK1	2100.0
Tozasertib	FYN	530.0
KW2449	ABL1(F317L)-nonphosphorylated	360.0
GSK 690693	GRK7	380.0
BMS345541	KIT(L576P)	3900.0
SNS-032	FLT3(N841I)	9300.0
Barasertib	LTK	3200.0
Erlotinib	MKNK1	690.0
KW2449	MERTK	750.0
Bosutinib	CSNK1E	110.0
Alvocidib	ABL1(F317L)-nonphosphorylated	2500.0
Barasertib	YES	3800.0
GSK461364	FLT3(ITD)	1500.0
PI103	IKKA	1700.0
Pazopanib	VGFR2	14.0
Fedratinib	BRAF	9800.0
NVP-TAE684	LRRK2(G2019S)	0.9
Imatinib	MELK	1900.0
Crizotinib	INSRR	600.0
PKC412	SRC	1200.0
Linifanib	LATS1	2100.0
Sorafenib	HCK	8500.0
Fedratinib	MP2K3	3500.0
NVP-TAE684	ULK2	1.8
PHA-665752	KKCC1	64.0
Sunitinib	ERK5	9900.0
NVP-TAE684	IKKE	1100.0
Lestaurtinib	DDR1	510.0
Canertinib	YSK4	700.0
Lestaurtinib	TNNI3K	2100.0
Dovitinib	MLK3	2200.0
Dovitinib	PHKG1	640.0
Linifanib	EPHB6	33.0
BI-2536	MYLK	97.0
Pictilisib	RIOK2	670.0
Ruxolitinib	MAP4K2	2000.0
Erlotinib	MINK	1300.0
Neratinib	FAK1	1900.0
R406	CLK2	1600.0
PKC412	FLT3	11.0
NVP-TAE684	EGFR(T790M)	7.1
Lestaurtinib	RIOK1	9.0
Bosutinib	CDK7	1200.0
RAF 265	TYK2(JH1domain-catalytic)	410.0
Neratinib	MST4	7.4
Masitinib	PGFRB	8.4
Canertinib	BMPR1B	2600.0
R406	LRRK2(G2019S)	27.0
Afatinib	EGFR(L747-T751del,Sins)	0.1
PKC412	FLT3(D835Y)	15.0
Pictilisib	PLK4	2600.0
Lestaurtinib	CDKL1	490.0
BI-2536	MYO3A	6300.0
Nintedanib	HCK	5300.0
Sunitinib	FLT3(N841I)	2.4
Sorafenib	PFCDPK1(P.falciparum)	220.0
Canertinib	KIT(V559D)	7900.0
Lestaurtinib	SRPK1	10.0
PHA-665752	ABL1(F317L)-phosphorylated	2900.0
Fedratinib	MERTK	820.0
PLX-4720	STK36	2900.0
R406	NEK1	170.0
Lestaurtinib	TAOK1	70.0
Canertinib	GAK	100.0
Lestaurtinib	M3K13	340.0
Fedratinib	ABL1(Q252H)-nonphosphorylated	110.0
PHA-665752	AURKC	300.0
NVP-TAE684	BIKE	1900.0
Dasatinib	MAP3K4	310.0
GDC-0879	BRAF	0.2
AC220	TRKB	620.0
Foretinib	M3K2	1900.0
Sunitinib	PKN1	710.0
Motesanib	ABL1(F317I)-nonphosphorylated	4000.0
Alvocidib	FLT3(ITD)	4600.0
SNS-032	MYLK4	2400.0
PKC412	EGFR(G719C)	1500.0
Sunitinib	ABL1-nonphosphorylated	270.0
NVP-TAE684	YANK3	55.0
PHA-665752	DCLK1	1400.0
Crizotinib	ABL1(F317L)-phosphorylated	590.0
PKC412	KIT(A829P)	43.0
Foretinib	FLT4	1.5
Lestaurtinib	TYK2(JH1domain-catalytic)	15.0
Tozasertib	MLTK	2800.0
GSK1838705A	JAK3(JH1domain-catalytic)	4700.0
Barasertib	EGFR	450.0
R406	JAK1(JH1domain-catalytic)	21.0
Ruxolitinib	RIOK3	2000.0
Motesanib	VGFR2	26.0
PKC412	ERN1	2300.0
PI103	DYRK1B	5700.0
Lestaurtinib	SLK	35.0
BI-2536	KC1G1	4500.0
Lestaurtinib	MARK4	120.0
SNS-032	PHKG2	460.0
Canertinib	ABL1(T315I)-nonphosphorylated	690.0
KW2449	PDPK1	650.0
Bosutinib	FLT3(K663Q)	2200.0
PI103	PIK3C2B	10.0
BI-2536	EGFR(L861Q)	2700.0
R406	IRAK4	140.0
Pazopanib	TAOK3	45.0
KW2449	CAMK1G	2100.0
Canertinib	ABL1(Y253F)-phosphorylated	42.0
Erlotinib	ABL1(M351T)-phosphorylated	66.0
Lapatinib	EGFR(G719C)	0.9
Fedratinib	RSK1(Kin.Dom.1-N-terminal)	1200.0
Nintedanib	PLK4	53.0
Pazopanib	CAMK1	2100.0
Gefitinib	FLT3(N841I)	3000.0
SNS-032	BRSK2	5600.0
SB 203580	RSK4(Kin.Dom.2-C-terminal)	250.0
Sunitinib	TIE1	3900.0
KW2449	NEK3	1000.0
Bosutinib	KIT(D816H)	180.0
Nilotinib	KIT(V559D,V654A)	260.0
R406	WEE1	890.0
Nilotinib	MRCKB	910.0
Fedratinib	MP2K5	360.0
Lestaurtinib	CAMK2B	59.0
PHA-665752	MAP4K5	79.0
BI-2536	EGFR(L747-S752del,P753S)	6300.0
Bosutinib	KPCD	1600.0
Tofacitinib	MAP4K2	4800.0
Erlotinib	EGFR	0.7
Fedratinib	SRPK1	160.0
Sunitinib	MYO3B	4500.0
Linifanib	MYO3B	3200.0
Imatinib	CLK1	4500.0
Crizotinib	IRAK1	49.0
Erlotinib	PLK4	1900.0
PKC412	PIK3C2G	570.0
Sunitinib	SRPK2	190.0
Lestaurtinib	RSK3(Kin.Dom.1-N-terminal)	88.0
Neratinib	STK36	5300.0
KW2449	PAK7	390.0
Barasertib	AURKB	4.6
PLX-4720	PLK4	3500.0
Neratinib	CHEK1	5700.0
PLX-4720	BMPR1B	3100.0
Vandetanib	MP2K5	49.0
Vandetanib	EPHA2	1100.0
KW2449	M4K1	63.0
GSK1838705A	PHKG1	1100.0
Sorafenib	FLT3(ITD)	79.0
Canertinib	TYRO3	1000.0
KW2449	MLK2	1500.0
Foretinib	KIT(D816V)	9.6
PHA-665752	FLT3(N841I)	470.0
Vandetanib	EPHB1	290.0
GSK1838705A	ROS1	15.0
NVP-TAE684	JAK3(JH1domain-catalytic)	17.0
Pazopanib	ABL1(F317L)-nonphosphorylated	4400.0
Fedratinib	MLK3	3100.0
Fedratinib	ERK5	66.0
Fedratinib	DCAMKL3	13.0
Sorafenib	RET(V804M)	22.0
Nintedanib	DYRK1B	1600.0
Tozasertib	ABL1(F317I)-phosphorylated	2100.0
Dovitinib	MARK2	1500.0
Dovitinib	MST1	200.0
Gefitinib	STK36	5700.0
R406	LYN	26.0
GSK461364	MLK1	3000.0
Barasertib	AAK1	3000.0
Sunitinib	EPHB6	1000.0
Alvocidib	TAK1	2900.0
Canertinib	MAP4K5	2600.0
Linifanib	FLT4	16.0
Afatinib	EGFR(T790M)	0.6
Tozasertib	PIP5K1A	130.0
R406	EPHA5	860.0
NVP-TAE684	MP2K5	200.0
Tozasertib	TEC	8700.0
GSK 690693	DCAMKL3	110.0
Ruxolitinib	JNK1	4800.0
Alvocidib	ERK5	620.0
Nintedanib	IRAK4	810.0
R406	MST1R	470.0
Sunitinib	EPHB1	480.0
Selumetinib	EGFR	7000.0
Foretinib	MKNK2	3.7
Fedratinib	STK16	6.6
Enzastaurin	RPS6KA4(Kin.Dom.1-N-terminal)	2500.0
Sunitinib	DAPK2	150.0
Vandetanib	ERBB2	2600.0
NVP-TAE684	CSK	1800.0
SB 203580	TYK2(JH2domain-pseudokinase)	2000.0
PHA-665752	M4K3	490.0
SNS-032	CDK4-cyclinD1	69.0
AC220	TNIK	2800.0
Ki20227	EGFR(L861Q)	3400.0
Afatinib	HIPK4	360.0
Fedratinib	LIMK2	7900.0
Lestaurtinib	DAPK1	80.0
SNS-032	RPS6KA5(Kin.Dom.1-N-terminal)	9000.0
KW2449	OSR1	1700.0
Imatinib	FLT3(ITD)	6300.0
Erlotinib	SLK	26.0
Vandetanib	FGFR3	1600.0
PHA-665752	ERK5	1700.0
KW2449	EPHB6	130.0
Erlotinib	RET	1300.0
Sorafenib	FLT3(D835Y)	82.0
Doramapimod	EPHA2	6200.0
KW2449	DYRK1A	180.0
PHA-665752	ROS1	3000.0
Pazopanib	ABL1-phosphorylated	650.0
Nintedanib	IRAK1	120.0
Motesanib	YES	5000.0
Fedratinib	CDK4-cyclinD3	870.0
Erlotinib	EGFR(L858R,T790M)	190.0
Sorafenib	ABL1(M351T)-phosphorylated	1200.0
Bosutinib	SIK1	30.0
Nintedanib	CLK1	8.8
Imatinib	PGFRA	31.0
Crizotinib	BLK	110.0
Lestaurtinib	GAK	7.3
Bosutinib	TLK2	2100.0
Lestaurtinib	DYRK1A	20.0
Tozasertib	MP2K1	1800.0
Sunitinib	SIK2	580.0
Crizotinib	RIOK1	6100.0
Fedratinib	ABL1(F317I)-nonphosphorylated	2100.0
Fedratinib	STK33	220.0
Vandetanib	MAP3K4	3000.0
PHA-665752	KIT(D816H)	4000.0
Barasertib	ABL1(F317I)-nonphosphorylated	3800.0
SNS-032	CDK2	69.0
PKC412	GRK4	110.0
Lestaurtinib	EGFR(L747-T751del,Sins)	560.0
Tozasertib	EPHB1	1900.0
GSK461364	GRK7	7500.0
Bosutinib	DDR1	120.0
Lestaurtinib	PIK3CA(H1047Y)	650.0
Fedratinib	TNK1	360.0
KW2449	AURKA	650.0
Linifanib	SGK3	1900.0
Foretinib	CSNK2A2	2800.0
Fedratinib	PIK4CB	1700.0
Tozasertib	BIKE	65.0
Afatinib	MET(M1250T)	6000.0
Foretinib	YSK4	5.5
Tozasertib	ABL1(T315I)-nonphosphorylated	9.7
SB 203580	MLTK	4400.0
Linifanib	BMPR1B	710.0
Fedratinib	TESK1	3200.0
KW2449	HIPK3	580.0
Linifanib	HIPK4	46.0
Alvocidib	EGFR(G719C)	520.0
Sunitinib	ABL1(M351T)-phosphorylated	120.0
Tozasertib	MET	670.0
Bosutinib	HIPK4	130.0
Neratinib	RSK1(Kin.Dom.1-N-terminal)	7400.0
KW2449	YSK1	4300.0
Nintedanib	ABL1(F317L)-nonphosphorylated	2300.0
Lestaurtinib	MP2K2	3.9
SNS-032	HIPK1	1700.0
Barasertib	DDR2	6600.0
Enzastaurin	CAMKK2	6700.0
Tozasertib	M3K13	180.0
Ki20227	TESK1	1100.0
Nintedanib	CDK16	21.0
Lestaurtinib	PIM2	250.0
GSK 690693	HIPK2	390.0
SB 203580	MP2K2	9600.0
Lestaurtinib	SNARK	1.0
GSK461364	PIM3	1100.0
KW2449	CAMK2A	4000.0
Erlotinib	EGFR(L747-T751del,Sins)	0.4
Vandetanib	LCK	17.0
PKC412	KIT(V559D,V654A)	1600.0
Sunitinib	FGR	270.0
NVP-TAE684	DMPK	2100.0
Nintedanib	MLK1	220.0
KW2449	IGF1R	920.0
AC220	MUSK	1000.0
R406	MET(Y1235D)	760.0
Crizotinib	ZAP70	4200.0
KW2449	STK16	29.0
Pazopanib	AURKC	750.0
Doramapimod	MRCKA	9400.0
Foretinib	MLTK	45.0
Masitinib	ABL1-phosphorylated	55.0
Imatinib	DRAK1	5300.0
Neratinib	GAK	250.0
BMS345541	DCAMKL3	1700.0
Foretinib	TEC	310.0
SNS-032	CDK14	690.0
KW2449	ABL1(H396P)-nonphosphorylated	17.0
Neratinib	ERBB4	2.4
R406	PLK2	34.0
NVP-TAE684	FLT3(D835Y)	2.0
Crizotinib	RIOK3	4000.0
Crizotinib	FGFR3	2700.0
Pazopanib	STK36	470.0
KW2449	EPHB1	2500.0
PI103	DAPK1	2400.0
NVP-TAE684	LATS1	1600.0
Lestaurtinib	ALK	71.0
Pazopanib	TIE1	700.0
KW2449	ERK8	1100.0
Alvocidib	MRCKB	3300.0
SB 203580	ACVR1B	3000.0
Nintedanib	FRK	2700.0
Linifanib	TRKB	1100.0
PKC412	LRRK2(G2019S)	180.0
Sunitinib	NUAK1	48.0
NVP-TAE684	MAP3K4	2000.0
Sunitinib	TNIK	25.0
Crizotinib	ABL1(E255K)-phosphorylated	170.0
Lestaurtinib	PIK4CB	290.0
GSK 690693	ROCK1	280.0
Ki20227	PGFRA	0.5
Crizotinib	TNK2	760.0
Foretinib	PCTK2	170.0
Erlotinib	TIE1	850.0
Fedratinib	BMPR1B	410.0
Bosutinib	KIT	420.0
NVP-TAE684	MARK4	12.0
Erlotinib	LTK	890.0
GSK 690693	AKT2	2.1
PHA-665752	PRP4	2600.0
GSK1838705A	IRAK1	8500.0
Bosutinib	AMPK-alpha1	3900.0
GSK1838705A	LTK	1.1
Sunitinib	S6K1	48.0
KW2449	PIP5K2B	94.0
Canertinib	DMPK	7000.0
R406	PKN1	660.0
Dasatinib	TYK2(JH1domain-catalytic)	1800.0
Fedratinib	CAMK1G	3200.0
Ki20227	ERBB4	7000.0
Pictilisib	PIK3CG	48.0
Gefitinib	M3K2	3300.0
SB 203580	EPHA6	1200.0
Nilotinib	ABL1(H396P)-nonphosphorylated	4.9
R406	MP2K6	480.0
Doramapimod	MERTK	3700.0
Bosutinib	RIPK2	3700.0
Ruxolitinib	PHKG1	5700.0
Lestaurtinib	CDK2	20.0
Erlotinib	KIT(D816V)	1600.0
Neratinib	STK35	4500.0
Ki20227	KIT(V559D,V654A)	3.2
Pictilisib	PIK3CA(C420R)	1.5
Tofacitinib	JAK1(JH1domain-catalytic)	1.6
Bosutinib	MLK3	2700.0
KW2449	EPHA6	1500.0
R406	IKKE	13.0
R406	RIOK2	3400.0
KW2449	VGFR1	73.0
Foretinib	EGFR(L858R)	190.0
Pazopanib	PGFRA	4.9
GSK461364	IRAK3	3500.0
Doramapimod	FLT3(N841I)	5000.0
PHA-665752	M4K1	150.0
Dasatinib	MAP4K5	45.0
SB 203580	TGFBR1	7100.0
KW2449	KC1G1	1200.0
Fedratinib	FLT3(D835H)	4.9
Crizotinib	MAP3K1	1100.0
Bosutinib	CDK15	1600.0
Fedratinib	DCLK1	190.0
PI103	CLK2	5500.0
Fedratinib	DDR2	950.0
Lestaurtinib	LRRK2(G2019S)	2.5
Nintedanib	CDK7	300.0
Crizotinib	MAP4K5	79.0
Bosutinib	EGFR(L861Q)	71.0
Erlotinib	MKNK2	1000.0
NVP-TAE684	ABL2	380.0
Lestaurtinib	DMPK2	2500.0
Linifanib	AURKA	1600.0
Bosutinib	GRK4	4900.0
Pazopanib	TIE2	3300.0
NVP-TAE684	SBK1	21.0
Erlotinib	FLT3(D835Y)	130.0
Lestaurtinib	HIPK3	250.0
Lestaurtinib	PAK2	43.0
R406	EGFR(L858R)	250.0
Tozasertib	LOK	120.0
AC220	RIPK1	890.0
Dasatinib	WEE1	7000.0
Linifanib	ROCK2	630.0
PI103	PIK4CB	3500.0
Ruxolitinib	ULK3	2400.0
PHA-665752	MAK	890.0
PKC412	LOK	590.0
Motesanib	EGFR(L861Q)	3900.0
Motesanib	FLT4	9.7
GSK1838705A	EGFR(L747-S752del,P753S)	3100.0
Canertinib	YES	1600.0
Doramapimod	JNK1	9100.0
R406	EPHA1	67.0
Ki20227	KIT(D816H)	7000.0
MLN8054	ROS1	3100.0
Lestaurtinib	MET	290.0
PKC412	CLK1	350.0
Ruxolitinib	LRRK2(G2019S)	90.0
NVP-TAE684	TGFBR1	190.0
Dovitinib	LYN	750.0
GSK461364	PIK3CB	2000.0
Foretinib	FLT3(R834Q)	11.0
PHA-665752	BMPR2	6200.0
Nintedanib	VGFR1	63.0
Lapatinib	ERBB2	7.0
Ruxolitinib	KGP2	690.0
Dasatinib	ABL1(F317I)-nonphosphorylated	0.1
Neratinib	TAOK3	4200.0
Canertinib	ALK	7700.0
Sunitinib	HIPK2	31.0
KW2449	ABL1-nonphosphorylated	63.0
RAF 265	EPHA8	1100.0
Alvocidib	DYRK1B	84.0
Gefitinib	IRAK1	69.0
Canertinib	MP2K5	60.0
Lestaurtinib	KCC2D	8.8
Foretinib	PFCDPK1(P.falciparum)	230.0
Sunitinib	MYO3A	3100.0
Lestaurtinib	IRAK3	16.0
GSK 690693	KIT(V559D)	7300.0
Crizotinib	ABL1(H396P)-phosphorylated	87.0
PHA-665752	TRKC	930.0
NVP-TAE684	SYK	1300.0
NVP-TAE684	CAMK2G	780.0
Ki20227	TYRO3	2000.0
Erlotinib	FLT3	1200.0
GSK1838705A	RSK2(Kin.Dom.1-N-terminal)	170.0
Erlotinib	ABL1(F317I)-nonphosphorylated	8200.0
Enzastaurin	CDKL2	3400.0
GSK461364	PIK3C2B	2800.0
Sunitinib	PFCDPK1(P.falciparum)	1300.0
PHA-665752	MP2K2	980.0
Nilotinib	EPHB6	500.0
PLX-4720	KIT(V559D,V654A)	4800.0
Vandetanib	FLT3(R834Q)	1300.0
Sorafenib	LYN	3000.0
Bosutinib	ERBB3	0.77
Bosutinib	CLK3	300.0
Dovitinib	MERTK	1800.0
R406	KIT(D816H)	6.5
Nintedanib	AXL	12.0
NVP-TAE684	PKAC-beta	4100.0
Lestaurtinib	MST2	2.4
Sorafenib	BRAF	540.0
KW2449	TLK1	2700.0
NVP-TAE684	MYLK	220.0
R406	DYRK1A	260.0
Tozasertib	MYLK2	43.0
BI-2536	MERTK	3100.0
R406	EPHB4	600.0
Fedratinib	GRK4	170.0
Doramapimod	TRKA	1000.0
Ki20227	RET(M918T)	920.0
Dovitinib	DRAK1	830.0
Imatinib	KIT(V559D,V654A)	91.0
Ki20227	BLK	120.0
PHA-665752	MST2	1900.0
Motesanib	YSK4	200.0
Dovitinib	CLK4	6500.0
Lestaurtinib	CDK5	410.0
KW2449	LOK	13.0
Pazopanib	AURKA	7100.0
Fedratinib	KCC2D	590.0
Motesanib	PGFRA	10.0
Fedratinib	HIPK1	860.0
BMS345541	ERK8	4500.0
Linifanib	RET(V804M)	54.0
Brivanib	ABL2	1800.0
Bosutinib	FLT3	2200.0
Dasatinib	EGFR(L747-T751del,Sins)	160.0
GSK 690693	TAOK2	1400.0
Sunitinib	STK39	140.0
RAF 265	VGFR1	800.0
Lestaurtinib	NEK2	4900.0
RAF 265	BRAF(V600E)	330.0
Foretinib	MK12	390.0
Pazopanib	KIT(A829P)	33.0
Doramapimod	CDC2L5	1100.0
Lestaurtinib	LOK	5.7
Motesanib	EGFR(L747-E749del,A750P)	960.0
Vandetanib	KIT(V559D,T670I)	2000.0
KW2449	STK35	630.0
Fedratinib	LCK	72.0
Tozasertib	PAK1	4400.0
Ruxolitinib	KPCE	530.0
PI103	PIK3CG	16.0
Lestaurtinib	RET(V804M)	4.7
GSK1838705A	ALK	0.6
Doramapimod	MK09	7.3
Crizotinib	FES	450.0
PLX-4720	FYN	2300.0
Ruxolitinib	CSNK1A1	1800.0
RAF 265	RET(M918T)	72.0
NVP-TAE684	MK09	280.0
Pictilisib	YSK4	4000.0
PHA-665752	MAP3K4	1800.0
Lestaurtinib	EGFR(G719S)	1100.0
Fedratinib	VGFR2	5200.0
Motesanib	CSF1R	5.6
GSK 690693	PAK6	21.0
Nintedanib	MERTK	8.5
Bosutinib	MAP4K2	3.1
Fedratinib	MET	8500.0
Ki20227	LOK	22.0
Ruxolitinib	JAK2(JH1domain-catalytic)	0.0
Alvocidib	PIM1	560.0
Gefitinib	IRAK3	1500.0
Bosutinib	KIT(A829P)	270.0
Lestaurtinib	ERN1	5.7
Erlotinib	CSNK1E	500.0
Afatinib	PHKG1	1300.0
Pictilisib	PIK3CA(Q546K)	1.7
Sorafenib	ABL1(F317L)-phosphorylated	7100.0
KW2449	AURKC	59.0
Fedratinib	RET	130.0
Doramapimod	EPHA7	860.0
KW2449	IRAK3	240.0
PKC412	PDPK1	190.0
Neratinib	MINK	29.0
Lestaurtinib	ABL1-nonphosphorylated	3200.0
Erlotinib	DRAK1	6300.0
Sunitinib	EGFR(G719C)	6800.0
GSK461364	FLT3(N841I)	690.0
BI-2536	ABL1(H396P)-phosphorylated	2600.0
GSK 690693	KIT(V559D,T670I)	1000.0
Pictilisib	PIK3CA	1.1
KW2449	RSK1(Kin.Dom.1-N-terminal)	3400.0
Pazopanib	KIT(V559D,T670I)	6.5
SNS-032	ERK3	500.0
Vandetanib	EGFR	9.5
Motesanib	FGR	6900.0
Fedratinib	SBK1	790.0
Neratinib	NUAK1	1500.0
Brivanib	KIT(V559D)	35.0
Enzastaurin	GRK7	1300.0
Afatinib	FLT3(D835H)	1800.0
PKC412	HIPK3	2300.0
Crizotinib	ERK5	510.0
Sunitinib	PAK7	640.0
Neratinib	MERTK	400.0
Motesanib	KIT(D816V)	410.0
KW2449	ABL1-phosphorylated	75.0
Tozasertib	PRP4	2500.0
BI-2536	FAK2	310.0
R406	ZAP70	21.0
Fedratinib	CLK1	2500.0
Tozasertib	MP2K2	2000.0
R406	ROCK1	590.0
Dasatinib	M4K1	980.0
Pazopanib	RET(M918T)	270.0
Tozasertib	MINK	1100.0
Dovitinib	JAK3(JH1domain-catalytic)	410.0
PHA-665752	DCAMKL2	990.0
Ki20227	HIPK4	5100.0
Fedratinib	KIT(A829P)	46.0
Dasatinib	FLT3(D835Y)	4800.0
Ruxolitinib	GRK4	6100.0
GSK1838705A	RSK3(Kin.Dom.1-N-terminal)	2900.0
GSK1838705A	STK16	7300.0
BI-2536	CAMK2A	1300.0
Doramapimod	BRAF	2700.0
Bosutinib	ABL1(F317I)-nonphosphorylated	0.63
R406	EPHB2	880.0
Foretinib	FER	37.0
Bosutinib	RIOK3	1600.0
Tozasertib	PLK4	9.2
Vandetanib	GAK	86.0
GSK 690693	SGK3	1900.0
Gefitinib	SBK1	560.0
NVP-TAE684	GAK	5.3
Nintedanib	TIE2	1400.0
Brivanib	ABL1(T315I)-nonphosphorylated	1700.0
Nilotinib	ABL1-phosphorylated	13.0
KW2449	AMPK-alpha1	430.0
Bosutinib	S6K1	660.0
Dasatinib	EGFR	120.0
Alvocidib	CAMK2A	1700.0
VX-745	YES	1600.0
KW2449	JAK1(JH2domain-pseudokinase)	190.0
Barasertib	TNIK	8500.0
Brivanib	KIT(L576P)	54.0
Imatinib	IRAK1	1200.0
Ruxolitinib	GAK	99.0
Sorafenib	FGFR3	4200.0
Tozasertib	MST4	3500.0
GSK1838705A	LRRK2(G2019S)	170.0
Lestaurtinib	AURKB	16.0
NVP-TAE684	KIT(V559D)	81.0
Foretinib	RET(V804M)	2.8
Pazopanib	PTK6	2300.0
GSK 690693	PGFRB	3900.0
Lestaurtinib	KCC4	3000.0
Doramapimod	RET	500.0
BI-2536	CIT	5200.0
Sorafenib	ABL1(H396P)-phosphorylated	2400.0
Tozasertib	RET(V804M)	13.0
Canertinib	HUNK	6400.0
Dovitinib	SRPK1	420.0
Ruxolitinib	PLK4	200.0
Gefitinib	EGFR(L747-E749del,A750P)	0.6
KW2449	ULK3	120.0
RAF 265	ABL1(Y253F)-phosphorylated	2700.0
R406	TNK2	70.0
Ki20227	ABL1(Q252H)-nonphosphorylated	64.0
Ruxolitinib	MP2K4	1800.0
Vandetanib	ABL1(F317I)-phosphorylated	170.0
PLX-4720	RIOK2	770.0
Fedratinib	RSK3(Kin.Dom.1-N-terminal)	7700.0
Canertinib	KIT	7800.0
Tozasertib	KIT(D816H)	1900.0
Bosutinib	SIK3	64.0
Foretinib	EPHA7	2.5
Sunitinib	PRKR	670.0
Linifanib	MET	1300.0
Nintedanib	DCAMKL3	770.0
Ki20227	MET	870.0
R406	MLK3	11.0
Vandetanib	IRAK1	1200.0
GSK1838705A	FES	52.0
Lestaurtinib	FER	28.0
Nintedanib	FLT3(R834Q)	17.0
Imatinib	TNNI3K	4300.0
MLN8054	ABL2	3300.0
Fedratinib	TYK2(JH2domain-pseudokinase)	450.0
Sunitinib	KIT(V559D,V654A)	0.2
Motesanib	ABL1-phosphorylated	6700.0
Dovitinib	YSK1	1200.0
Dovitinib	FLT3(N841I)	4.8
PKC412	AMPK-alpha2	460.0
Afatinib	EGFR(G719S)	0.2
Tozasertib	YES	470.0
Linifanib	JNK3	4300.0
Neratinib	MAP3K3	130.0
Doramapimod	FLT3(ITD)	3000.0
PKC412	JAK2(JH1domain-catalytic)	94.0
Alvocidib	GSK3A	1300.0
Pazopanib	ABL2	3000.0
Brivanib	DDR1	160.0
Vandetanib	CSNK1E	3000.0
Bosutinib	HCK	3.4
Nintedanib	FGFR4	1800.0
NVP-TAE684	MELK	99.0
KW2449	RSK3(Kin.Dom.1-N-terminal)	620.0
Motesanib	ABL1(Y253F)-phosphorylated	4500.0
R406	CSNK2A1	64.0
Canertinib	ABL1(F317L)-nonphosphorylated	1500.0
Lestaurtinib	CAMK2G	26.0
Nilotinib	EPHA4	330.0
Tozasertib	LIMK2	2600.0
Fedratinib	RIOK2	2600.0
Canertinib	STK36	4500.0
SNS-032	DYRK1B	200.0
Lestaurtinib	SRMS	820.0
Foretinib	IRAK3	370.0
Doramapimod	EPHB1	4900.0
GSK1838705A	FAK1	200.0
R406	PKAC-beta	510.0
Lestaurtinib	ROS1	26.0
NVP-TAE684	PKAC-alpha	4000.0
Barasertib	MP2K5	2.8
NVP-TAE684	ABL1(Q252H)-phosphorylated	70.0
NVP-TAE684	TBK1	470.0
NVP-TAE684	BTK	23.0
Afatinib	EGFR(L858R,T790M)	1.1
Bosutinib	LOK	7.0
Gefitinib	MYLK2	1900.0
PI103	PIK3CA(C420R)	1.3
PHA-665752	HIPK1	93.0
PHA-665752	PIP5K2B	1600.0
Afatinib	EGFR(S752-I759del)	0.1
R406	SIK2	78.0
Pazopanib	ROS1	920.0
Erlotinib	RIPK4	4900.0
Vandetanib	M4K1	5500.0
Fedratinib	TLK2	2000.0
Imatinib	ABL1(H396P)-nonphosphorylated	5.9
Ruxolitinib	IKKE	1200.0
Nilotinib	ABL1(Q252H)-nonphosphorylated	10.0
KW2449	IRAK1	48.0
Lestaurtinib	OSR1	8000.0
Canertinib	TAK1	3300.0
Enzastaurin	PHKG1	4200.0
NVP-TAE684	CLK3	210.0
Sorafenib	EPHB1	3000.0
Canertinib	BLK	45.0
GSK461364	FLT3(K663Q)	650.0
Nilotinib	FYN	1600.0
KW2449	LYN	3100.0
Fedratinib	WEE2	6000.0
NVP-TAE684	TAOK3	44.0
Afatinib	MK09	2100.0
Pazopanib	PGFRB	2.0
Foretinib	EGFR(L861Q)	86.0
Nintedanib	AURKC	190.0
Sunitinib	GCN2(Kin.Dom.2,S808G)	180.0
AC220	EPHA7	3700.0
Ki20227	MST1	7700.0
Pictilisib	MTOR	200.0
Lestaurtinib	GSK3B	1300.0
Fedratinib	KGP2	1600.0
Imatinib	ABL1(M351T)-phosphorylated	44.0
Tofacitinib	LCK	460.0
Crizotinib	SRPK3	8200.0
Fedratinib	CDK9	8800.0
NVP-TAE684	KKCC1	50.0
Ki20227	ABL1(F317I)-nonphosphorylated	940.0
PKC412	PKN1	9.3
Ki20227	BTK	7400.0
R406	GRK1	870.0
Nintedanib	DDR2	42.0
KW2449	SYK	670.0
Gefitinib	HCK	4400.0
SB 203580	BRAF	710.0
Ruxolitinib	ABL1(M351T)-phosphorylated	6200.0
RAF 265	ABL1-nonphosphorylated	300.0
KW2449	ABL1(T315I)-phosphorylated	5.9
Dovitinib	IKKE	480.0
NVP-TAE684	ACVR2B	4300.0
Lestaurtinib	INSRR	1800.0
SNS-032	STK36	260.0
PLX-4720	BRAF	330.0
Dovitinib	IRAK1	170.0
Lestaurtinib	PKAC-alpha	220.0
Lestaurtinib	AKT1	4400.0
Bosutinib	TAOK2	1900.0
PLX-4720	BRAF(V600E)	100.0
Nintedanib	TGFBR1	4200.0
Tozasertib	MAP3K4	2500.0
Linifanib	TAOK3	260.0
Sunitinib	FGFR3(G697C)	1400.0
AC220	MLCK	410.0
PHA-665752	ABL1(T315I)-nonphosphorylated	3800.0
BI-2536	CAMK2G	1200.0
Sunitinib	AURKB	380.0
Tofacitinib	DCLK1	6700.0
Lestaurtinib	MAK	1700.0
Sunitinib	GRK7	180.0
Dovitinib	VGFR2	68.0
Dasatinib	EGFR(L858R,T790M)	2200.0
KW2449	CSNK1G3	1200.0
Canertinib	EPHA4	3600.0
Alvocidib	KCC4	3200.0
Dasatinib	ACVR2B	570.0
Motesanib	ABL1(F317L)-phosphorylated	7700.0
Afatinib	LOK	4300.0
MLN8054	VGFR1	1000.0
Bosutinib	PHKG2	1300.0
GSK1838705A	RIPK5	4300.0
Lestaurtinib	EPHA2	790.0
Dasatinib	TAOK3	2300.0
Bosutinib	KPCT	910.0
Enzastaurin	RSK2(Kin.Dom.1-N-terminal)	87.0
Dovitinib	SNARK	130.0
Doramapimod	LCK	1200.0
Dasatinib	SIK1	3.9
R406	AMPK-alpha1	300.0
Enzastaurin	MST2	1900.0
Sorafenib	MLTK	6.3
SNS-032	PAK3	3500.0
Ruxolitinib	TAOK1	1300.0
Barasertib	EIF2AK1	1500.0
Lestaurtinib	PIK3CA(E545K)	7400.0
Lestaurtinib	YANK2	5900.0
KW2449	MARK3	1300.0
Ruxolitinib	RSK4(Kin.Dom.2-C-terminal)	150.0
R406	SNARK	65.0
Gefitinib	ABL1(H396P)-phosphorylated	460.0
Fedratinib	PAK4	3800.0
Alvocidib	IKKE	3100.0
Pazopanib	RET	310.0
PKC412	RIOK2	97.0
Alvocidib	CAMKK2	430.0
Nintedanib	EPHA2	2900.0
Fedratinib	STK39	1600.0
AC220	FLT3(D835H)	3.7
Masitinib	KIT(D816H)	1500.0
Sunitinib	MST3	63.0
R406	DAPK2	62.0
R406	AMPK-alpha2	750.0
Foretinib	SYK	280.0
Fedratinib	DCAMKL2	870.0
Alvocidib	M4K3	4500.0
Lestaurtinib	JAK1(JH1domain-catalytic)	8.8
GSK461364	ROCK1	4900.0
R406	MP2K1	320.0
Doramapimod	TAK1	150.0
PKC412	MYLK	2000.0
NVP-TAE684	TNK2	2.0
Vandetanib	EGFR(L747-T751del,Sins)	8.9
Linifanib	CSF1R	3.4
Tozasertib	SRPK1	82.0
Imatinib	ABL2	10.0
Nintedanib	BTK	310.0
NVP-TAE684	VGFR1	550.0
Dasatinib	TGFBR1	230.0
Neratinib	LYN	820.0
Alvocidib	HIPK3	4300.0
Foretinib	ERK8	73.0
Nilotinib	TIE2	1000.0
Gefitinib	SRC	3800.0
Foretinib	FGFR2	800.0
PKC412	YSK1	1800.0
Neratinib	DRAK1	340.0
Bosutinib	MST3	380.0
Tozasertib	TAOK3	81.0
PKC412	HUNK	240.0
Afatinib	ABL1(M351T)-phosphorylated	1200.0
Gefitinib	SLK	920.0
Bosutinib	ANKK1	2100.0
Ruxolitinib	RIOK1	2500.0
PHA-665752	RET(V804M)	510.0
NVP-TAE684	FES	4.8
GSK 690693	CAMK1D	2500.0
Linifanib	CDC2L1	1300.0
GSK1838705A	CSNK1E	780.0
Crizotinib	AURKB	76.0
PKC412	EGFR(S752-I759del)	1800.0
PHA-665752	RIOK1	470.0
Pictilisib	JAK1(JH2domain-pseudokinase)	430.0
Sorafenib	CDK3	3800.0
Doramapimod	ABL1(Q252H)-nonphosphorylated	830.0
PHA-665752	SIK2	2500.0
Alvocidib	LTK	2200.0
Gefitinib	ABL1(E255K)-phosphorylated	400.0
Nintedanib	INSR	24.0
Alvocidib	GSK3B	730.0
Ruxolitinib	MARK2	660.0
Foretinib	BMX	200.0
Crizotinib	MST2	990.0
Brivanib	EPHA6	190.0
PD184352	AURKC	1800.0
R406	GSK3B	120.0
Sorafenib	ABL1(T315I)-phosphorylated	1500.0
R406	OSR1	3100.0
Lestaurtinib	FLT3(R834Q)	7.0
KW2449	NEK2	5300.0
Nintedanib	RIOK3	36.0
Imatinib	ABL1(Y253F)-phosphorylated	130.0
Brivanib	ABL1(Y253F)-phosphorylated	1100.0
BMS345541	CDK7	680.0
Fedratinib	PIP5K2B	160.0
PLX-4720	RAF1	170.0
Enzastaurin	KGP1	1100.0
PKC412	CAMKK2	73.0
Barasertib	HIPK2	3700.0
RAF 265	ABL1(T315I)-nonphosphorylated	6100.0
Sunitinib	MLK1	3400.0
Barasertib	MET(Y1235D)	5700.0
R406	GSK3A	2500.0
Sunitinib	MARK1	1200.0
Crizotinib	TRKA	95.0
Alvocidib	FLT3(D835H)	5000.0
Enzastaurin	KCC2D	2800.0
Fedratinib	DYRK1B	9500.0
KW2449	TIE2	1100.0
KW2449	MAPKAPK5	1200.0
Fedratinib	EGFR(L861Q)	5800.0
Dasatinib	ABL1-phosphorylated	0.05
SB 203580	EGFR(L747-E749del,A750P)	1700.0
NVP-TAE684	RET(V804L)	120.0
KW2449	DAPK2	1800.0
Pazopanib	PFCDPK1(P.falciparum)	370.0
Foretinib	IKKE	1400.0
PI103	PIK3CD	17.0
Masitinib	KIT(L576P)	7.9
Motesanib	ABL1-nonphosphorylated	680.0
Nintedanib	ZAP70	3500.0
Neratinib	HCK	490.0
Bosutinib	KIT(L576P)	520.0
Barasertib	ERBB2	4300.0
Masitinib	ABL1(M351T)-phosphorylated	140.0
Tozasertib	IGF1R	740.0
Sorafenib	ABL1(Q252H)-phosphorylated	5500.0
R406	SIK1	53.0
KW2449	SRPK2	15.0
Fedratinib	FGFR3	360.0
KW2449	ROCK2	250.0
GSK1838705A	RSK4(Kin.Dom.1-N-terminal)	3000.0
Sorafenib	EPHA8	2400.0
BMS345541	HIPK4	8100.0
Barasertib	MP2K2	4200.0
NVP-TAE684	NEK7	2300.0
Linifanib	CDK8	95.0
Lestaurtinib	YSK4	0.5
Fedratinib	RIOK1	100.0
Sunitinib	CDK4-cyclinD1	6200.0
PLX-4720	CSK	2200.0
Tozasertib	MLCK	15.0
Dovitinib	HIPK3	5100.0
KW2449	BTK	1000.0
Gefitinib	ABL1(Y253F)-phosphorylated	360.0
Bosutinib	ABL1(T315I)-phosphorylated	3.6
Lestaurtinib	PAK6	9.9
KW2449	BLK	3500.0
NVP-TAE684	MINK	330.0
R406	LIMK2	1400.0
Nilotinib	CSF1R	45.0
Imatinib	LCK	40.0
Sorafenib	FGFR2	2700.0
Linifanib	FLT3(N841I)	2.6
Pazopanib	ABL1-nonphosphorylated	620.0
Bosutinib	KIT(V559D)	430.0
Erlotinib	KIT(L576P)	3500.0
Gefitinib	TNIK	6900.0
Doramapimod	EGFR(L747-T751del,Sins)	6800.0
NVP-TAE684	CSNK1A1L	5200.0
Lestaurtinib	CAMK1D	47.0
KW2449	TAOK1	1800.0
Barasertib	SRMS	7900.0
Neratinib	EGFR(G719S)	0.9
Tozasertib	ACVR1	1900.0
Foretinib	DMPK2	180.0
Fedratinib	FAK2	220.0
Fedratinib	SIK3	1900.0
Enzastaurin	CLK4	1600.0
Lestaurtinib	MAP4K5	43.0
Fedratinib	M4K1	1300.0
NVP-TAE684	RSK3(Kin.Dom.1-N-terminal)	33.0
R406	LKB1	3400.0
R406	NEK7	11.0
Tozasertib	ABL1(H396P)-nonphosphorylated	3.3
Lestaurtinib	DMPK	240.0
Nintedanib	ERK5	2500.0
Sorafenib	MP2K5	190.0
Nintedanib	ABL1(Q252H)-phosphorylated	28.0
Erlotinib	TNNI3K	570.0
SNS-032	MYLK2	980.0
Fedratinib	ALK	650.0
Fedratinib	AMPK-alpha2	4700.0
Sunitinib	TSSK1	6300.0
KW2449	MST4	1100.0
RAF 265	YSK1	6800.0
Canertinib	FLT3(R834Q)	490.0
GSK 690693	DAPK1	3000.0
Nintedanib	MAP3K3	34.0
Nilotinib	EPHB4	730.0
PHA-665752	ABL1(Y253F)-phosphorylated	1200.0
Ki20227	FRK	310.0
PKC412	FLT3(ITD)	11.0
PHA-665752	KIT(A829P)	4300.0
Dasatinib	FGFR2	1400.0
Crizotinib	MST1R	25.0
Lestaurtinib	PAK4	24.0
NVP-TAE684	RSK1(Kin.Dom.1-N-terminal)	160.0
Sunitinib	CSF1R	2.5
Crizotinib	DCLK1	330.0
Barasertib	HIPK4	97.0
Fedratinib	FLT4	2000.0
Sorafenib	TAOK2	540.0
Dovitinib	HUNK	410.0
Foretinib	MAP4K2	2000.0
Enzastaurin	HIPK1	1000.0
Pazopanib	EPHB6	81.0
RAF 265	MAP4K5	830.0
Lestaurtinib	BRSK1	25.0
Lestaurtinib	KIT(L576P)	40.0
Tozasertib	YSK4	51.0
Sunitinib	HCK	880.0
PHA-665752	LOK	290.0
Nintedanib	TYK2(JH2domain-pseudokinase)	500.0
Alvocidib	EGFR	3700.0
Fedratinib	ABL1(T315I)-phosphorylated	65.0
Nintedanib	FGFR1	92.0
Dovitinib	KIT(V559D,T670I)	26.0
Imatinib	PGFRB	14.0
Tofacitinib	RSK4(Kin.Dom.2-C-terminal)	540.0
Fedratinib	PTK6	1200.0
Nintedanib	CSF1R	48.0
Vandetanib	STK35	56.0
Enzastaurin	RSK1(Kin.Dom.1-N-terminal)	1600.0
Foretinib	LTK	110.0
Imatinib	KIT(V559D,T670I)	2500.0
NVP-TAE684	NEK6	1300.0
VX-745	FGR	1300.0
MLN8054	EPHA5	1400.0
Nintedanib	ITK	210.0
Sunitinib	LATS1	630.0
Dasatinib	PTK6	7.8
Doramapimod	VGFR2	3900.0
SB 203580	MRCKA	6200.0
Brivanib	YSK4	500.0
Tozasertib	EPHA6	4700.0
Dasatinib	KIT(V559D,V654A)	2.7
RAF 265	CDK11	5100.0
Enzastaurin	CDK2	5000.0
RAF 265	SRC	1100.0
Brivanib	KIT(V559D,T670I)	17.0
R406	PLK4	4.2
Dovitinib	M4K1	44.0
PHA-665752	CDK15	510.0
AC220	RIPK2	2700.0
Ki20227	MLTK	3300.0
Nintedanib	PAK2	3300.0
Tozasertib	TNK2	4400.0
NVP-TAE684	MST1	330.0
Sunitinib	DYRK2	680.0
Tozasertib	TTK	8100.0
Dovitinib	RPS6KA5(Kin.Dom.1-N-terminal)	680.0
Dasatinib	FGFR1	3700.0
Canertinib	MKNK2	1800.0
PKC412	SNARK	63.0
R406	FER	130.0
Doramapimod	EPHA3	880.0
Dasatinib	BRAF	500.0
Masitinib	PIM1	1300.0
Pazopanib	MLK3	740.0
PLX-4720	HIPK2	5000.0
BMS345541	ERK5	620.0
Sorafenib	MAP4K4	4800.0
NVP-TAE684	KIT(A829P)	220.0
Foretinib	FLT3(D835H)	1.4
Foretinib	EGFR(L747-S752del,P753S)	210.0
Barasertib	HCK	3900.0
NVP-TAE684	PHKG1	17.0
Lestaurtinib	RSK2(Kin.Dom.1-N-terminal)	290.0
GSK461364	KIT(A829P)	7200.0
Pazopanib	NEK5	7300.0
Vandetanib	FYN	360.0
Sorafenib	ABL1(Y253F)-phosphorylated	660.0
Sunitinib	EPHA3	2100.0
Linifanib	MKNK1	4900.0
PHA-665752	AAK1	320.0
Canertinib	ERBB2	56.0
Crizotinib	EPHA4	360.0
Foretinib	CSF1R	1.8
Nilotinib	MK09	5800.0
Tozasertib	RET(M918T)	26.0
PKC412	BIKE	220.0
Tozasertib	TRKB	240.0
Fedratinib	S6K1	2000.0
KW2449	ITK	240.0
SNS-032	ERK5	650.0
RAF 265	KIT(D816H)	8700.0
Alvocidib	ABL1(F317L)-phosphorylated	890.0
Nintedanib	KIT(V559D)	6.3
Afatinib	ABL1(T315I)-phosphorylated	870.0
GSK1838705A	EGFR(L858R)	2900.0
Tozasertib	BRSK1	8400.0
Nintedanib	ABL2	2000.0
Fedratinib	BMPR2	2900.0
Enzastaurin	M4K1	1800.0
Erlotinib	GCN2(Kin.Dom.2,S808G)	4400.0
Pazopanib	LYN	1100.0
Erlotinib	CSNK1D	3500.0
Doramapimod	ABL1(F317L)-nonphosphorylated	1300.0
Dovitinib	TLK2	2600.0
Bosutinib	CLK2	1700.0
PD184352	PGFRB	3100.0
VX-745	PGFRB	8400.0
Afatinib	EGFR(L747-E749del,A750P)	0.1
Dovitinib	LKB1	3700.0
Canertinib	TXK	700.0
GSK461364	MERTK	4600.0
BI-2536	EGFR(L747-T751del,Sins)	4800.0
Fedratinib	TNNI3K	1800.0
KW2449	TLK2	1800.0
Alvocidib	KPCD3	170.0
Linifanib	FLT3(D835Y)	11.0
Motesanib	AURKC	1900.0
Sorafenib	FLT3(N841I)	11.0
Pazopanib	JAK3(JH1domain-catalytic)	6900.0
Gefitinib	EPHA5	1500.0
Fedratinib	PGFRA	2700.0
Crizotinib	IRAK4	3600.0
Lestaurtinib	RSK4(Kin.Dom.1-N-terminal)	110.0
NVP-TAE684	TYK2(JH1domain-catalytic)	77.0
Neratinib	EPHB6	2800.0
Ruxolitinib	ABL1(F317L)-phosphorylated	2200.0
Fedratinib	JAK1(JH1domain-catalytic)	18.0
Bosutinib	MAP3K4	110.0
BMS345541	RPS6KA4(Kin.Dom.2-C-terminal)	2300.0
Lestaurtinib	ACVR2A	2500.0
Doramapimod	MUSK	1900.0
Foretinib	ABL1(H396P)-phosphorylated	110.0
Brivanib	ABL1(T315I)-phosphorylated	450.0
PHA-665752	RIPK1	1500.0
BMS345541	MYLK4	700.0
Doramapimod	KIT(L576P)	260.0
Linifanib	MET(M1250T)	690.0
Neratinib	MP2K7	530.0
Vandetanib	SLK	95.0
Lestaurtinib	ROCK1	56.0
Doramapimod	SLK	150.0
Bosutinib	TEC	3200.0
Alvocidib	PIP5K1C	2600.0
R406	CAMK1G	460.0
Ruxolitinib	CAMK2B	310.0
PKC412	NUAK1	41.0
GSK461364	SRPK3	7600.0
PI103	PIK3CA(E545K)	1.5
Crizotinib	JAK2(JH1domain-catalytic)	290.0
NVP-TAE684	TXK	480.0
Vandetanib	ABL1-nonphosphorylated	48.0
Gefitinib	EPHB6	3200.0
Crizotinib	BMX	3600.0
Alvocidib	TBK1	470.0
NVP-TAE684	KPCT	1500.0
Bosutinib	FYN	11.0
R406	KIT(D816V)	2.5
KW2449	MST3	1100.0
Nilotinib	KIT	29.0
NVP-TAE684	EPHA3	4000.0
KW2449	M3K2	72.0
NVP-TAE684	RIPK5	57.0
Vandetanib	PLK4	620.0
Vandetanib	SIK3	3900.0
Canertinib	FLT3(D835Y)	730.0
Nintedanib	MYLK2	4000.0
Linifanib	LIMK2	4700.0
Ruxolitinib	VRK2	4000.0
Doramapimod	JNK3	110.0
Sorafenib	PLK4	4500.0
Canertinib	KIT(V559D,T670I)	1900.0
AC220	DDR2	1100.0
Dovitinib	PCTK2	3000.0
Enzastaurin	FLT4	3800.0
MLN8054	FGFR2	1700.0
Pictilisib	PIK3CB	16.0
Bosutinib	CLK4	3200.0
Erlotinib	RIPK2	680.0
PLX-4720	LIMK2	620.0
Lestaurtinib	ANKK1	32.0
AC220	SLK	4600.0
Foretinib	EGFR(G719C)	120.0
Alvocidib	CDK9	6.4
Dovitinib	PLK2	570.0
Afatinib	ABL1(Q252H)-phosphorylated	380.0
Lestaurtinib	MARK2	14.0
PHA-665752	KCC2D	2900.0
Nintedanib	HIPK4	1200.0
Canertinib	DRAK2	7300.0
Ki20227	EPHA8	3900.0
Bosutinib	SLK	4.7
MLN8054	EPHA7	1000.0
GSK 690693	DCLK1	2400.0
KW2449	EGFR(G719C)	2700.0
SGX523	ABL1(H396P)-nonphosphorylated	3400.0
Nilotinib	PFCDPK1(P.falciparum)	790.0
Neratinib	FGR	1900.0
Vandetanib	ACVR1	150.0
NVP-TAE684	CDK4-cyclinD1	1400.0
Ki20227	MINK	2600.0
Sunitinib	ABL1(Q252H)-nonphosphorylated	240.0
Nintedanib	KIT(L576P)	2.7
Pictilisib	JNK1	1500.0
Linifanib	TNIK	2800.0
Masitinib	ABL1(E255K)-phosphorylated	140.0
Ruxolitinib	CAMK1D	120.0
Gefitinib	JNK3	3200.0
Dasatinib	KIT(A829P)	0.66
Sunitinib	ABL1(H396P)-phosphorylated	140.0
Canertinib	MP2K1	1800.0
PHA-665752	AMPK-alpha2	770.0
Bosutinib	MET	2200.0
Bosutinib	M3K12	670.0
Dasatinib	ABL1(H396P)-phosphorylated	0.05
Nintedanib	RPS6KA5(Kin.Dom.1-N-terminal)	200.0
Sorafenib	RET(V804L)	39.0
Lestaurtinib	RSK1(Kin.Dom.1-N-terminal)	28.0
Brivanib	VGFR1	10.0
Bosutinib	STK33	37.0
Canertinib	RIPK2	300.0
Crizotinib	TAOK3	490.0
Bosutinib	PAK3	5700.0
Dovitinib	ABL1(H396P)-nonphosphorylated	42.0
Nintedanib	FGFR3(G697C)	140.0
Nintedanib	KGP1	14.0
Fedratinib	MYLK4	130.0
Sunitinib	PGFRA	0.8
KW2449	CDK14	870.0
SNS-032	FLT3(D835H)	7400.0
Fedratinib	ABL1-nonphosphorylated	180.0
Sunitinib	DDR1	2000.0
Gefitinib	FLT3	3100.0
NVP-TAE684	PGFRA	840.0
Alvocidib	RSK4(Kin.Dom.2-C-terminal)	800.0
SB 203580	EGFR(T790M)	2500.0
Fedratinib	NEK3	640.0
Crizotinib	KPCD1	990.0
Canertinib	SIK3	700.0
Ruxolitinib	KCC2D	90.0
R406	TESK1	360.0
GSK 690693	PAK4	18.0
Foretinib	ERBB3	1500.0
Fedratinib	VGFR1	4300.0
Nintedanib	JNK3	270.0
Canertinib	ABL1(Q252H)-phosphorylated	22.0
Lestaurtinib	PTK6	1700.0
Fedratinib	PLK4	96.0
Fedratinib	TXK	1500.0
R406	PGFRB	3.3
Tofacitinib	ROCK1	470.0
Nintedanib	CDK2	1400.0
Pazopanib	FRK	750.0
Dasatinib	EGFR(T790M)	2300.0
PLX-4720	CSF1R	2700.0
BI-2536	YSK4	480.0
Lestaurtinib	S6K1	69.0
Motesanib	LYN	160.0
Dasatinib	ERBB3	18.0
Lestaurtinib	KGP2	25.0
KW2449	KIT(V559D)	23.0
RAF 265	SYK	4400.0
PKC412	ABL1(T315I)-nonphosphorylated	4900.0
Tozasertib	FGFR3(G697C)	820.0
Dasatinib	MP2K2	1400.0
PKC412	EGFR	1300.0
Nintedanib	FLT3(N841I)	2.6
Dovitinib	RIOK2	260.0
GSK461364	RPS6KA4(Kin.Dom.2-C-terminal)	740.0
Neratinib	INSRR	4600.0
Tozasertib	FGFR2	570.0
Sunitinib	TAK1	93.0
KW2449	SgK110	230.0
Nintedanib	RET(V804M)	9.6
Brivanib	ABL1-nonphosphorylated	1100.0
Bosutinib	TSSK1	4600.0
Doramapimod	EPHA4	2900.0
Foretinib	EPHB2	3.9
R406	MAP3K4	840.0
Lestaurtinib	ERBB3	5500.0
PHA-665752	IRAK1	1600.0
NVP-TAE684	MP2K6	2000.0
Bosutinib	RET(V804M)	4200.0
Fedratinib	IRAK4	1200.0
NVP-TAE684	KIT	110.0
RAF 265	KIT(V559D)	170.0
GSK1838705A	GRK7	540.0
Fedratinib	RPS6KA5(Kin.Dom.2-C-terminal)	2200.0
PHA-665752	HIPK2	120.0
Foretinib	EGFR(T790M)	470.0
KW2449	CSNK1A1	1200.0
BI-2536	ERK5	3200.0
Fedratinib	MK09	240.0
Tofacitinib	ABL1(T315I)-phosphorylated	2200.0
Foretinib	ROS1	14.0
PKC412	ABL1(H396P)-nonphosphorylated	3100.0
NVP-TAE684	PAK1	650.0
Lestaurtinib	CDK14	720.0
Dovitinib	FRK	2300.0
Sunitinib	ROCK1	460.0
Dovitinib	FGFR1	150.0
Lestaurtinib	FLT3(D835Y)	0.6
Dovitinib	BMPR2	3100.0
Ruxolitinib	CSNK2A2	3300.0
Sorafenib	STK36	3800.0
Dovitinib	ABL1(Q252H)-phosphorylated	58.0
Sunitinib	ABL1(H396P)-nonphosphorylated	74.0
Afatinib	ABL1(Q252H)-nonphosphorylated	790.0
Tofacitinib	ABL1(H396P)-nonphosphorylated	4500.0
PHA-665752	M3K13	3200.0
R406	MKNK2	130.0
Dovitinib	PKN2	9900.0
PHA-665752	TYRO3	2000.0
Dasatinib	DDR2	3.2
PHA-665752	INSR	2300.0
Afatinib	BLK	220.0
PKC412	SRPK2	330.0
PLX-4720	ABL1(F317L)-nonphosphorylated	940.0
Sorafenib	M4K1	4800.0
Ruxolitinib	TNK2	2600.0
Fedratinib	MINK	8900.0
Lestaurtinib	CIT	85.0
Lestaurtinib	FLT3(D835H)	0.7
Lestaurtinib	LATS1	30.0
Lestaurtinib	PRP4	550.0
Lestaurtinib	MET(M1250T)	480.0
PHA-665752	CDKL2	2400.0
Alvocidib	LRRK2(G2019S)	2000.0
Alvocidib	FAK2	3100.0
Foretinib	MP2K1	12.0
Sunitinib	MAP3K3	220.0
Fedratinib	IGF1R	2200.0
GSK 690693	SIK2	6900.0
PHA-665752	RSK4(Kin.Dom.1-N-terminal)	6800.0
Crizotinib	AURKC	4300.0
PHA-665752	ULK1	2000.0
Ki20227	EGFR(G719S)	2000.0
Nintedanib	EPHB4	1100.0
R406	MUSK	100.0
NVP-TAE684	AMPK-alpha2	49.0
Foretinib	FLT3(N841I)	1.5
Lestaurtinib	IGF1R	4200.0
PI103	PIK3C2G	41.0
Crizotinib	IRAK3	31.0
Foretinib	FGFR3(G697C)	1600.0
Tozasertib	MARK4	4900.0
Pazopanib	MET(Y1235D)	2100.0
Ruxolitinib	DCLK1	68.0
BI-2536	PHKG2	1600.0
Ruxolitinib	MP2K3	470.0
R406	FLT3(D835Y)	0.4
KW2449	NIM1	1100.0
BI-2536	PLK3	4.0
R406	PAK6	310.0
PKC412	CLK3	3600.0
Bosutinib	EGFR(L747-S752del,P753S)	38.0
Fedratinib	EPHA3	7100.0
Crizotinib	AMPK-alpha1	2400.0
Brivanib	KIT(V559D,V654A)	12.0
Crizotinib	LCK	30.0
Alvocidib	FRK	1200.0
Tozasertib	FGFR3	860.0
Barasertib	EGFR(S752-I759del)	5200.0
Alvocidib	ULK2	470.0
R406	NUAK1	75.0
PKC412	IRAK3	180.0
AC220	VGFR1	41.0
GSK 690693	KGP1	210.0
Lestaurtinib	EPHB2	6900.0
PHA-665752	JAK2(JH1domain-catalytic)	430.0
Tozasertib	TIE1	270.0
Linifanib	KIT(A829P)	17.0
Nintedanib	DRAK1	110.0
PKC412	MARK3	21.0
Ruxolitinib	PHKG2	1000.0
GSK461364	PLK3	740.0
Afatinib	ABL1(F317L)-phosphorylated	230.0
Barasertib	KIT(V559D,V654A)	480.0
Foretinib	EIF2AK1	980.0
Dasatinib	DMPK2	1200.0
PHA-665752	JAK1(JH2domain-pseudokinase)	2700.0
GSK461364	TAOK3	1400.0
Pazopanib	CDC2L2	1300.0
Nintedanib	GRK7	1200.0
Lestaurtinib	NEK6	4400.0
Bosutinib	RET	4800.0
Gefitinib	KIT(A829P)	1800.0
Dovitinib	ABL1(F317L)-nonphosphorylated	1500.0
Sorafenib	JAK3(JH1domain-catalytic)	7300.0
Vandetanib	ABL1(Q252H)-phosphorylated	16.0
Sunitinib	CLK1	22.0
Lestaurtinib	CDKL2	43.0
Dasatinib	TESK1	33.0
SNS-032	DYRK1A	340.0
PKC412	TIE1	1400.0
Lapatinib	EGFR(L858R)	2.8
Fedratinib	TGFBR2	1100.0
KW2449	EPHA3	810.0
Gefitinib	CIT	1300.0
Nilotinib	EPHA3	110.0
Brivanib	LCK	1100.0
KW2449	ALK	660.0
SNS-032	HIPK2	1500.0
Dovitinib	ABL1-nonphosphorylated	100.0
Brivanib	RIPK2	2900.0
Crizotinib	CAMKK2	1500.0
Dasatinib	SIK2	6.4
PKC412	KPCD2	6300.0
Tofacitinib	GRK7	4300.0
Canertinib	ADCK4	3400.0
Tozasertib	MARK3	2500.0
R406	MARK3	1900.0
Fedratinib	AAK1	35.0
PHA-665752	SRPK1	41.0
Doramapimod	EGFR(T790M)	2400.0
PLX-4720	FGFR1	5300.0
GSK461364	RSK2(Kin.Dom.1-N-terminal)	190.0
Foretinib	PAK3	4100.0
Bosutinib	PAK1	2300.0
Masitinib	EPHA3	2500.0
NVP-TAE684	SIK1	15.0
Erlotinib	JAK2(JH1domain-catalytic)	3700.0
GDC-0879	RIPK2	2500.0
Canertinib	MET	5600.0
Canertinib	RIOK1	8400.0
RAF 265	BLK	7900.0
PKC412	TNIK	1600.0
Pictilisib	MELK	5700.0
Lestaurtinib	TYRO3	650.0
Foretinib	FGR	40.0
MLN8054	EPHA3	2100.0
R406	BIKE	1900.0
Nintedanib	DAPK3	2100.0
Crizotinib	ABL1(Q252H)-nonphosphorylated	97.0
Lestaurtinib	AXL	35.0
Pictilisib	HIPK2	520.0
Bosutinib	EPHB3	210.0
Tozasertib	PKN2	5000.0
PKC412	EPHB6	3100.0
Foretinib	RIPK5	510.0
AC220	FLT3(ITD)	8.8
NVP-TAE684	CAMK1G	3000.0
R406	EPHA4	150.0
Lestaurtinib	PRKX	42.0
PKC412	CLK2	860.0
Tozasertib	JAK1(JH1domain-catalytic)	5900.0
Ruxolitinib	BRAF(V600E)	4200.0
Vandetanib	TESK1	3700.0
NVP-TAE684	SIK3	1300.0
Nintedanib	PCTK3	510.0
Sunitinib	BRSK1	3500.0
Pazopanib	MP2K5	480.0
KW2449	ANKK1	82.0
GSK461364	RSK4(Kin.Dom.1-N-terminal)	350.0
Lestaurtinib	DRAK2	5.0
Lestaurtinib	ULK1	1000.0
MLN8054	AURKC	26.0
Crizotinib	M4K1	39.0
Alvocidib	KPCE	380.0
BI-2536	DCLK1	5900.0
Sunitinib	SRC	2100.0
Canertinib	ERBB3	210.0
Lestaurtinib	EGFR(L861Q)	800.0
PKC412	RET(M918T)	130.0
PKC412	MLK1	15.0
Pazopanib	PIP5K1C	1900.0
Ruxolitinib	ABL1(H396P)-nonphosphorylated	1100.0
Brivanib	ABL1-phosphorylated	640.0
Enzastaurin	STK16	2500.0
KW2449	MELK	210.0
Neratinib	EGFR(L861Q)	0.4
KW2449	MLCK	4.3
KW2449	ABL2	250.0
Lestaurtinib	FRK	740.0
Dasatinib	FLT3(K663Q)	3200.0
Crizotinib	FLT3(ITD)	730.0
R406	ERN1	1600.0
Pazopanib	ABL1(Y253F)-phosphorylated	480.0
Enzastaurin	FLT3(N841I)	250.0
Foretinib	MYLK2	2300.0
Foretinib	MK11	760.0
NVP-TAE684	CSF1R	48.0
Fedratinib	PRP4	390.0
Sunitinib	CAMK1G	440.0
Ruxolitinib	TRKA	1500.0
SB 203580	TNNI3K	3500.0
Linifanib	ERK8	2800.0
Vandetanib	TXK	3700.0
PKC412	LATS2	2200.0
Alvocidib	KPCD	590.0
Dasatinib	NEK2	6500.0
BI-2536	CLK3	630.0
PLX-4720	AURKB	2300.0
Linifanib	FLT3(ITD)	8.8
KW2449	DRAK1	2.9
Nintedanib	CDK4-cyclinD3	720.0
PKC412	RET(V804M)	20.0
SGX523	MET	0.2
BI-2536	CLK1	940.0
Canertinib	TGFBR1	9600.0
Nintedanib	KPCD1	990.0
Foretinib	AMPK-alpha1	730.0
PKC412	LCK	280.0
PHA-665752	DDR1	70.0
Foretinib	EPHA6	1.1
Sunitinib	EGFR(L858R,T790M)	860.0
Nilotinib	ABL1(H396P)-phosphorylated	21.0
Neratinib	YANK2	6400.0
Lestaurtinib	PFCDPK1(P.falciparum)	5.6
Erlotinib	ERBB2	2900.0
Lestaurtinib	PGFRB	29.0
Enzastaurin	CLK2	430.0
KW2449	KKCC1	210.0
BMS345541	DYRK2	2100.0
Lestaurtinib	PIK3CA(Q546K)	5400.0
SB 203580	BMPR1B	3300.0
Foretinib	ITK	69.0
Lestaurtinib	ABL1(Y253F)-phosphorylated	910.0
Linifanib	M4K3	3200.0
Bosutinib	ERK5	2300.0
Brivanib	ABL1(F317L)-nonphosphorylated	4100.0
Dasatinib	WEE2	200.0
Sorafenib	BRAF(V600E)	260.0
Nintedanib	ALK	31.0
KW2449	PKN1	580.0
Sunitinib	KCC4	890.0
KW2449	DAPK1	360.0
MLN8054	MERTK	730.0
Gefitinib	SNARK	4600.0
KW2449	MAP4K4	33.0
Fedratinib	ADCK3	7000.0
Fedratinib	TAOK1	1300.0
NVP-TAE684	EPHA1	39.0
Dasatinib	EGFR(G719C)	170.0
Fedratinib	TYK2(JH1domain-catalytic)	21.0
Lestaurtinib	MAPKAPK5	930.0
PLX-4720	TESK1	1500.0
PLX-4720	HIPK4	5400.0
GSK461364	DAPK1	1400.0
Bosutinib	M4K3	5.1
Ruxolitinib	DRAK1	6200.0
NVP-TAE684	ZAP70	1600.0
Sunitinib	MLK3	1300.0
Canertinib	ABL1(M351T)-phosphorylated	38.0
Neratinib	AXL	190.0
PLX-4720	PTK6	48.0
Foretinib	STK36	180.0
Canertinib	KIT(D816H)	600.0
Pictilisib	CLK1	1100.0
Dovitinib	MYLK4	80.0
Afatinib	CSNK1E	1300.0
NVP-TAE684	KPCE	2000.0
Lestaurtinib	IRAK4	1.7
Linifanib	EPHB2	1400.0
PLX-4720	ACVR2B	3200.0
Lestaurtinib	PIK3CA(C420R)	4900.0
MLN8054	BMX	3100.0
Pictilisib	RSK4(Kin.Dom.1-N-terminal)	5400.0
Pazopanib	ACVR2B	2400.0
GSK 690693	MAP3K3	880.0
BI-2536	KPCD3	350.0
Foretinib	KIT(V559D)	2.1
Nintedanib	STK33	1100.0
Nintedanib	RSK3(Kin.Dom.1-N-terminal)	58.0
Nilotinib	TIE1	1000.0
Erlotinib	FLT4	2100.0
Fedratinib	SRMS	5000.0
Dasatinib	KIT	0.81
Sorafenib	ERK8	46.0
Dovitinib	FLT3	0.6
Alvocidib	KPCD1	520.0
BI-2536	IRAK4	2100.0
Sorafenib	TTK	3500.0
BI-2536	CAMK1D	5400.0
Tozasertib	RSK2(Kin.Dom.1-N-terminal)	6400.0
PKC412	ZAP70	2600.0
Linifanib	CDK7	2900.0
Sunitinib	PKN2	1300.0
R406	EPHA3	360.0
NVP-TAE684	MAP3K1	4300.0
R406	ROCK2	560.0
Lestaurtinib	MST3	760.0
Foretinib	CLK1	550.0
NVP-TAE684	PAK2	5800.0
BI-2536	ABL1(E255K)-phosphorylated	5900.0
Linifanib	STK33	3800.0
Crizotinib	YSK4	980.0
Afatinib	MKNK2	1600.0
Bosutinib	EPHB2	8.4
Sunitinib	FLT3(K663Q)	0.2
PKC412	AKT3	4400.0
Sunitinib	KIT(L576P)	1.3
Dasatinib	FGR	0.5
Enzastaurin	AXL	3300.0
Dasatinib	VGFR2	2900.0
Foretinib	SRMS	18.0
Fedratinib	CSK	5900.0
Bosutinib	EPHA1	2300.0
NVP-TAE684	SLK	21.0
R406	FGFR3	56.0
PHA-665752	DRAK1	4000.0
NVP-TAE684	NEK3	8800.0
PI103	PIK3CA(E545A)	1.5
Bosutinib	BMPR2	580.0
Crizotinib	FYN	1300.0
Ruxolitinib	MAP3K1	4200.0
Lestaurtinib	NIM1	1800.0
PI103	PIK3CA(E542K)	1.4
NVP-TAE684	EPHA7	200.0
GSK 690693	PKN1	34.0
Tozasertib	MAP3K3	1900.0
Dasatinib	YES	0.3
PKC412	PHKG2	1400.0
Tofacitinib	KCC2D	2700.0
Bosutinib	EPHA6	1100.0
Sunitinib	TBK1	120.0
KW2449	S6K1	310.0
KW2449	NEK9	520.0
Neratinib	FLT3(K663Q)	4900.0
NVP-TAE684	CTK	2800.0
PLX-4720	MP2K5	0.2
PKC412	EGFR(G719S)	5300.0
Foretinib	CAMKK2	4400.0
Linifanib	INSRR	3900.0
Bosutinib	ULK1	1200.0
Nintedanib	KPCD3	640.0
NVP-TAE684	ADCK4	92.0
PLX-4720	ABL1(H396P)-nonphosphorylated	510.0
Ruxolitinib	ERN1	2500.0
Canertinib	BIKE	3800.0
SB 203580	RSK1(Kin.Dom.2-C-terminal)	320.0
Brivanib	HCK	2700.0
NVP-TAE684	GCN2(Kin.Dom.2,S808G)	1100.0
Doramapimod	TRKB	570.0
Brivanib	CSF1R	1900.0
Neratinib	PAK2	79.0
KW2449	ABL1(F317I)-phosphorylated	530.0
R406	TLK2	380.0
Tozasertib	MYLK4	2200.0
PKC412	DAPK2	890.0
Tozasertib	SIK2	1700.0
Foretinib	INSRR	53.0
Sunitinib	PIP5K1A	5400.0
Nintedanib	HIPK1	1300.0
Barasertib	ABL1(E255K)-phosphorylated	9600.0
PLX-4720	VGFR2	2100.0
Ki20227	TGFBR2	320.0
NVP-TAE684	BMPR2	3900.0
GDC-0879	MINK	1000.0
Nintedanib	YES	80.0
RAF 265	MAP4K2	5000.0
Lestaurtinib	TNK1	9.3
MLN8054	EPHB3	3500.0
Gefitinib	DAPK3	5700.0
PHA-665752	NUAK1	620.0
R406	CHEK1	2500.0
Fedratinib	HIPK4	220.0
Canertinib	SLK	1800.0
NVP-TAE684	EPHB3	1900.0
BI-2536	RIOK1	2200.0
Lestaurtinib	RIOK2	6700.0
Linifanib	FLT3(R834Q)	16.0
NVP-TAE684	EPHA4	910.0
Dovitinib	ANKK1	79.0
KW2449	GAK	260.0
Barasertib	RET(V804L)	140.0
PKC412	RIOK1	1200.0
KW2449	KIT	53.0
Ruxolitinib	NEK7	4900.0
Lestaurtinib	MAP3K3	6.0
NVP-TAE684	TRKB	130.0
Sunitinib	CSNK2A1	900.0
Crizotinib	BMPR1B	230.0
Enzastaurin	GSK3B	8.3
RAF 265	PTK6	3600.0
Gefitinib	CDK7	610.0
Dasatinib	SLK	720.0
Tozasertib	ABL1(Q252H)-nonphosphorylated	3.8
Nintedanib	MP2K3	2100.0
Lestaurtinib	PKN2	1.8
NVP-TAE684	ABL1(H396P)-phosphorylated	160.0
Fedratinib	IRAK3	120.0
Alvocidib	ABL1(E255K)-phosphorylated	1600.0
Crizotinib	ADCK4	1100.0
Vandetanib	ERBB4	480.0
Tozasertib	STK16	610.0
BI-2536	EGFR	2200.0
Dovitinib	FYN	440.0
Doramapimod	ABL1(F317I)-nonphosphorylated	4900.0
Nilotinib	TAOK3	1700.0
NVP-TAE684	YES	23.0
NVP-TAE684	FLT3(N841I)	11.0
R406	MARK2	280.0
Ki20227	IRAK3	2300.0
Tozasertib	TAOK1	290.0
PI103	CLK1	3900.0
Fedratinib	ERN1	1200.0
Foretinib	FRK	3.8
PKC412	AAK1	48.0
Fedratinib	TLK1	1300.0
KW2449	BMPR1A	1900.0
Dovitinib	CDK7	2600.0
GSK 690693	RPS6KA5(Kin.Dom.2-C-terminal)	160.0
Dovitinib	ABL1(F317I)-phosphorylated	4500.0
Enzastaurin	HIPK2	720.0
Sorafenib	CDK2	8700.0
Gefitinib	KIT(D816H)	5500.0
NVP-TAE684	IGF1R	2.7
NVP-TAE684	TNK1	1.8
PLX-4720	FRK	1900.0
Lestaurtinib	WEE2	7900.0
Neratinib	LOK	13.0
Sorafenib	RET	13.0
PLX-4720	EPHB6	860.0
GSK461364	DAPK3	5500.0
R406	CSNK2A2	14.0
Dovitinib	NEK7	5600.0
Nintedanib	ICK	1700.0
Ruxolitinib	GRK1	730.0
SNS-032	ERK4	4100.0
Motesanib	ABL2	4500.0
Tozasertib	PHKG2	4400.0
Nintedanib	PKN1	740.0
Sorafenib	KIT(V559D,T670I)	18.0
R406	FLT3(ITD)	0.5
GSK461364	RIOK3	2300.0
Masitinib	KIT	8.1
NVP-TAE684	INSR	2.4
BI-2536	CSNK1A1	3100.0
R406	EPHA6	120.0
Bosutinib	RIOK1	2200.0
Sunitinib	ABL1(T315I)-phosphorylated	55.0
Crizotinib	ABL1(F317I)-nonphosphorylated	2700.0
RAF 265	CSF1R	250.0
Barasertib	FLT3(R834Q)	130.0
R406	STK35	1400.0
Sunitinib	FAK1	440.0
Barasertib	LOK	2800.0
SNS-032	CDC2L2	48.0
Ki20227	PGFRB	0.3
Sunitinib	MAST1	200.0
PI103	RAF1	3700.0
Enzastaurin	SNARK	4100.0
Dasatinib	RET(V804L)	3200.0
Ki20227	LIMK2	500.0
Tozasertib	LCK	61.0
Gefitinib	RIPK2	530.0
Dovitinib	EPHB6	220.0
GSK 690693	CIT	200.0
Doramapimod	RIPK2	5800.0
Vandetanib	IRAK4	75.0
Sunitinib	DAPK1	120.0
Foretinib	MK14	320.0
Tofacitinib	LRRK2(G2019S)	550.0
Lestaurtinib	CDK3	420.0
Dovitinib	CDK16	430.0
Crizotinib	M3K2	72.0
Sunitinib	CSNK2A2	160.0
Dovitinib	FLT3(D835H)	6.1
Doramapimod	ANKK1	1000.0
Neratinib	YSK1	12.0
NVP-TAE684	FGFR1	47.0
RAF 265	ABL1(Q252H)-nonphosphorylated	440.0
GDC-0879	JNK3	2500.0
Sorafenib	VGFR2	59.0
Lestaurtinib	EPHA3	160.0
Alvocidib	EGFR(E746-A750del)	1200.0
SB 203580	MET(Y1235D)	7900.0
KW2449	CIT	650.0
Bosutinib	KPCE	2400.0
Fedratinib	CDK4-cyclinD1	5000.0
Sunitinib	RIOK1	35.0
Erlotinib	BIKE	1200.0
Vandetanib	FGR	270.0
GSK1838705A	KCC4	470.0
Enzastaurin	KPCT	36.0
Barasertib	MKNK2	1200.0
Sorafenib	CDK7	140.0
Fedratinib	ABL1(F317L)-nonphosphorylated	450.0
Sorafenib	MLCK	9600.0
Bosutinib	SRC	1.0
BI-2536	KC1G2	5700.0
Doramapimod	EPHA6	2000.0
KW2449	CDK7	190.0
Fedratinib	EPHA8	7700.0
Dasatinib	ABL1(F317L)-nonphosphorylated	0.03
Nintedanib	FLT3	3.8
BI-2536	DAPK2	930.0
PKC412	YSK4	15.0
Ki20227	KIT(D816V)	580.0
Lestaurtinib	CDK16	27.0
NVP-TAE684	CDK4-cyclinD3	400.0
Nintedanib	FGR	300.0
R406	PAK7	69.0
Tozasertib	TXK	2700.0
PKC412	TNK1	83.0
Tozasertib	FLT3(N841I)	4.3
Ruxolitinib	IRAK1	290.0
Bosutinib	MP2K2	9.9
Neratinib	EGFR(L747-E749del,A750P)	0.6
BI-2536	MET	2400.0
Linifanib	VGFR2	8.1
Alvocidib	GRK1	650.0
Dasatinib	ABL1(Q252H)-nonphosphorylated	0.04
Dasatinib	ABL1(F317I)-phosphorylated	0.04
GSK 690693	RPS6KA4(Kin.Dom.2-C-terminal)	51.0
Sorafenib	CDKL3	490.0
PLX-4720	ABL1(F317L)-phosphorylated	5700.0
KW2449	KIT(L576P)	21.0
Fedratinib	EGFR(L858R,T790M)	570.0
Lestaurtinib	BLK	160.0
Crizotinib	SNARK	120.0
Foretinib	EGFR(L747-T751del,Sins)	160.0
RAF 265	TAK1	490.0
Enzastaurin	TLK2	1400.0
Linifanib	MST1R	7600.0
Doramapimod	KIT(V559D)	230.0
Ruxolitinib	PAK4	1600.0
PHA-665752	PAK3	1100.0
Nilotinib	EPHA1	590.0
Pazopanib	SIK2	7300.0
PI103	CSNK2A2	2900.0
Lestaurtinib	EGFR(L747-S752del,P753S)	1400.0
Alvocidib	PLK4	8400.0
Enzastaurin	DYRK1B	1000.0
Canertinib	ERK3	1700.0
SNS-032	CDK16	7.1
Nintedanib	RSK2(Kin.Dom.1-N-terminal)	65.0
Bosutinib	ABL1(E255K)-phosphorylated	0.05
GSK461364	ULK2	1400.0
Fedratinib	BLK	650.0
KW2449	HIPK1	430.0
KW2449	ABL1(Q252H)-nonphosphorylated	47.0
Ki20227	ABL1-nonphosphorylated	95.0
Crizotinib	TAOK2	900.0
Masitinib	ABL1(Q252H)-phosphorylated	4.6
R406	M4K1	1400.0
Selumetinib	EGFR(E746-A750del)	5700.0
PKC412	LTK	3000.0
Nilotinib	RET(M918T)	1100.0
KW2449	RIPK5	660.0
Lestaurtinib	LTK	490.0
Bosutinib	AXL	52.0
MLN8054	ABL1(Q252H)-phosphorylated	1300.0
GSK1838705A	GRK1	830.0
Ruxolitinib	SRPK1	2100.0
Brivanib	EGFR(L858R)	5100.0
Sunitinib	PDPK1	3500.0
Lestaurtinib	STK35	810.0
Bosutinib	MST1R	6300.0
NVP-TAE684	EGFR(L858R)	46.0
Neratinib	MET(M1250T)	6700.0
Dasatinib	YSK4	79.0
KW2449	FES	750.0
Lestaurtinib	DYRK2	22.0
Crizotinib	ACVR1B	860.0
GSK 690693	PRKR	2000.0
Ki20227	LCK	260.0
MLN8054	FLT4	3100.0
Crizotinib	NEK7	5700.0
R406	TRKB	900.0
Nintedanib	ACVR1	600.0
Sunitinib	ABL1(Q252H)-phosphorylated	76.0
Fedratinib	SRPK2	100.0
AC220	KIT	4.8
Pazopanib	MAP4K4	2200.0
Vandetanib	EGFR(L747-S752del,P753S)	7.9
Sunitinib	ULK2	13.0
Doramapimod	TRKC	190.0
Sorafenib	TIE2	2100.0
Motesanib	EGFR(L747-T751del,Sins)	2600.0
Ki20227	FGR	1800.0
Sunitinib	PRP4	390.0
Bosutinib	PKMYT1	350.0
Dovitinib	M3K13	170.0
Dasatinib	BMPR1A	7000.0
Afatinib	EGFR	0.3
Nilotinib	KIT(L576P)	22.0
Pazopanib	FLT3(D835H)	1100.0
RAF 265	KIT(D816V)	6200.0
Nilotinib	DDR1	1.1
Erlotinib	STK36	4400.0
Gefitinib	YSK4	240.0
Dovitinib	PHKG2	9000.0
Ruxolitinib	ULK2	190.0
Pazopanib	HCK	5700.0
Nintedanib	INSRR	21.0
PI103	HIPK3	310.0
Lestaurtinib	MAP3K15	3.4
Fedratinib	MP2K1	5100.0
Tozasertib	EPHA8	500.0
Pazopanib	BRAF(V600E)	430.0
R406	NEK3	170.0
Sunitinib	FLT4	50.0
Fedratinib	YES	120.0
Foretinib	M3K13	16.0
PKC412	JAK1(JH1domain-catalytic)	670.0
Imatinib	KIT(D816V)	980.0
Imatinib	FRK	1500.0
GSK1838705A	EGFR(L861Q)	1400.0
KW2449	EGFR(L858R,T790M)	640.0
Pazopanib	PI42C	280.0
KW2449	NEK6	120.0
NVP-TAE684	MP2K4	150.0
NVP-TAE684	SRPK3	2900.0
PKC412	PIP5K2B	270.0
KW2449	PGFRA	130.0
Tofacitinib	ULK3	6400.0
Lapatinib	MP2K5	1100.0
PHA-665752	IKKE	700.0
R406	DDR2	43.0
Lestaurtinib	EGFR(S752-I759del)	1400.0
Lestaurtinib	MAST1	19.0
Motesanib	M3K2	6900.0
Nintedanib	GSK3A	430.0
Fedratinib	CSNK2A2	120.0
Tozasertib	PAK7	3300.0
Sorafenib	ABL1(Q252H)-nonphosphorylated	130.0
Dasatinib	SBK1	1200.0
PLX-4720	KIT	180.0
Dasatinib	MP2K1	1000.0
Dovitinib	EGFR(L858R,T790M)	940.0
Foretinib	EPHA4	1.9
Dovitinib	MLK1	9900.0
Pazopanib	ABL1(H396P)-phosphorylated	700.0
Nilotinib	EPHA6	640.0
Erlotinib	EGFR(L858R)	1.0
PLX-4720	MP2K1	550.0
Crizotinib	ITK	2000.0
R406	NEK9	16.0
Nintedanib	FLT3(D835Y)	0.4
NVP-TAE684	EGFR(L747-E749del,A750P)	72.0
Lestaurtinib	MYLK	13.0
Canertinib	SRMS	6700.0
Dasatinib	MRCKA	2000.0
Neratinib	JNK1	3300.0
SB 203580	GSK3B	1700.0
NVP-TAE684	DAPK2	870.0
Foretinib	MLK1	1000.0
GSK461364	NEK1	1800.0
Fedratinib	EGFR(L747-T751del,Sins)	3800.0
Nilotinib	SRC	1900.0
Dasatinib	BMX	1.4
Ruxolitinib	TAOK2	310.0
Alvocidib	CDKL5	7.1
Sorafenib	MYLK2	5400.0
Fedratinib	MST4	7500.0
Foretinib	CIT	3200.0
Tozasertib	SRC	170.0
Masitinib	EGFR(L861Q)	4700.0
NVP-TAE684	JAK2(JH1domain-catalytic)	16.0
PLX-4720	HIPK3	9700.0
Foretinib	ABL1(F317L)-nonphosphorylated	20.0
Ruxolitinib	SNARK	320.0
Fedratinib	ERBB4	2000.0
PKC412	DDR1	7200.0
Nintedanib	FGFR2	350.0
Dasatinib	EPHA4	1.2
Lestaurtinib	FLT3(ITD)	1.5
Afatinib	DYRK1A	970.0
KW2449	TNK2	1600.0
R406	FYN	28.0
R406	AURKA	160.0
SNS-032	CSNK1D	1800.0
Vandetanib	S6K1	1600.0
Motesanib	JAK1(JH1domain-catalytic)	5200.0
Enzastaurin	SLK	3100.0
Foretinib	ABL1(H396P)-nonphosphorylated	10.0
Bosutinib	TNK2	29.0
R406	MKNK1	230.0
Nintedanib	MP2K5	1.8
PKC412	AKT1	950.0
Pictilisib	PIK3CA(E545K)	1.2
Lestaurtinib	MLK1	3.5
Erlotinib	ABL1(H396P)-nonphosphorylated	89.0
Motesanib	TNNI3K	220.0
PKC412	FER	1200.0
Barasertib	FLT3	8.2
Crizotinib	PIP5K1A	3200.0
Alvocidib	ACVR2A	3100.0
Lestaurtinib	EPHB6	98.0
Dovitinib	PKNB(M.tuberculosis)	300.0
Sunitinib	MET(M1250T)	1200.0
Fedratinib	LIMK1	940.0
Pictilisib	FLT3(ITD)	2200.0
KW2449	ACVR2A	320.0
Dovitinib	MAST1	40.0
Dasatinib	ABL1(F317L)-phosphorylated	0.02
MLN8054	FGR	220.0
Lestaurtinib	AURKC	4.1
Masitinib	PGFRA	25.0
Barasertib	ABL1-nonphosphorylated	1500.0
Pazopanib	BRAF	730.0
GSK461364	PIK3CD	3100.0
Fedratinib	CAMK1	1600.0
Lestaurtinib	SYK	9.5
Alvocidib	MAK	28.0
Nintedanib	FGFR3	93.0
Tozasertib	ABL1(F317I)-nonphosphorylated	7200.0
Motesanib	TAK1	1300.0
NVP-TAE684	KIT(L576P)	49.0
Bosutinib	LRRK2(G2019S)	830.0
Enzastaurin	YSK4	1600.0
PD184352	MP2K2	370.0
Crizotinib	TNK1	320.0
Nintedanib	CSNK1D	1300.0
PLX-4720	PFCDPK1(P.falciparum)	1.7
Ki20227	VGFR2	18.0
Lestaurtinib	PIK3CA(M1043I)	1100.0
KW2449	PKNB(M.tuberculosis)	240.0
Linifanib	MST2	1500.0
PHA-665752	FAK2	910.0
Sunitinib	AMPK-alpha2	89.0
Linifanib	S6K1	2800.0
Dovitinib	FLT3(R834Q)	7.5
NVP-TAE684	KPCD3	90.0
PHA-665752	MYLK	7900.0
Dasatinib	EPHA8	0.24
Lestaurtinib	FLT4	17.0
Ki20227	MET(M1250T)	1500.0
Sunitinib	TTK	63.0
Bosutinib	PKN1	2900.0
Tozasertib	IKKE	2600.0
Fedratinib	ABL1(H396P)-phosphorylated	61.0
R406	FGFR1	44.0
GSK461364	NIM1	6400.0
SNS-032	HIPK3	2000.0
NVP-TAE684	FAK1	1.1
R406	PAK2	340.0
GSK 690693	PIM2	680.0
Fedratinib	NEK4	1600.0
Pazopanib	NLK	4400.0
R406	MP2K2	730.0
BI-2536	EGFR(G719S)	1300.0
Alvocidib	EPHA3	3300.0
Linifanib	EPHB3	1400.0
Tozasertib	FES	7400.0
GSK461364	MAP3K1	1500.0
NVP-TAE684	EGFR(L858R,T790M)	3.4
Sunitinib	MAP4K2	33.0
Nintedanib	ABL1(H396P)-nonphosphorylated	45.0
GSK 690693	DAPK3	560.0
Nintedanib	MP2K4	3700.0
Nintedanib	DCLK1	540.0
Afatinib	GAK	79.0
BI-2536	PLK2	0.8
Lestaurtinib	KIT(D816V)	7.1
RAF 265	TIE1	150.0
SB 203580	ERBB4	4800.0
Tozasertib	RET(V804L)	8.6
SB 203580	ABL1(H396P)-phosphorylated	3900.0
Neratinib	ABL1(Q252H)-nonphosphorylated	7100.0
Brivanib	BLK	2000.0
Motesanib	KIT(L576P)	1.3
RAF 265	TNIK	1500.0
Masitinib	KIT(V559D,V654A)	4.7
Doramapimod	ABL1(T315I)-phosphorylated	550.0
KW2449	ULK2	130.0
Dasatinib	MST1	3800.0
Fedratinib	EGFR(T790M)	580.0
NVP-TAE684	HCK	410.0
BMS345541	TYK2(JH2domain-pseudokinase)	2000.0
Canertinib	MAP3K4	8400.0
R406	IKKA	120.0
PI103	FLT3	2500.0
Lestaurtinib	ABL1(F317L)-phosphorylated	2200.0
PKC412	MAST1	190.0
Foretinib	PGFRB	1.0
SB 203580	PTK6	3900.0
NVP-TAE684	M4K3	65.0
Sorafenib	ABL1(F317L)-nonphosphorylated	770.0
PKC412	AKT2	780.0
NVP-TAE684	MERTK	19.0
Ki20227	ABL1(M351T)-phosphorylated	430.0
MLN8054	CLK3	2300.0
PLX-4720	YES	1800.0
PHA-665752	LKB1	2600.0
Ki20227	RET	2500.0
Ruxolitinib	DCAMKL3	260.0
Alvocidib	MINK	1300.0
Ruxolitinib	HIPK1	1200.0
Sunitinib	NDR2	970.0
Fedratinib	SgK110	2900.0
Dasatinib	MYLK2	3500.0
Ki20227	SLK	60.0
PHA-665752	ABL1(Q252H)-phosphorylated	9300.0
Dasatinib	SYK	2900.0
Lestaurtinib	MK09	320.0
Bosutinib	EPHA4	18.0
Alvocidib	PI42C	870.0
Pictilisib	DYRK2	7600.0
KW2449	SRPK3	200.0
Pazopanib	KIT(D816V)	500.0
Alvocidib	KIT(D816H)	9000.0
Ki20227	KIT(L576P)	0.9
Brivanib	EPHB6	1400.0
Dovitinib	MELK	1600.0
Crizotinib	TXK	850.0
PKC412	MKNK2	950.0
R406	PIP5K1C	130.0
Lestaurtinib	TLK1	110.0
Lestaurtinib	TXK	660.0
Lestaurtinib	WEE1	1200.0
PLX-4720	CDK8	1900.0
Alvocidib	ABL1(M351T)-phosphorylated	1900.0
Alvocidib	PIM3	600.0
Linifanib	TIE1	110.0
Enzastaurin	RSK3(Kin.Dom.1-N-terminal)	220.0
AC220	KIT(V559D)	5.0
Sorafenib	ABL1-phosphorylated	1400.0
AC220	KIT(D816H)	320.0
Barasertib	KIT	17.0
SNS-032	ULK1	2800.0
Tozasertib	LYN	650.0
Vandetanib	EGFR(L861Q)	11.0
PHA-665752	SRPK3	1600.0
Alvocidib	ABL1(Q252H)-phosphorylated	1200.0
PLX-4720	TGFBR2	890.0
Lestaurtinib	PGFRA	350.0
PKC412	PIM1	560.0
NVP-TAE684	DRAK2	7100.0
Gefitinib	ABL1(Q252H)-nonphosphorylated	1100.0
Foretinib	PCTK3	250.0
KW2449	MET(Y1235D)	570.0
SB 203580	BRAF(V600E)	530.0
AC220	YSK4	2000.0
Dovitinib	KIT(D816H)	170.0
KW2449	ROCK1	300.0
Dovitinib	RIOK1	420.0
Nintedanib	CSNK2A1	7500.0
SB 203580	EGFR(E746-A750del)	340.0
Bosutinib	MP2K3	2600.0
Masitinib	ABL1(Y253F)-phosphorylated	25.0
Enzastaurin	FLT3	330.0
SB 203580	RAF1	980.0
Gefitinib	EGFR	1.0
BI-2536	HIPK3	3600.0
Barasertib	CHK2	1400.0
Fedratinib	RIPK1	5300.0
SB 203580	NLK	25.0
Alvocidib	AAK1	5300.0
Nintedanib	CAMK2A	3600.0
Ruxolitinib	RPS6KA4(Kin.Dom.2-C-terminal)	340.0
Lestaurtinib	IRAK1	6.1
Afatinib	ABL1(Y253F)-phosphorylated	830.0
Sunitinib	LOK	19.0
PHA-665752	FLT3(D835Y)	96.0
PKC412	TIE2	1900.0
Dovitinib	PFCDPK1(P.falciparum)	610.0
NVP-TAE684	ABL1(Y253F)-phosphorylated	100.0
KW2449	MLK1	650.0
BI-2536	GRK7	850.0
NVP-TAE684	RSK4(Kin.Dom.1-N-terminal)	27.0
Nilotinib	KIT(D816V)	770.0
Crizotinib	RET(M918T)	1300.0
Sorafenib	HIPK4	3.3
BI-2536	CDK7	3500.0
Fedratinib	DRAK2	45.0
R406	PLK1	830.0
Canertinib	ERK4	5400.0
PHA-665752	MINK	250.0
Alvocidib	EPHA2	2500.0
Sunitinib	MARK2	310.0
Canertinib	ABL1(T315I)-phosphorylated	69.0
Crizotinib	BIKE	740.0
Enzastaurin	DYRK1A	160.0
Crizotinib	SYK	2500.0
Fedratinib	ZAP70	3800.0
Tozasertib	MLK2	1800.0
Canertinib	ABL1(F317I)-phosphorylated	1000.0
Pictilisib	CLK4	1500.0
Sunitinib	TLK1	740.0
Foretinib	KKCC1	550.0
RAF 265	KIT(V559D,V654A)	850.0
Pazopanib	MYLK2	2000.0
Crizotinib	ABL1(F317L)-nonphosphorylated	610.0
Enzastaurin	PGFRB	3300.0
KW2449	CSNK1D	2300.0
Fedratinib	CAMKK2	4000.0
Ki20227	SRMS	400.0
Sorafenib	TNNI3K	280.0
Tozasertib	ITK	350.0
Enzastaurin	CDK7	2600.0
Dovitinib	SIK2	3700.0
Neratinib	MAP4K5	0.7
Masitinib	DDR2	26.0
MLN8054	ABL1(Y253F)-phosphorylated	1000.0
Lestaurtinib	NEK1	2500.0
R406	PKN2	2600.0
Fedratinib	LOK	2900.0
Canertinib	M3K2	3800.0
Crizotinib	M3K13	230.0
Canertinib	IRAK4	1200.0
RAF 265	BRAF	1200.0
Tozasertib	PAK6	9700.0
KW2449	M3K12	67.0
NVP-TAE684	STK36	1400.0
SGX523	MET(M1250T)	0.8
R406	PTK6	360.0
KW2449	MKNK2	1200.0
Nintedanib	MAP4K2	290.0
Crizotinib	MINK	4400.0
Vandetanib	FRK	170.0
GSK 690693	PAK7	8.9
Dovitinib	RIOK3	690.0
Dovitinib	RET	71.0
Sunitinib	PAK4	2300.0
R406	BRAF	240.0
PHA-665752	CDK4-cyclinD1	2500.0
Lestaurtinib	RPS6KA5(Kin.Dom.1-N-terminal)	42.0
PKC412	PRKX	960.0
R406	CLK4	360.0
Vandetanib	EGFR(L747-E749del,A750P)	12.0
NVP-TAE684	AMPK-alpha1	27.0
Tozasertib	KIT(A829P)	380.0
Alvocidib	MAP3K3	9900.0
PKC412	ICK	5900.0
Nilotinib	FGR	320.0
Barasertib	VGFR1	110.0
Nintedanib	TAK1	4.1
Alvocidib	RSK3(Kin.Dom.1-N-terminal)	4300.0
NVP-TAE684	BMPR1B	0.9
Pazopanib	CAMK1G	3700.0
R406	SLK	33.0
Bosutinib	MP2K1	19.0
Nintedanib	PKN2	1400.0
Pazopanib	TAOK1	240.0
Erlotinib	ULK3	920.0
Dovitinib	ROCK1	760.0
Dovitinib	FLT3(D835Y)	5.2
Tozasertib	YSK1	4800.0
Masitinib	LCK	31.0
PHA-665752	ROCK2	8700.0
PLX-4720	MP2K2	1100.0
Masitinib	ABL1(H396P)-nonphosphorylated	11.0
Barasertib	BTK	1200.0
Crizotinib	TGFBR1	1000.0
Crizotinib	BTK	7800.0
Dasatinib	NLK	260.0
Foretinib	LIMK2	1700.0
Linifanib	EGFR(G719C)	6500.0
PLX-4720	MYLK4	3400.0
Sunitinib	LATS2	460.0
Sorafenib	MK11	230.0
NVP-TAE684	DCAMKL2	16.0
Fedratinib	CLK2	2300.0
AC220	ERK8	270.0
Enzastaurin	CLK1	510.0
Barasertib	CDC2L5	1100.0
Barasertib	ABL1(T315I)-phosphorylated	4800.0
Erlotinib	ABL1(Y253F)-phosphorylated	76.0
KW2449	NDR1	390.0
BI-2536	FES	1900.0
Pictilisib	MYLK4	780.0
Foretinib	CSK	120.0
KW2449	CDKL2	1400.0
Enzastaurin	HIPK4	1200.0
Pictilisib	DAPK1	4000.0
Foretinib	MAP4K4	190.0
R406	MARK4	89.0
GDC-0879	JAK1(JH2domain-pseudokinase)	7800.0
Bosutinib	TIE1	2900.0
NVP-TAE684	JAK1(JH2domain-pseudokinase)	300.0
Sunitinib	ABL1(T315I)-nonphosphorylated	150.0
Nintedanib	PDPK1	2800.0
Fedratinib	WEE1	390.0
VX-745	EPHA1	4700.0
BI-2536	DAPK3	130.0
Fedratinib	EGFR(L858R)	3300.0
Ruxolitinib	RET	720.0
Pictilisib	FLT3(D835Y)	710.0
Sorafenib	TNK1	2300.0
Neratinib	CDK7	5100.0
Ki20227	ABL1(F317L)-phosphorylated	1000.0
Tozasertib	ABL1(Q252H)-phosphorylated	9.4
Linifanib	TAOK1	320.0
Barasertib	RET(V804M)	240.0
Sorafenib	MAP4K5	1600.0
GSK 690693	MARK2	720.0
KW2449	RIOK2	5000.0
R406	FLT3(K663Q)	0.7
KW2449	CDK4-cyclinD1	820.0
Dasatinib	BLK	0.21
KW2449	ICK	2200.0
PI103	LIMK2	3500.0
Lestaurtinib	GCN2(Kin.Dom.2,S808G)	4.1
PHA-665752	CASK	1700.0
Vandetanib	EGFR(G719S)	5.9
Fedratinib	AMPK-alpha1	2400.0
Fedratinib	BMX	1200.0
Enzastaurin	S6K1	1800.0
Dovitinib	BLK	190.0
Dasatinib	SIK3	28.0
Barasertib	ABL1(M351T)-phosphorylated	2200.0
GSK 690693	PIM1	940.0
MLN8054	EPHA1	1800.0
Gefitinib	FLT3(K663Q)	5100.0
Fedratinib	PFCDPK1(P.falciparum)	1200.0
PHA-665752	CAMK1D	1500.0
Vandetanib	TYRO3	93.0
Sunitinib	SGK3	220.0
KW2449	GCN2(Kin.Dom.2,S808G)	330.0
Tozasertib	ABL1(H396P)-phosphorylated	3.1
AC220	LYN	5700.0
Sunitinib	SgK110	1900.0
Lestaurtinib	TAOK2	500.0
Crizotinib	NIM1	4600.0
KW2449	CSNK2A2	230.0
Sorafenib	MK12	7600.0
Nintedanib	SRPK2	36.0
Sunitinib	CSNK1A1L	550.0
Canertinib	MET(Y1235D)	830.0
Sorafenib	NLK	640.0
PKC412	KPCD3	3200.0
Afatinib	EPHA6	340.0
Dovitinib	CHEK1	1200.0
GSK 690693	CLK2	730.0
PLX-4720	SIK2	1900.0
PKC412	GRK7	48.0
RAF 265	PGFRA	1100.0
Tozasertib	CAMK1D	4900.0
Sunitinib	M3K12	100.0
Nintedanib	MAP3K15	1400.0
KW2449	FGFR4	2300.0
Fedratinib	MKNK1	7300.0
Alvocidib	KCC2D	1600.0
Ruxolitinib	MKNK2	200.0
Enzastaurin	DMPK	2200.0
Ki20227	VGFR1	130.0
PKC412	FYN	2100.0
Bosutinib	ABL1(M351T)-phosphorylated	0.04
Nintedanib	IKKA	4500.0
BI-2536	RPS6KA4(Kin.Dom.2-C-terminal)	12.0
Fedratinib	KKCC1	1800.0
PKC412	PAK3	180.0
Barasertib	KIT(V559D,T670I)	7.9
PI103	BRAF(V600E)	2300.0
Foretinib	IKKA	5900.0
Enzastaurin	KIT(L576P)	5200.0
Foretinib	SIK1	160.0
VX-745	MK14	2.8
Sunitinib	CDK7	330.0
Alvocidib	CSF1R	2800.0
Sorafenib	YSK4	99.0
Sunitinib	CDK5	6900.0
PKC412	FLT3(K663Q)	2.0
R406	JNK1	38.0
Vandetanib	FLT4	1100.0
Nilotinib	MP2K5	190.0
Dovitinib	SRC	1800.0
Crizotinib	DMPK	1400.0
SNS-032	CLK1	410.0
PLX-4720	PIK4CB	1200.0
Tozasertib	SYK	1800.0
Lapatinib	EGFR	2.4
Masitinib	LYN	61.0
BMS345541	KIT(V559D)	5700.0
Fedratinib	BIKE	32.0
Vandetanib	RIPK2	4.6
Pazopanib	FLT4	27.0
Nintedanib	SRPK3	12.0
PKC412	BLK	500.0
Erlotinib	TYK2(JH2domain-pseudokinase)	2400.0
Sunitinib	TRKA	100.0
PKC412	MAP4K4	650.0
Neratinib	ERBB3	7.7
Tozasertib	TBK1	490.0
Sunitinib	CAMK1	970.0
Nilotinib	CLK4	7100.0
RAF 265	FER	8600.0
Lestaurtinib	FGFR3(G697C)	730.0
Lestaurtinib	TTK	6.5
Dovitinib	NUAK1	240.0
Enzastaurin	STK33	4900.0
Ki20227	CSF1R	0.8
PHA-665752	SNARK	910.0
Pazopanib	RIPK2	580.0
Dasatinib	TYK2(JH2domain-pseudokinase)	110.0
Bosutinib	SNARK	220.0
Doramapimod	DDR1	1.9
Foretinib	MP2K2	13.0
KW2449	PGFRB	30.0
Afatinib	MKNK1	1800.0
Crizotinib	FAK2	190.0
Fedratinib	MLTK	650.0
Bosutinib	ROCK2	360.0
Nintedanib	RET(M918T)	30.0
BI-2536	KCC2D	2400.0
Bosutinib	SRMS	100.0
PHA-665752	TAOK1	460.0
NVP-TAE684	LYN	280.0
NVP-TAE684	MKNK2	44.0
Erlotinib	VGFR1	4400.0
GSK1838705A	MP2K3	1000.0
Lestaurtinib	LCK	430.0
Doramapimod	EGFR(L747-E749del,A750P)	5300.0
SNS-032	ADCK4	2900.0
Nilotinib	HCK	390.0
Alvocidib	DRAK1	4100.0
Lestaurtinib	ABL1(T315I)-nonphosphorylated	950.0
R406	TSSK1	1000.0
Sunitinib	CAMK2B	1400.0
Barasertib	PGFRA	38.0
GSK461364	FLT3(D835H)	410.0
Fedratinib	MYLK	520.0
Ki20227	MP2K5	7.4
Tofacitinib	CAMK2A	3500.0
PLX-4720	MINK	7100.0
Dasatinib	M3K2	140.0
Dasatinib	ADCK3	190.0
Imatinib	EPHA8	1400.0
Lestaurtinib	PIK3C2G	230.0
Nilotinib	MK11	36.0
Fedratinib	EIF2AK1	1000.0
R406	ERBB4	600.0
Foretinib	ULK3	450.0
VX-745	SRC	5500.0
Fedratinib	KPCE	8100.0
GSK 690693	ULK1	5900.0
Brivanib	RET(M918T)	360.0
Pazopanib	M4K1	750.0
Sunitinib	MST4	340.0
Foretinib	KPCD3	7500.0
Nintedanib	BIKE	2.2
NVP-TAE684	EPHB6	350.0
Nintedanib	PAK3	210.0
Sunitinib	DDR2	2900.0
Sunitinib	TRKC	5100.0
Sunitinib	VGFR2	1.5
Foretinib	SIK2	640.0
Sunitinib	TRKB	590.0
Tozasertib	AMPK-alpha2	350.0
Pazopanib	MET	2000.0
KW2449	FLT4	1300.0
KW2449	MAP3K3	120.0
R406	LTK	800.0
Sorafenib	DDR1	1.5
KW2449	RIPK2	3700.0
Neratinib	M4K3	7.7
KW2449	SIK2	560.0
Motesanib	FLT3(D835Y)	9500.0
Lestaurtinib	MLCK	12.0
Foretinib	JNK1	5700.0
Pazopanib	MAP4K2	2700.0
Ruxolitinib	JAK3(JH1domain-catalytic)	2.0
Foretinib	CDK11	87.0
KW2449	DCLK1	2000.0
SB 203580	SLK	3700.0
R406	KPCD	4100.0
Dovitinib	LATS2	530.0
Fedratinib	TNK2	64.0
PKC412	MK09	5000.0
Gefitinib	TXK	6000.0
Vandetanib	PHKG2	7900.0
Alvocidib	EIF2AK1	870.0
R406	MET(M1250T)	230.0
Nintedanib	PGFRA	16.0
PHA-665752	FAK1	1900.0
BI-2536	RIOK3	4400.0
Bosutinib	PGFRB	200.0
Dovitinib	RPS6KA4(Kin.Dom.1-N-terminal)	590.0
Nintedanib	KKCC1	630.0
Gefitinib	LTK	5500.0
Nintedanib	MST1	9.0
Dasatinib	LIMK1	570.0
PHA-665752	MP2K5	1400.0
GSK 690693	KGP2	3.1
KW2449	KIT(D816V)	160.0
Sorafenib	RET(M918T)	7.4
Fedratinib	EGFR	3400.0
Erlotinib	TYRO3	3900.0
Neratinib	FER	510.0
Ki20227	FLT3(D835H)	9500.0
R406	STK16	1.7
Ruxolitinib	AAK1	120.0
Dovitinib	FGR	190.0
BI-2536	TAOK3	1700.0
NVP-TAE684	RET	150.0
Brivanib	FGFR1	99.0
NVP-TAE684	PHKG2	13.0
KW2449	MK11	1400.0
Lestaurtinib	KPCD2	8.1
NVP-TAE684	DYRK1A	2900.0
Bosutinib	MYLK	490.0
Vandetanib	KIT(V559D,V654A)	560.0
Pazopanib	DDR2	98.0
Ki20227	ABL1(F317L)-nonphosphorylated	340.0
Erlotinib	KCC2D	6400.0
Ruxolitinib	PLK3	710.0
Fedratinib	PHKG2	1600.0
KW2449	PLK4	21.0
Fedratinib	SLK	680.0
PKC412	EGFR(L747-E749del,A750P)	620.0
Lapatinib	EGFR(T790M)	860.0
SGX523	YSK4	6400.0
Afatinib	ERBB2	5.0
Sunitinib	ABL2	1000.0
Brivanib	EGFR(L861Q)	5300.0
Erlotinib	EGFR(S752-I759del)	1.6
Gefitinib	IRAK4	540.0
R406	TRKA	170.0
Brivanib	EGFR(G719S)	2600.0
Afatinib	ABL1(T315I)-nonphosphorylated	2600.0
NVP-TAE684	EGFR(S752-I759del)	400.0
Erlotinib	MAP3K3	2300.0
Nintedanib	LKB1	18.0
R406	YES	35.0
PHA-665752	HIPK4	1300.0
Bosutinib	MET(Y1235D)	3100.0
SB 203580	RIPK2	24.0
PLX-4720	SRC	4700.0
Foretinib	MERTK	0.3
NVP-TAE684	TYK2(JH2domain-pseudokinase)	1900.0
Neratinib	MLTK	1500.0
Vandetanib	RET	34.0
GSK 690693	KPCE	5.3
Brivanib	ABL1(F317L)-phosphorylated	2300.0
Tozasertib	ABL1(T315I)-phosphorylated	9.3
GSK 690693	AKT3	3.0
Tofacitinib	PKNB(M.tuberculosis)	2000.0
Foretinib	KIT(V559D,T670I)	2.4
Fedratinib	PLK3	1600.0
Tozasertib	AURKC	6.3
Foretinib	CLK4	850.0
Dovitinib	PRP4	560.0
Dovitinib	SRPK3	250.0
Erlotinib	EGFR(L747-S752del,P753S)	0.5
Lestaurtinib	FAK2	41.0
KW2449	RIPK4	130.0
KW2449	TRKC	250.0
KW2449	PHKG2	140.0
Dasatinib	MAP4K4	3100.0
Fedratinib	BRAF(V600E)	9300.0
Lestaurtinib	ERK8	4.9
AC220	FLT3(R834Q)	5.1
Fedratinib	FRK	200.0
NVP-TAE684	EPHA5	3700.0
Crizotinib	KIT(D816V)	3700.0
Lestaurtinib	MYO3A	260.0
R406	FAK2	29.0
Afatinib	MET(Y1235D)	2600.0
KW2449	ABL1(F317I)-nonphosphorylated	1600.0
Fedratinib	MET(M1250T)	4400.0
Lestaurtinib	PIK3C2B	5200.0
Bosutinib	ZAP70	1600.0
PKC412	FGFR1	1600.0
Imatinib	ABL1(E255K)-phosphorylated	170.0
Bosutinib	STK35	2.0
Doramapimod	KIT(V559D,T670I)	260.0
SNS-032	CDK11	950.0
Tofacitinib	RSK3(Kin.Dom.2-C-terminal)	600.0
Ruxolitinib	CAMK1	470.0
Sunitinib	IGF1R	2600.0
Foretinib	MET(Y1235D)	0.8
SNS-032	MKNK2	4300.0
Foretinib	LCK	6.0
NVP-TAE684	MYO3A	67.0
Fedratinib	LYN	500.0
Fedratinib	KIT(D816V)	160.0
Dovitinib	RSK4(Kin.Dom.1-N-terminal)	4600.0
Lestaurtinib	EPHA5	5900.0
GSK 690693	STK36	2600.0
Bosutinib	BIKE	350.0
Imatinib	ABL1-phosphorylated	21.0
NVP-TAE684	ABL1(E255K)-phosphorylated	190.0
R406	RAF1	840.0
Ki20227	EPHA1	2600.0
Lestaurtinib	CDK8	8000.0
R406	FRK	68.0
Lestaurtinib	DCAMKL3	1100.0
AC220	KIT(L576P)	6.3
Fedratinib	FGFR1	280.0
Dovitinib	FGFR4	4300.0
BI-2536	PI42C	110.0
R406	FGFR3(G697C)	67.0
Ruxolitinib	TYK2(JH2domain-pseudokinase)	1400.0
Lestaurtinib	SRC	640.0
SB 203580	ADCK4	3100.0
NVP-TAE684	MAP4K5	190.0
PLX-4720	STK16	1900.0
NVP-TAE684	PTK6	36.0
Sunitinib	PHKG1	5.5
PI103	FLT3(D835H)	5900.0
Tozasertib	ERBB3	7100.0
PLX-4720	ABL1-nonphosphorylated	460.0
PKC412	RSK2(Kin.Dom.1-N-terminal)	740.0
Sunitinib	KC1G2	110.0
Lestaurtinib	LKB1	57.0
Sorafenib	VGFR1	31.0
Motesanib	BRAF(V600E)	280.0
NVP-TAE684	IRAK4	77.0
Barasertib	MAP4K5	160.0
GSK1838705A	EGFR(S752-I759del)	3800.0
Neratinib	YES	240.0
Dasatinib	TEC	13.0
Nintedanib	EPHB6	140.0
Foretinib	TNNI3K	130.0
Crizotinib	MET(M1250T)	0.6
Sorafenib	FLT3(D835H)	30.0
Dovitinib	ULK3	170.0
Lestaurtinib	TRKC	14.0
Ruxolitinib	ULK1	300.0
Sorafenib	KIT(L576P)	25.0
Lestaurtinib	CDK15	1300.0
Sunitinib	ABL1(F317I)-nonphosphorylated	3600.0
Lapatinib	EGFR(E746-A750del)	8.6
Dovitinib	SRPK2	290.0
Sorafenib	ABL1(H396P)-nonphosphorylated	520.0
Lestaurtinib	ABL1(Q252H)-phosphorylated	830.0
NVP-TAE684	SNRK	300.0
BI-2536	EGFR(L747-E749del,A750P)	1100.0
Bosutinib	TRKC	3400.0
Nintedanib	LOK	87.0
RAF 265	AMPK-alpha1	4500.0
Alvocidib	M4K1	3300.0
KW2449	BRSK2	1200.0
Tozasertib	MP2K5	260.0
Sorafenib	SRMS	9800.0
R406	TAOK2	640.0
BI-2536	CSNK1E	380.0
Sunitinib	JAK1(JH1domain-catalytic)	6000.0
Tozasertib	ANKK1	5600.0
Sunitinib	MYLK4	15.0
GSK461364	CSNK2A2	990.0
KW2449	MLK3	230.0
Dovitinib	ABL1(H396P)-phosphorylated	60.0
PKC412	KIT	220.0
Linifanib	RPS6KA4(Kin.Dom.1-N-terminal)	7200.0
Sorafenib	RIPK2	1300.0
PHA-665752	SLK	350.0
BI-2536	FLT3(D835Y)	3000.0
Nintedanib	SIK1	670.0
Erlotinib	ADCK4	2500.0
Lestaurtinib	M3K6	170.0
Linifanib	CDK11	74.0
Pazopanib	TNIK	310.0
Ruxolitinib	YSK1	6300.0
R406	TYK2(JH1domain-catalytic)	190.0
Enzastaurin	ICK	680.0
Enzastaurin	TNK1	3400.0
Nintedanib	LRRK2(G2019S)	37.0
Pazopanib	KIT(V559D,V654A)	30.0
SNS-032	TAOK2	1800.0
PKC412	CSK	8700.0
NVP-TAE684	EGFR(G719S)	1600.0
AC220	PGFRA	11.0
SB 203580	JNK3	35.0
Pazopanib	DDR1	57.0
Lestaurtinib	MAPKAPK2	230.0
GSK1838705A	INSRR	8.6
Gefitinib	GAK	13.0
Sorafenib	EPHA1	3100.0
PKC412	LATS1	1100.0
Sorafenib	MUSK	130.0
Pictilisib	CDK16	1100.0
Gefitinib	LOK	470.0
Nintedanib	TNIK	53.0
Imatinib	ABL1(F317I)-nonphosphorylated	8.3
Fedratinib	HIPK3	1300.0
Dasatinib	ABL2	0.17
Lestaurtinib	PAK1	30.0
Erlotinib	CSK	9600.0
Fedratinib	GCN2(Kin.Dom.2,S808G)	100.0
RAF 265	TNK1	6400.0
NVP-TAE684	RIOK3	3500.0
Linifanib	FRK	400.0
Crizotinib	STK35	610.0
Bosutinib	ABL1(Y253F)-phosphorylated	0.04
Ki20227	PLK4	140.0
Foretinib	LYN	9.1
PKC412	MINK	170.0
Nintedanib	CAMKK2	920.0
NVP-TAE684	NDR1	440.0
Selumetinib	MP2K2	530.0
Enzastaurin	KGP2	170.0
Sorafenib	MK09	7400.0
Bosutinib	KPCD3	4600.0
Afatinib	ABL1(H396P)-phosphorylated	500.0
KW2449	PCTK2	1900.0
Erlotinib	RPS6KA4(Kin.Dom.2-C-terminal)	7000.0
RAF 265	STK36	8300.0
Afatinib	LCK	570.0
Dasatinib	VRK2	3200.0
Sunitinib	HIPK4	160.0
Bosutinib	DDR2	140.0
PKC412	KPCD	320.0
Bosutinib	HIPK1	520.0
Gefitinib	CSNK1D	3200.0
Pazopanib	FGFR3	740.0
MLN8054	ABL1(T315I)-phosphorylated	2800.0
Canertinib	LRRK2(G2019S)	1100.0
Tozasertib	KIT(D816V)	290.0
Nintedanib	GRK4	17.0
Lestaurtinib	FES	370.0
Fedratinib	NEK2	1700.0
Foretinib	FGFR1	690.0
Doramapimod	TIE2	20.0
Lestaurtinib	IKKA	9.0
Neratinib	BLK	85.0
Alvocidib	CAMK2G	2600.0
Ruxolitinib	TAK1	730.0
Linifanib	ALK	1600.0
R406	KIT(V559D,V654A)	410.0
Tozasertib	KIT(V559D,T670I)	430.0
Lestaurtinib	MYO3B	770.0
Ruxolitinib	HIPK2	1000.0
Dovitinib	AXL	3800.0
Gefitinib	EPHA3	5500.0
Lapatinib	PIK3C2G	7500.0
Canertinib	MP2K2	1600.0
Dovitinib	JAK2(JH1domain-catalytic)	130.0
BMS345541	CDC2L2	390.0
PLX-4720	ABL2	2700.0
PHA-665752	GAK	1300.0
Neratinib	MAST1	5500.0
Sunitinib	BMPR2	570.0
PLX-4720	SLK	5100.0
Pazopanib	CDK16	1200.0
GSK1838705A	TNK1	1500.0
Dovitinib	TRKA	100.0
Tozasertib	RIOK3	600.0
Fedratinib	NEK1	3400.0
Canertinib	EGFR(G719S)	0.19
Imatinib	LYN	890.0
PKC412	M4K1	2100.0
NVP-TAE684	SNARK	1.2
KW2449	KIT(D816H)	240.0
Alvocidib	ROCK2	1500.0
Alvocidib	IRAK4	1500.0
Foretinib	CHK2	57.0
BI-2536	CSNK1G3	2400.0
GSK 690693	KIT(D816H)	360.0
R406	DDR1	9.3
SB 203580	CSNK1A1	75.0
Foretinib	MLK2	530.0
Pazopanib	SRC	2800.0
Lapatinib	EGFR(G719S)	2.1
Gefitinib	EPHA6	590.0
PHA-665752	TSSK1	2100.0
Sunitinib	ROCK2	140.0
Fedratinib	CAMK2A	300.0
PLX-4720	DCAMKL3	2500.0
Canertinib	CSNK1E	420.0
Enzastaurin	TLK1	510.0
Tofacitinib	BIKE	7100.0
Lestaurtinib	RET(V804L)	6.7
Vandetanib	EPHB2	440.0
Dovitinib	STK16	1500.0
Ruxolitinib	RET(V804M)	190.0
Enzastaurin	FLT3(D835Y)	40.0
Dovitinib	PAK3	770.0
SNS-032	ICK	150.0
Canertinib	EPHB4	1800.0
Fedratinib	SYK	2700.0
Nilotinib	MLTK	11.0
Motesanib	VGFR1	12.0
Tofacitinib	DMPK	1200.0
Foretinib	ERBB2	580.0
Canertinib	DYRK1A	1500.0
Lapatinib	PIK3C2B	670.0
Fedratinib	PKNB(M.tuberculosis)	100.0
Lestaurtinib	CHK2	210.0
Bosutinib	TBK1	250.0
Brivanib	STK35	26.0
GDC-0879	CSNK1D	1400.0
Motesanib	MAP3K3	2100.0
Motesanib	FLT3(ITD)	1000.0
Lestaurtinib	MP2K3	5.0
Barasertib	PGFRB	41.0
Fedratinib	MP2K2	3100.0
Fedratinib	ACVR1	150.0
Fedratinib	TRKB	3100.0
NVP-TAE684	PAK7	390.0
Dasatinib	TXK	2.1
Tofacitinib	JAK2(JH1domain-catalytic)	0.6
Pazopanib	TXK	2600.0
GSK1838705A	TAOK3	1400.0
Brivanib	VGFR2	5.0
Nilotinib	ABL1(Y253F)-phosphorylated	13.0
PKC412	EGFR(L858R)	760.0
Sorafenib	EPHA6	370.0
GSK461364	PLK1	0.1
KW2449	FLT3	15.0
RAF 265	SLK	510.0
Lestaurtinib	ACVRL1	2200.0
GSK461364	IRAK1	6400.0
R406	FGFR2	73.0
BI-2536	NIM1	770.0
Linifanib	RET(M918T)	120.0
Bosutinib	PHKG1	340.0
Bosutinib	SRPK3	3900.0
Fedratinib	PAK2	6000.0
KW2449	SRMS	2700.0
Ruxolitinib	RET(V804L)	280.0
PHA-665752	MST4	3800.0
Crizotinib	TYRO3	800.0
Linifanib	VGFR1	7.5
Fedratinib	HIPK2	1000.0
NVP-TAE684	PKN1	340.0
Lestaurtinib	LATS2	1.0
PLX-4720	LIMK1	2400.0
MLN8054	FGFR3(G697C)	1300.0
Gefitinib	ERBB4	410.0
PHA-665752	KIT	3200.0
Dasatinib	MK14	27.0
Canertinib	TNNI3K	5600.0
Sunitinib	ITK	13.0
PLX-4720	FGR	62.0
PKC412	MET	690.0
Foretinib	TYRO3	2.0
Afatinib	FRK	1400.0
Barasertib	KIT(D816V)	4600.0
Tozasertib	SLK	82.0
SB 203580	FRK	1800.0
Erlotinib	EPHB4	2200.0
Sunitinib	RSK1(Kin.Dom.2-C-terminal)	5000.0
Sorafenib	FGR	7800.0
Fedratinib	MAP4K2	2100.0
Motesanib	BRAF	630.0
Lestaurtinib	PHKG1	0.4
Crizotinib	ROS1	4.1
Tozasertib	MST1	200.0
BI-2536	EGFR(T790M)	360.0
Afatinib	HCK	2200.0
MLN8054	CSK	9000.0
R406	ABL1-phosphorylated	340.0
Linifanib	MK12	2000.0
Dovitinib	KIT(L576P)	1.6
Sorafenib	KIT(A829P)	20.0
PKC412	TSSK1	4800.0
Ruxolitinib	RSK3(Kin.Dom.2-C-terminal)	150.0
GSK1838705A	DAPK3	1200.0
Gefitinib	MET(Y1235D)	3500.0
Masitinib	ABL1(H396P)-phosphorylated	140.0
Tozasertib	FGFR4	7200.0
Nintedanib	NUAK1	160.0
Lestaurtinib	CSK	260.0
Neratinib	KPCD2	1100.0
R406	RPS6KA4(Kin.Dom.2-C-terminal)	44.0
KW2449	HUNK	460.0
Barasertib	AXL	390.0
SB 203580	EGFR	1700.0
Sunitinib	FLT3(ITD)	1.0
AC220	MAP4K4	2500.0
Doramapimod	MAP4K4	90.0
Nintedanib	ABL1(F317I)-phosphorylated	2600.0
R406	EGFR(L861Q)	190.0
Doramapimod	PGFRA	1200.0
Lestaurtinib	PKNB(M.tuberculosis)	55.0
Afatinib	ABL1(H396P)-nonphosphorylated	500.0
Bosutinib	M3K13	480.0
Nintedanib	RIPK1	240.0
Crizotinib	IKKE	710.0
Nintedanib	ABL1(E255K)-phosphorylated	63.0
Foretinib	PLK4	3.5
Fedratinib	ACVR1B	6700.0
Vandetanib	KIT(L576P)	140.0
R406	RIOK3	210.0
Fedratinib	CAMK1D	460.0
Lestaurtinib	PIK3CA(H1047L)	49.0
SNS-032	DRAK1	440.0
R406	ABL1(H396P)-phosphorylated	390.0
Enzastaurin	CDK3	1100.0
RAF 265	TAOK1	3900.0
Dovitinib	ABL1(Y253F)-phosphorylated	46.0
PLX-4720	LYN	1100.0
PLX-4720	SGK3	7200.0
GSK1838705A	EGFR(E746-A750del)	2200.0
Erlotinib	ABL1(Q252H)-nonphosphorylated	230.0
Crizotinib	TYK2(JH1domain-catalytic)	210.0
VX-745	ABL2	1900.0
Dovitinib	CLK1	6800.0
Bosutinib	MP2K6	1300.0
Vandetanib	BLK	66.0
Nilotinib	MK14	460.0
Crizotinib	LOK	44.0
Alvocidib	HIPK4	2000.0
Neratinib	CSNK1G3	7800.0
SNS-032	VGFR1	9900.0
Bosutinib	TNIK	31.0
GSK 690693	KIT(L576P)	2600.0
Lapatinib	ERBB4	54.0
Dovitinib	WEE1	1200.0
Linifanib	TRKC	210.0
Lapatinib	SLK	3300.0
Foretinib	HIPK2	220.0
Nilotinib	M4K1	890.0
SNS-032	BRAF	1300.0
Crizotinib	EPHB1	120.0
Foretinib	EPHB1	12.0
R406	ABL1(Q252H)-nonphosphorylated	630.0
NVP-TAE684	ADCK3	1700.0
Lestaurtinib	MP2K7	80.0
GDC-0879	TNIK	2300.0
Alvocidib	CDK2	550.0
PKC412	FAK2	660.0
GSK 690693	KPCL	2.4
Tozasertib	MAPKAPK2	3800.0
Afatinib	SBK1	4800.0
BI-2536	CHK2	7700.0
Pictilisib	RSK2(Kin.Dom.1-N-terminal)	3000.0
Enzastaurin	KPCL	46.0
Crizotinib	FLT3(D835H)	500.0
Nintedanib	FYN	630.0
NVP-TAE684	KGP2	240.0
Pictilisib	HIPK1	1100.0
RAF 265	MP2K5	1900.0
Sunitinib	MK09	2400.0
Tozasertib	DDR1	28.0
GSK1838705A	TSSK1	470.0
Dovitinib	SLK	300.0
Sunitinib	HIPK3	41.0
GSK1838705A	JNK1	210.0
PHA-665752	ABL1(M351T)-phosphorylated	1700.0
Sorafenib	EPHA2	2000.0
Foretinib	MAK	1800.0
Imatinib	RAF1	1700.0
Ki20227	MET(Y1235D)	560.0
SB 203580	JNK1	1100.0
NVP-TAE684	ACVR1	29.0
Bosutinib	ROCK1	870.0
Foretinib	BLK	5.4
Dovitinib	PGFRA	54.0
Tozasertib	VGFR2	2000.0
PI103	JAK1(JH2domain-pseudokinase)	2000.0
Alvocidib	CDK11	57.0
PI103	HIPK2	290.0
PHA-665752	INSRR	3500.0
Pazopanib	TTK	150.0
Gefitinib	PHKG2	2700.0
Linifanib	EPHA7	110.0
GSK 690693	PAK1	550.0
Barasertib	LYN	1600.0
Canertinib	EGFR	0.19
Erlotinib	ERBB4	230.0
Canertinib	ABL1(H396P)-phosphorylated	57.0
KW2449	KIT(V559D,V654A)	76.0
Bosutinib	ABL1(F317I)-phosphorylated	0.18
GDC-0879	ACVR1B	2400.0
Lestaurtinib	AKT2	2100.0
Bosutinib	FAK2	390.0
Dovitinib	ULK2	54.0
RAF 265	KIT(L576P)	83.0
Gefitinib	ABL1-phosphorylated	480.0
Crizotinib	CDKL2	2100.0
Nintedanib	PIP5K2B	17.0
Nintedanib	ABL1(M351T)-phosphorylated	52.0
Bosutinib	PLK1	1800.0
Nintedanib	RSK1(Kin.Dom.1-N-terminal)	180.0
KW2449	CAMK1D	530.0
Pictilisib	PIK3CA(I800L)	7.1
Tozasertib	FGFR1	550.0
Sunitinib	RPS6KA4(Kin.Dom.1-N-terminal)	96.0
PHA-665752	TAOK2	1200.0
Bosutinib	EGFR(S752-I759del)	110.0
R406	PIK4CB	930.0
SB 203580	TTK	2500.0
Tozasertib	DCAMKL3	3600.0
Sunitinib	EPHA6	960.0
Dovitinib	KIT(A829P)	45.0
NVP-TAE684	GRK4	3500.0
RAF 265	FRK	590.0
BMS345541	STK36	6500.0
PHA-665752	TRKA	320.0
PHA-665752	MET	0.3
PKC412	KGP1	250.0
Lestaurtinib	LYN	190.0
NVP-TAE684	HIPK2	4400.0
PI103	DYRK2	4100.0
Barasertib	S6K1	2800.0
PHA-665752	MYLK2	960.0
Sunitinib	MET(Y1235D)	4700.0
Vandetanib	EGFR(E746-A750del)	4.8
MLN8054	DAPK2	9100.0
PKC412	KIT(D816V)	7.7
NVP-TAE684	EPHB2	1500.0
Tofacitinib	FYN	1100.0
Lestaurtinib	TAOK3	86.0
Gefitinib	EGFR(L747-S752del,P753S)	0.6
R406	MERTK	170.0
GSK461364	PGFRB	2900.0
Fedratinib	HCK	2100.0
Ki20227	KIT(V559D,T670I)	10.0
Sorafenib	EPHA4	3000.0
Masitinib	CSF1R	7.6
MLN8054	TNK1	2400.0
Dovitinib	YSK4	12.0
Fedratinib	FER	1100.0
Lestaurtinib	ZAP70	16.0
Crizotinib	TBK1	690.0
Foretinib	MYO3B	690.0
Nintedanib	ABL1(F317I)-nonphosphorylated	6900.0
Crizotinib	FLT3(D835Y)	210.0
Ki20227	LYN	710.0
GSK1838705A	LRRK2	730.0
Erlotinib	TNIK	4500.0
BI-2536	MYO3B	3500.0
Nintedanib	RIOK1	23.0
Tozasertib	EPHA1	1000.0
Ki20227	ABL1(H396P)-nonphosphorylated	140.0
Foretinib	TNIK	210.0
Crizotinib	EPHA8	280.0
Bosutinib	CIT	2400.0
PHA-665752	PHKG2	2400.0
Linifanib	EPHB4	1400.0
SNS-032	CSNK1A1	1000.0
KW2449	FYN	660.0
NVP-TAE684	ALK	1.1
Nintedanib	RET	31.0
PI103	DAPK3	840.0
NVP-TAE684	FLT3(D835H)	4.9
Canertinib	FLT3(K663Q)	1600.0
Canertinib	RSK1(Kin.Dom.2-C-terminal)	6200.0
Barasertib	AURKA	400.0
Fedratinib	FLT3(K663Q)	13.0
Dovitinib	LRRK2(G2019S)	880.0
Lestaurtinib	EPHB4	6900.0
Tozasertib	M3K2	1100.0
SNS-032	KPCD3	750.0
Ki20227	ABL1-phosphorylated	320.0
Tozasertib	AAK1	290.0
Ki20227	AURKB	160.0
Canertinib	FLT3	2700.0
Motesanib	PGFRB	9.1
Motesanib	FLT3(R834Q)	3800.0
Bosutinib	JAK3(JH1domain-catalytic)	1200.0
Vandetanib	FGFR3(G697C)	6900.0
Gefitinib	LYN	990.0
RAF 265	ABL1(H396P)-nonphosphorylated	920.0
Erlotinib	ABL1(E255K)-phosphorylated	63.0
Nintedanib	FLT3(K663Q)	4.5
PHA-665752	ABL1(E255K)-phosphorylated	770.0
Sunitinib	KIT(D816H)	110.0
KW2449	HIPK4	1000.0
R406	PI42C	120.0
GSK1838705A	KPCD1	650.0
Pazopanib	LIMK2	390.0
GSK 690693	NLK	3400.0
Ruxolitinib	SgK110	5800.0
RAF 265	ABL2	1900.0
KW2449	CHEK1	710.0
Alvocidib	EPHB1	1500.0
Dovitinib	ABL1(T315I)-phosphorylated	31.0
R406	EGFR(L747-E749del,A750P)	260.0
Vandetanib	EPHA3	2000.0
R406	TXK	140.0
NVP-TAE684	ABL1(T315I)-nonphosphorylated	52.0
Canertinib	PGFRA	5200.0
Barasertib	TIE2	1900.0
Sorafenib	ABL2	2900.0
KW2449	RSK4(Kin.Dom.1-N-terminal)	440.0
Erlotinib	DAPK3	6000.0
Dovitinib	AURKB	280.0
Foretinib	HIPK1	420.0
Sunitinib	FGFR2	570.0
NVP-TAE684	CDK16	560.0
MLN8054	EGFR(L747-S752del,P753S)	6400.0
Nilotinib	ABL1-nonphosphorylated	10.0
Barasertib	CSF1R	1400.0
Foretinib	EPHB3	85.0
KW2449	PIP5K1A	51.0
Tozasertib	PAK2	5700.0
Sunitinib	BMPR1B	2400.0
Tofacitinib	TNK1	120.0
Lestaurtinib	ROCK2	71.0
Tozasertib	BTK	4400.0
SNS-032	CDK8	1200.0
Erlotinib	PI42C	1000.0
Fedratinib	JAK3(JH1domain-catalytic)	74.0
Ruxolitinib	DAPK2	97.0
Sorafenib	MKNK2	130.0
NVP-TAE684	PAK3	29.0
Sunitinib	RIPK5	1300.0
Erlotinib	ABL1(H396P)-phosphorylated	58.0
BI-2536	STK33	1100.0
Neratinib	NEK2	250.0
KW2449	DYRK2	390.0
Ruxolitinib	KIT(D816H)	6300.0
Alvocidib	EGFR(L747-E749del,A750P)	2300.0
Neratinib	PAK1	210.0
Lestaurtinib	DRAK1	3.4
Dasatinib	ACVRL1	460.0
Bosutinib	ABL2	1.5
Nilotinib	EPHA2	230.0
PHA-665752	EPHA8	3900.0
Sunitinib	AKT2	2700.0
PKC412	RET	350.0
SGX523	JNK1	4200.0
Dovitinib	NEK2	2000.0
GSK1838705A	FLT3(D835Y)	3000.0
Lestaurtinib	ABL1(F317I)-phosphorylated	4900.0
R406	DAPK1	55.0
Dovitinib	CSF1R	60.0
Nilotinib	ABL1(Q252H)-phosphorylated	21.0
R406	PLK3	5.1
PKC412	EGFR(L861Q)	2800.0
PKC412	PIM2	3100.0
Sorafenib	ABL1-nonphosphorylated	130.0
Sunitinib	DCAMKL2	2700.0
Nintedanib	MET(M1250T)	340.0
Motesanib	MLTK	8.0
Sunitinib	OSR1	530.0
Tozasertib	PGFRA	1600.0
Bosutinib	M3K2	30.0
NVP-TAE684	FGFR3(G697C)	120.0
NVP-TAE684	AAK1	470.0
Alvocidib	RSK4(Kin.Dom.1-N-terminal)	2100.0
PHA-665752	MP2K1	1100.0
Pictilisib	FLT3(N841I)	3900.0
KW2449	PFCDPK1(P.falciparum)	2400.0
KW2449	CLK4	49.0
KW2449	SNARK	54.0
Ruxolitinib	M3K2	41.0
R406	FLT3(D835H)	0.7
Tozasertib	PIP5K2B	140.0
Vandetanib	ABL1(Y253F)-phosphorylated	9.0
Dasatinib	STK35	770.0
Alvocidib	ACVRL1	4500.0
Nilotinib	ABL1(F317L)-nonphosphorylated	12.0
R406	EGFR(L747-S752del,P753S)	560.0
Sunitinib	FLT3	0.4
Tozasertib	PHKG1	2200.0
Sunitinib	SLK	56.0
Nintedanib	MARK2	1400.0
Dasatinib	MP2K5	3.3
GSK 690693	HIPK3	200.0
BI-2536	PRKR	460.0
Bosutinib	CSNK1A1	280.0
Gefitinib	PI42C	7500.0
Dovitinib	NDR1	660.0
Vandetanib	FGFR2	1100.0
SNS-032	CDKL5	1.7
Alvocidib	MP2K4	2300.0
Erlotinib	ABL1(Q252H)-phosphorylated	61.0
Neratinib	CDK16	2300.0
Dasatinib	ACVR1	620.0
Enzastaurin	KIT(D816V)	1100.0
Erlotinib	ERK4	2500.0
Canertinib	EGFR(L747-T751del,Sins)	0.26
Erlotinib	SRC	700.0
R406	SgK110	190.0
Sunitinib	DYRK1A	200.0
Gefitinib	BLK	1200.0
Nintedanib	EPHA1	1200.0
Tozasertib	ULK3	310.0
Foretinib	CSNK1E	4600.0
R406	SRPK1	590.0
Alvocidib	ABL1(Y253F)-phosphorylated	1600.0
MLN8054	HCK	1500.0
Tozasertib	HUNK	9800.0
KW2449	KC1G2	580.0
Dasatinib	CSK	1.0
PHA-665752	CSNK1E	860.0
Alvocidib	MAP4K2	89.0
Pictilisib	CLK2	600.0
BI-2536	EGFR(L858R)	1300.0
MLN8054	ABL1-nonphosphorylated	1100.0
Neratinib	PAK6	7500.0
GSK461364	BIKE	470.0
Lestaurtinib	KIT(V559D,V654A)	380.0
BI-2536	PIK3CD	7600.0
R406	PAK4	96.0
Sunitinib	KC1G1	930.0
Neratinib	HIPK4	1500.0
Erlotinib	EGFR(T790M)	140.0
Dasatinib	CSNK1E	1500.0
PLX-4720	LCK	1800.0
Pazopanib	PRKR	1900.0
AC220	KIT(D816V)	150.0
Enzastaurin	ERK8	76.0
Barasertib	EGFR(L747-S752del,P753S)	8800.0
Ki20227	PTK6	70.0
PKC412	FGFR2	2400.0
Sunitinib	STK16	250.0
PLX-4720	HCK	2700.0
Neratinib	STK33	940.0
R406	TBK1	23.0
Sunitinib	ALK	170.0
Lestaurtinib	MAP3K4	2600.0
Dovitinib	MARK3	3400.0
Neratinib	MET(Y1235D)	4200.0
Sorafenib	EPHB4	1800.0
Pazopanib	BIKE	8800.0
NVP-TAE684	LRRK2	1.4
SB 203580	MK11	70.0
Vandetanib	YANK1	5000.0
R406	PHKG2	940.0
KW2449	TRKA	270.0
Dasatinib	MAP3K3	280.0
KW2449	HCK	4300.0
NVP-TAE684	PLK3	210.0
Gefitinib	EGFR(L861Q)	1.4
RAF 265	EPHA1	7800.0
Nintedanib	JAK2(JH1domain-catalytic)	14.0
Dovitinib	TRKB	720.0
Ruxolitinib	IKKB	2300.0
Lestaurtinib	CAMK1	130.0
BI-2536	HIPK2	2900.0
KW2449	MP2K3	150.0
GDC-0879	BMPR1B	1800.0
Pictilisib	FLT3	2600.0
Vandetanib	CSK	2500.0
RAF 265	ABL1(H396P)-phosphorylated	5600.0
Tozasertib	KPCT	5300.0
Crizotinib	CDK7	330.0
Neratinib	CAMK1D	5600.0
Lestaurtinib	PIK3CB	6700.0
Fedratinib	ROS1	600.0
Lestaurtinib	GRK4	12.0
RAF 265	LOK	60.0
Erlotinib	YES	2200.0
PKC412	JAK3(JH1domain-catalytic)	12.0
BI-2536	RSK4(Kin.Dom.2-C-terminal)	1300.0
Lestaurtinib	EPHA7	260.0
Pazopanib	RIPK1	260.0
Bosutinib	RSK3(Kin.Dom.1-N-terminal)	3200.0
Pazopanib	CSF1R	7.9
NVP-TAE684	SgK110	54.0
GSK 690693	KPCT	16.0
Doramapimod	MRCKB	910.0
Nintedanib	LCK	6.2
Bosutinib	MYO3A	6200.0
GSK1838705A	DYRK1A	1200.0
Sunitinib	FAK2	82.0
Erlotinib	TXK	3800.0
Sunitinib	ABL1(F317L)-nonphosphorylated	730.0
Dasatinib	GCN2(Kin.Dom.2,S808G)	1600.0
Foretinib	ABL1-nonphosphorylated	5.6
Alvocidib	RSK3(Kin.Dom.2-C-terminal)	1500.0
Erlotinib	SIK2	2600.0
Pictilisib	CSNK2A2	2400.0
Ki20227	MP2K1	1700.0
PHA-665752	ICK	400.0
PKC412	FRK	2400.0
Sunitinib	NDR1	410.0
Alvocidib	EGFR(G719S)	4000.0
Nintedanib	LTK	150.0
Canertinib	EGFR(L861Q)	0.22
Crizotinib	PLK4	60.0
Lestaurtinib	M3K12	840.0
Lapatinib	MP2K7	4400.0
KW2449	MST1	560.0
RAF 265	KIT(V559D,T670I)	240.0
Bosutinib	EGFR(L747-T751del,Sins)	30.0
R406	EPHA8	1300.0
Crizotinib	ABL1-phosphorylated	110.0
SB 203580	TGFBR2	1800.0
KW2449	TXK	580.0
PKC412	BRSK2	650.0
Fedratinib	MARK1	700.0
Dasatinib	PFCDPK1(P.falciparum)	640.0
KW2449	EPHA7	390.0
GSK 690693	TAOK1	620.0
Motesanib	SLK	1300.0
Dasatinib	ABL1(E255K)-phosphorylated	0.05
GDC-0879	YSK4	910.0
Afatinib	JNK3	2000.0
Erlotinib	EPHB1	1100.0
Neratinib	KPCD3	2400.0
PHA-665752	PAK7	2600.0
Fedratinib	SNRK	230.0
Sorafenib	CDK15	2900.0
Nintedanib	FLT3(D835H)	0.7
Alvocidib	GRK7	980.0
Bosutinib	NLK	2200.0
Fedratinib	MARK4	970.0
Foretinib	FYN	88.0
Ki20227	HCK	440.0
PKC412	DRAK2	4700.0
KW2449	BMX	1900.0
Ruxolitinib	RIOK2	1200.0
Lestaurtinib	JAK3(JH1domain-catalytic)	2.3
Tofacitinib	DCAMKL3	12.0
Dasatinib	LYN	0.57
BMS345541	ERK3	4300.0
Dovitinib	MST4	540.0
KW2449	IRAK4	680.0
Gefitinib	PHKG1	3700.0
Sunitinib	IKKE	620.0
R406	AAK1	410.0
Lestaurtinib	MINK	3.6
Ki20227	FLT4	390.0
Nilotinib	ABL1(E255K)-phosphorylated	36.0
Enzastaurin	KPCD	25.0
Ruxolitinib	CAMK2G	100.0
Erlotinib	ABL1(F317L)-nonphosphorylated	640.0
RAF 265	M4K3	7500.0
Dovitinib	MP2K2	350.0
Nintedanib	ABL1(Q252H)-nonphosphorylated	73.0
Dasatinib	EGFR(S752-I759del)	330.0
Enzastaurin	KPCE	8.9
Motesanib	BLK	2200.0
PKC412	ABL1(T315I)-phosphorylated	790.0
PKC412	IKKB	6300.0
PHA-665752	PGFRA	2000.0
Vandetanib	LTK	550.0
PLX-4720	TNIK	2500.0
Linifanib	PKAC-alpha	6900.0
Doramapimod	MK14	0.5
Sorafenib	DDR2	6.6
Ki20227	ABL2	950.0
BI-2536	MINK	1600.0
SB 203580	LCK	2800.0
Canertinib	HIPK4	1100.0
Doramapimod	BLK	680.0
PKC412	MET(Y1235D)	560.0
Nilotinib	KIT(V559D,T670I)	150.0
Fedratinib	KIT(V559D,V654A)	3500.0
Canertinib	LTK	5100.0
Dovitinib	FGFR3	230.0
Tozasertib	MELK	240.0
NVP-TAE684	MP2K3	170.0
Afatinib	EGFR(L747-S752del,P753S)	0.1
PLX-4720	ABL1-phosphorylated	2300.0
Doramapimod	KIT(V559D,V654A)	2400.0
Ruxolitinib	RSK4(Kin.Dom.1-N-terminal)	1400.0
Pictilisib	PIK3CA(M1043I)	4.5
Dasatinib	EGFR(G719S)	79.0
Imatinib	KIT(L576P)	14.0
Fedratinib	NEK11	1200.0
Linifanib	PLK3	8500.0
Dasatinib	MLTK	45.0
Sunitinib	LRRK2	110.0
Bosutinib	TNNI3K	170.0
Sorafenib	ABL1(T315I)-nonphosphorylated	590.0
NVP-TAE684	HIPK1	4400.0
PKC412	CHEK1	1300.0
Vandetanib	FLT3(D835H)	560.0
SNS-032	TAOK3	620.0
Bosutinib	DMPK	91.0
PKC412	PGFRB	110.0
Lestaurtinib	PIM1	200.0
Lestaurtinib	CDC2L5	1000.0
Pazopanib	ALK	2200.0
AC220	FLT3(N841I)	4.1
Ruxolitinib	AURKC	8700.0
Nintedanib	MYO3B	2700.0
Canertinib	EGFR(T790M)	0.1
Alvocidib	RIPK5	4200.0
Nilotinib	BLK	500.0
PHA-665752	RSK2(Kin.Dom.1-N-terminal)	9900.0
Ruxolitinib	HIPK3	1200.0
Dovitinib	FLT3(K663Q)	1.1
Fedratinib	ICK	1900.0
GSK 690693	MST4	5400.0
Alvocidib	EGFR(L858R,T790M)	750.0
Linifanib	MP2K5	1200.0
Tozasertib	EPHA3	1500.0
Pazopanib	MLK1	290.0
Lestaurtinib	SIK2	15.0
NVP-TAE684	LOK	82.0
KW2449	MYLK	740.0
PLX-4720	ABL1(Q252H)-nonphosphorylated	200.0
Fedratinib	NDR1	5800.0
KW2449	PKN2	880.0
BMS345541	CDK16	890.0
Nintedanib	CDK4-cyclinD1	160.0
Neratinib	MLK2	4600.0
Gefitinib	SIK2	2100.0
GSK 690693	ULK2	2300.0
Nilotinib	LOK	6800.0
Masitinib	BRAF(V600E)	1800.0
Neratinib	IRAK1	2300.0
Linifanib	RPS6KA5(Kin.Dom.1-N-terminal)	1200.0
GSK 690693	YSK4	33.0
PKC412	SYK	88.0
R406	FGR	33.0
Dasatinib	RET(M918T)	390.0
NVP-TAE684	CAMKK2	11.0
Fedratinib	YSK4	19.0
R406	YSK1	9200.0
Pictilisib	CSNK1D	1200.0
Lestaurtinib	MKNK1	56.0
PKC412	SIK3	98.0
Foretinib	EGFR	440.0
Fedratinib	EGFR(L747-E749del,A750P)	1500.0
Foretinib	MK09	670.0
Sunitinib	RSK4(Kin.Dom.1-N-terminal)	2400.0
Tozasertib	CDK16	230.0
Neratinib	BTK	160.0
KW2449	ACVR2B	370.0
Fedratinib	RPS6KA4(Kin.Dom.2-C-terminal)	140.0
PHA-665752	TAK1	5300.0
MLN8054	DRAK1	190.0
Crizotinib	FER	270.0
Sunitinib	MP2K4	700.0
Bosutinib	CHK2	120.0
Nilotinib	KIT(D816H)	540.0
Ruxolitinib	MAP3K3	150.0
Fedratinib	LATS2	8000.0
Dovitinib	MP2K5	32.0
GSK1838705A	CSNK1D	3500.0
Ki20227	SRC	2300.0
Ki20227	ABL1(E255K)-phosphorylated	1200.0
RAF 265	LYN	370.0
MLN8054	EPHA2	370.0
Vandetanib	EGFR(L858R)	8.7
Tozasertib	JAK3(JH1domain-catalytic)	630.0
PHA-665752	EPHB6	2900.0
Ruxolitinib	TBK1	1700.0
KW2449	FLT3(R834Q)	60.0
Foretinib	ABL1(F317I)-phosphorylated	250.0
R406	DCAMKL3	600.0
Ruxolitinib	ABL1-nonphosphorylated	3700.0
NVP-TAE684	ABL1(F317I)-phosphorylated	14.0
Nilotinib	LCK	47.0
Lestaurtinib	TNK2	6.6
GSK461364	LOK	69.0
Fedratinib	KGP1	3800.0
Dovitinib	AURKC	1100.0
PKC412	CAMK1G	1800.0
Neratinib	M3K12	370.0
Motesanib	KIT(D816H)	180.0
KW2449	FGFR3	1200.0
Tozasertib	TNK1	83.0
Dasatinib	EPHB4	0.34
GSK461364	PIP5K1C	6700.0
Bosutinib	FLT3(N841I)	3400.0
NVP-TAE684	IRAK1	45.0
Motesanib	EGFR(G719C)	2300.0
Sunitinib	RSK2(Kin.Dom.1-N-terminal)	580.0
Dovitinib	MINK	9.1
Bosutinib	TRKB	1200.0
Vandetanib	LOK	81.0
Lestaurtinib	NEK9	5400.0
Bosutinib	CSK	32.0
RAF 265	EPHA2	2900.0
R406	ADCK3	1100.0
Fedratinib	JNK1	260.0
Dasatinib	CSF1R	0.58
Ruxolitinib	LTK	440.0
Selumetinib	EGFR(L861Q)	8900.0
KW2449	SRPK1	55.0
Barasertib	STK36	4600.0
Pazopanib	FGFR1	990.0
Sunitinib	YES	120.0
NVP-TAE684	CLK1	12.0
Alvocidib	VRK2	63.0
NVP-TAE684	CDK7	190.0
PKC412	MLK3	17.0
Nintedanib	GRK1	1000.0
Alvocidib	PGFRA	5900.0
Ruxolitinib	RET(M918T)	630.0
R406	NEK11	170.0
SNS-032	KPCD1	1200.0
NVP-TAE684	TSSK1	25.0
KW2449	INSRR	420.0
AC220	EPHA3	6500.0
Lestaurtinib	FLT3	8.5
Tozasertib	MAP4K2	2600.0
Pictilisib	CAMK1G	6800.0
PKC412	SIK1	160.0
Tofacitinib	TYK2(JH1domain-catalytic)	4.8
RAF 265	MET(Y1235D)	1400.0
Erlotinib	TTK	3700.0
Erlotinib	EGFR(G719C)	0.9
Alvocidib	FLT3(N841I)	6500.0
NVP-TAE684	RIPK2	9600.0
GSK1838705A	FER	9.3
Fedratinib	RIPK2	6100.0
RAF 265	PRKR	950.0
RAF 265	RIPK1	5400.0
Foretinib	TNK1	21.0
Neratinib	MP2K1	14.0
GSK1838705A	CLK1	21.0
PKC412	TRKC	1700.0
Linifanib	ABL1(T315I)-nonphosphorylated	4400.0
AC220	KIT(A829P)	3.6
Gefitinib	EGFR(L858R)	0.9
R406	NIM1	660.0
KW2449	TYK2(JH1domain-catalytic)	160.0
KW2449	AMPK-alpha2	440.0
Dasatinib	FRK	0.31
Neratinib	TNIK	140.0
NVP-TAE684	EGFR	180.0
Gefitinib	ERBB2	3500.0
BI-2536	NEK2	2000.0
Tozasertib	CAMK1G	6500.0
R406	PIP5K2B	1200.0
Nilotinib	FRK	86.0
KW2449	ABL1(Q252H)-phosphorylated	22.0
Dovitinib	MST3	430.0
GSK1838705A	RIOK2	2000.0
Lestaurtinib	TRKB	14.0
PHA-665752	AXL	110.0
Tozasertib	EPHB2	5600.0
R406	KCC2D	3000.0
PKC412	AMPK-alpha1	180.0
Crizotinib	TIE1	110.0
SB 203580	PIP5K1C	2600.0
Foretinib	MELK	300.0
Dovitinib	MAP4K2	1900.0
GSK 690693	PIM3	750.0
Lestaurtinib	RPS6KA4(Kin.Dom.2-C-terminal)	1300.0
Sunitinib	PTK6	4600.0
R406	GRK7	2000.0
Sunitinib	FLT3(D835H)	4.3
Foretinib	SLK	3.0
Ruxolitinib	DYRK1A	910.0
Motesanib	FRK	99.0
AC220	MKNK2	2600.0
Nintedanib	SRPK1	37.0
PLX-4720	ABL1(Y253F)-phosphorylated	1900.0
Brivanib	MINK	310.0
Foretinib	CAMK1	5900.0
Fedratinib	PAK7	1200.0
Tofacitinib	PKN1	170.0
Vandetanib	KIT(A829P)	34.0
NVP-TAE684	AXL	12.0
Canertinib	CSK	6100.0
Erlotinib	EPHA8	940.0
Dasatinib	MAP4K2	1300.0
Motesanib	KIT(V559D,T670I)	13.0
Dovitinib	ABL1(M351T)-phosphorylated	48.0
Nilotinib	BRAF(V600E)	570.0
Fedratinib	CTK	1700.0
Nintedanib	FAK2	81.0
PKC412	KIT(V559D)	200.0
Ruxolitinib	CSNK2A1	4200.0
PD184352	CAMK2A	3400.0
KW2449	LRRK2(G2019S)	45.0
Foretinib	TXK	530.0
Lestaurtinib	CHEK1	2.8
GSK461364	ANKK1	6200.0
BI-2536	NEK3	720.0
Crizotinib	ANKK1	780.0
Pazopanib	KIT(L576P)	1.8
Neratinib	MST3	6.5
Vandetanib	EPHA4	1600.0
Sorafenib	PGFRB	37.0
Foretinib	NEK9	470.0
AC220	LOK	2100.0
R406	KPCD3	3900.0
Sunitinib	ULK3	42.0
Lestaurtinib	STK36	3800.0
Erlotinib	TNK1	630.0
Fedratinib	EPHB4	2100.0
Sunitinib	KPCD2	380.0
Nintedanib	M3K13	140.0
KW2449	STK39	890.0
MLN8054	ABL1(E255K)-phosphorylated	1900.0
GSK461364	CAMK2B	2900.0
MLN8054	PLK4	410.0
Crizotinib	SgK110	240.0
Sunitinib	RIPK4	2100.0
NVP-TAE684	CLK4	110.0
MLN8054	DDR1	4200.0
PLX-4720	KC1G2	4100.0
KW2449	MST1R	810.0
Crizotinib	CDC2L1	760.0
R406	IGF1R	1300.0
Foretinib	EGFR(L858R,T790M)	1800.0
SNS-032	PCTK2	13.0
Lestaurtinib	FGFR2	660.0
Nintedanib	ABL1(T315I)-phosphorylated	10.0
Sunitinib	DAPK3	22.0
Sunitinib	DCAMKL3	110.0
PKC412	MARK2	100.0
Barasertib	PLK4	4700.0
PLX-4720	FLT3(R834Q)	3000.0
Sunitinib	M3K2	57.0
GDC-0879	MP2K5	5100.0
Sunitinib	WEE1	1100.0
Fedratinib	CDK16	3100.0
Bosutinib	ABL1(H396P)-phosphorylated	0.06
Linifanib	EPHA6	330.0
Erlotinib	MK09	2000.0
Linifanib	MST4	8300.0
R406	TYRO3	1900.0
Enzastaurin	FLT3(D835H)	49.0
GSK461364	YSK4	2800.0
Lestaurtinib	RIPK2	640.0
Nintedanib	HIPK2	790.0
Alvocidib	ABL1(F317I)-phosphorylated	5900.0
R406	YANK1	2300.0
Foretinib	AURKB	43.0
GSK461364	MAP4K2	3200.0
Bosutinib	EGFR(G719C)	98.0
Lestaurtinib	MRCKA	9200.0
KW2449	FGFR1	370.0
SB 203580	EGFR(G719C)	710.0
Bosutinib	TXK	72.0
PHA-665752	STK33	840.0
Canertinib	DDR1	400.0
Sunitinib	KIT(V559D)	0.4
Dasatinib	EPHB3	6.9
Fedratinib	ABL1(H396P)-nonphosphorylated	45.0
Sunitinib	MUSK	490.0
PKC412	IKKE	160.0
BI-2536	DAPK1	540.0
PKC412	RSK1(Kin.Dom.1-N-terminal)	690.0
Linifanib	LOK	460.0
NVP-TAE684	CAMK2B	1900.0
Pazopanib	SRMS	2500.0
Neratinib	EGFR(E746-A750del)	2.3
Sunitinib	PCTK2	1200.0
Doramapimod	FRK	1200.0
Bosutinib	SYK	290.0
KW2449	SIK1	670.0
PKC412	TTK	350.0
Pictilisib	PIK3CA(E542K)	1.5
Lestaurtinib	EGFR	1100.0
Sorafenib	CIT	6200.0
Lestaurtinib	NEK7	4000.0
Dovitinib	PIP5K2B	260.0
GSK1838705A	GAK	270.0
Pazopanib	CDC2L1	2100.0
PLX-4720	PGFRA	190.0
Sorafenib	KIT(D816H)	430.0
Sunitinib	CAMK2A	80.0
Nintedanib	RPS6KA4(Kin.Dom.1-N-terminal)	620.0
Sunitinib	SBK1	200.0
R406	ERK8	640.0
KW2449	AAK1	48.0
RAF 265	ABL1(M351T)-phosphorylated	2000.0
Fedratinib	JAK1(JH2domain-pseudokinase)	2000.0
Afatinib	DRAK1	2300.0
NVP-TAE684	KIT(D816V)	26.0
Alvocidib	TYK2(JH2domain-pseudokinase)	35.0
Fedratinib	TSSK1	1300.0
Nilotinib	DDR2	33.0
Erlotinib	RET(M918T)	330.0
Lestaurtinib	EPHA1	380.0
Ki20227	MERTK	460.0
Linifanib	KIT(L576P)	1.9
Fedratinib	KIT(D816H)	160.0
KW2449	CDK4-cyclinD3	730.0
Dasatinib	PGFRB	0.63
Foretinib	ABL1(M351T)-phosphorylated	36.0
Pazopanib	BLK	2600.0
Crizotinib	INSR	340.0
Sorafenib	FGFR1	2800.0
Dasatinib	MST4	1900.0
Bosutinib	CLK1	600.0
Bosutinib	EGFR(L858R,T790M)	390.0
Fedratinib	LRRK2	870.0
GSK 690693	LATS2	140.0
Dovitinib	NEK9	9100.0
Crizotinib	AAK1	2300.0
Dovitinib	FGFR2	410.0
Sunitinib	NIM1	850.0
Foretinib	CDK9	1600.0
Vandetanib	ABL1(E255K)-phosphorylated	13.0
Dovitinib	CDK4-cyclinD1	1200.0
Gefitinib	CSNK1E	430.0
Neratinib	CSNK1E	290.0
Doramapimod	EPHA8	270.0
Alvocidib	ICK	0.7
Foretinib	HIPK3	43.0
R406	EGFR	300.0
KW2449	CSNK1E	630.0
KW2449	TNIK	28.0
KW2449	RET(M918T)	47.0
R406	SBK1	93.0
Canertinib	SRC	1100.0
NVP-TAE684	DAPK3	2200.0
Lestaurtinib	DAPK3	82.0
Sunitinib	MET	7200.0
NVP-TAE684	LATS2	2000.0
NVP-TAE684	ULK1	0.8
BMS345541	RSK1(Kin.Dom.2-C-terminal)	3300.0
Foretinib	S6K1	1200.0
Foretinib	FAK2	14.0
